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Abstract of the Dissertation 
Total Synthesis of Anthraquinone–Xanthone Natural Products 
 
and 
 
Intermolecular Alkenylation of Silyl Enol Ethers 
 
by 
Stephen Daniel Holmbo 
Doctor of Philosophy in Chemistry 
Unicersity of California, Irvine, 2019 
Professor Sergey V. Pronin, Chair 
 
 In Chapter One the isolation, biosynthesis, and bioactivity of the anthraquinone–
xanthone heterodimers is discussed. Additionally, a review of previous synthetic efforts 
towards this class of natural products is provided, along with reported syntheses of related 
anthraquinone- and xanthone-derived natural products. 
 Chapter Two discusses synthetic efforts towards the anthraquinone–xanthone 
heterodimer natural products. This includes model system studies aimed at the construction 
of the bicyclo[3.2.2]nonane core, as well as our first generation synthesis of the 
benzocycloheptenone precursor. Our optimized route involves the development of an 
iodine(III)-mediated arylation enol ethers, which allows for rapid construction of a key 
intermediate in the synthesis. A Hauser–Kraus annulation–aldol reaction sequence enables 
assembly of the bicyclo[3.2.2]nonane core, which is then carried on to complete the first total 
synthesis of acremoxanthone A in 10 steps from commercial material. 
xv 
 In Chapter Three an overview of previously reported methods for the alkenylation of 
ketones is provided, followed by the development of the intermolecular In(III)-catalyzed 
alkenylation of silyl enol ethers with alkynes. This reaction is demonstrated on a variety of 
cyclic and acyclic substrates to provide the corresponding 2-siloxy-1,4-dienes, via a formal 
ene reaction, or β,γ-unsaturated ketones. Additionally, mechanistic investigations are 
discussed, including a proposed mechanism for the intermolecular formal ene reaction.   
 
 
 
 
 
1 
Chapter 1: Anthraquinone–Xanthone Heterodimeric Natural Products 
1.1 Anthraquinone–Xanthone Heterodimers 
1.1.1 Introduction to and Isolation of the Anthraquinone–Xanthone Heterodimers 
 The anthraquinone–xanthone heterodimer natural products comprise a diverse 
range of aromatic polyketides, each containing a bicyclo[3.2.2]nonane ring system. The 
members of this class all contain a xanthone and anthraquinone moiety which are fused to 
form the central bicycle. Variation among the congeners of this class can occur on either the 
anthraquinone or xanthone fragment. Further variation can also arise depending on which 
end of the anthraquinone subunit is involved in the dimerization to form the core. While 
many congeners have been isolated, only a few attempts have been made towards 
synthesizing any natural products of this class. 
 
2 
 
Figure 1.1: Representative Examples of Anthraquinone–Xanthone Heterodimers. 
 The first members of this class to be isolated were the beticolins, which were isolated 
from Cercospora beticola; the causal agent of the sugar beet leaf spot disease.1 However, this 
initial isolation did not include a proposed structure. Instead the yellow compound that was 
isolated was referred to as C. beticola toxin (CBT).2 In 1992 Ducrot and coworkers isolated 
two isomers from CBT and called them beticolin 1 (1.15, Figure 1.2) and 2 (1.16).3 The initial 
3 
structure they proposed for beticolin 1 had the xanthone cyclized ortho to the chlorine 
substituent, however, this structure was later revised by the same group to the para-cyclized 
structure of beticolin 1 (1.15).4 Shortly after Ducrot’s initial publication another group also 
isolated two compounds from CBT, which they called cebetin A and cebetin B (1.17).5  The 
former was determined to be beticolin 1 (revised structure), while the latter was the stable 
dimagnesium dimer of beticolin 1. Continued investigations into the natural products 
produced by C. beticola has resulted in the discovery of twenty beticolins, which are 
designated b0–b19 based on their Rf values. Of these twenty compounds only eight have 
established structures.6,7 
 
Figure 1.2: Structures of Beticolin 1, Beticolin 2, and Cebetin B. 
 The xanthoquinodins are fungal metabolites that were first isolated in 1993 from 
Humicola sp. FO-888. 8 Unlike the beticolins, these heterodimers lack chlorination on the 
xanthone moiety, and result from dimerization on the other end of the anthraquinone 
fragment; placing the methyl substituent on the aromatic ring as opposed to the bridge of 
4 
the bicycle (cf. xanthoquinodin A2 (1.7)). Interestingly, it was found that upon heating in 
solution each xanthoquinodin can interconvert to the other congeners.9 The only exception 
to this is xanthoquinodin A3 (1.9, Figure 1.1) which is suspected to be unable to convert back 
to the other members due to its unique lactone ring. In 2013 five new xanthoquinodins (A4–
A6 and B4 and B5), along with three previously known xanthoquinodins (A1–A3), were 
isolated from Chaetomium elatum in a report which also compares their cytotoxicity.10  
 The next members of this class to be isolated were the acremonidins in 2003.11 From 
the fungal culture Acremonium sp. strain LL-Cyan 416 He and coworkers were able to isolate 
acremonidins A–E (cf. acremonidin A (1.1), Figure 1.1). The distinguishing structural 
characteristic of the acremonidins is that, unlike the other anthraquinone–xanthone 
heterodimers, the xanthone fragment is replaced with a benzophenone that has not 
undergone cyclization to the characteristic xanthone moiety. In 2009 the first two 
acremoxanthones (A1 (1.4) and A2(1.5), Figure 1.1) were isolated from the fungal strain 
Acremonium sp. BCC 31806.12 From the same strain the Isaka group also isolated 
acremonidins A and C. While the acremoxanthones are structurally very similar to the 
acremonidins, the acremoxanthones do contain the complete xanthone fragment instead of 
the benzophenone.  In 2016 three new acremonidins (F–H) were isolated from the insect 
fungus Verticillium sp. BCC33181, along with two new acremoxanthones (F and G).13 Along 
with the five new heterodimers, Pittayakhajonwut and coworkers also isolated 
acremonidins A and C as well as acremoxanthones A and B. 
 In 2010 a Japanese group isolated three new anthraquinone–xanthone heterodimers, 
JBIR-97(1.18, Figure 1.3), -98, and -99, from a culture of Tritirachium sp. SpB081112MEf2, 
a fungus derived from the marine sponge Pseudoceratina purpurea.14 Similar to the 
5 
beticolins, these natural products contain a methyl group on the bridge of the 
bicyclo[3.2.2]nonane system. While this report presented the general structure of JBIR-97, -
98, and -99, the relative configuration of any of the stereocenters was not determined. It was 
not until 2016, when Imhoff isolated JBIR-97–99 from the fungus Engyodontium album strain 
LF069 which was discovered on a marine sponge, that the relative stereochemistry of the 
JBIRs was finally determined.15 This report also included the isolation of six new 
anthraquinone–xanthone heterodimers, which were given the names engyodontochone A–
F. This report is the most recent discovery of new members of the anthroquinone–xanthone 
class of natural products. 
 
Figure 1.3: Representative Examples of the Engyodontochones and JBIR’s 
1.1.2 Biosynthesis of the Anthraquinone–Xanthone Heterodimers 
The biosynthesis of the anthraquinone–xanthone heterodimers involves the 
heterodimerization of two smaller polyketide subunits: the anthraquinone and the 
xanthone. As is the case with all aromatic polyketides, the biosynthesis of these subunits 
begins with a series of Claisen condensations of an acyl-CoA starter unit with malonyl-CoA 
extender units facilitated by polyketide synthases.16 This process results in the formation of 
octaketide 1.19 (Scheme 1.1); the precursor to chrysophanol 1.20. Chrysophanol itself is a 
common anthraquinone natural product, which is used as a defense compound in various 
6 
eukaryotic organisms such as: plants, lichens, fungi and insects.17 This anthraquinone then 
undergoes an oxidative cleavage to form benzophenone 1.21.18 At this stage the 
benzophenone can undergo a variety of transformations depending on the producing 
organism. The first possibility is that it can directly cyclize and decarboxylate to form 
xanthone 1.22. In another pathway, suggested by Krohn and coworkers, the benzophenone 
undergoes another oxidation prior to cyclization to produce dihydroxanthone 1.23, which 
can then be converted to 1.22 via a decarboxylation/elimination sequence. Finally, the 
tetrahydroxanthone (1.24) can be produced through an oxidation/cyclization/reduction 
sequence from the benzophenone.  
 At this stage the anthraquinone and xanthone subunits can undergo the 
heterodimerization in a variety of ways. One source of variation results from the end of the 
anthraquinone subunit that is involved in the coupling; this can be either the “head” or the 
“tail” as shown in Scheme 1.2.19 A “tail-to-tail” coupling results in a bicyclo[3.2.2]nonane core 
containing a methyl substituent on the alkene bridge; a motif seen in the JBIRs, 
engyodontochones, and beticolins (cf. JBIR-97 (1.18), Scheme 1.1). Alternatively, a “head-to-
Scheme 1.1: Anthraquinone and Xanthone Biosynthesis. 
7 
tail” coupling produces the bicyclic core found in the xanthoquinodins, acremoxanthones, 
and acremonidins (cf. xanthoquinodin A2 (1.7)).  Lastly the heterodimerization can occur at 
the para position, with respect to the phenol on the xanthone, instead of the ortho. This gives 
rise to the para- and ortho-isomers observed for many members of this class of natural 
products.  
 It is also possible for variation in the xanthone moiety of the heterodimers to occur 
after the heterodimerization of the anthraquinone and xanthone. This was first 
demonstrated for the xanthoquinodins, when Ōmura and coworkers took isolated samples 
of the xanthoquinodins and heated them in methanol.20 They found that each 
xanthoquinodin could be converted to almost any of the other congeners (Figure 1.4), except 
for xanthoquinodin A3 (1.9) and B3 (1.28) where the formation of the lactone removes those 
compounds from the equilibrium. While it is not a very common motif among the 
Scheme 1.2: Anthraquinone–Xanthone Heterodimerization Examples. 
8 
anthraquinone xanthone heterodimers, similar lactones are observed in various families of 
xanthone-containing natural products. A similar isomerization was found by Ducrot and 
coworkers for the beticolins, however, in this case the isomerization was conducted under 
mildly basic conditions.21 In this study the authors determined that the para-isomers were 
preferred under basic conditions, and further suggest that the ortho-isomers are formed 
Figure 1.4: (A) Equilibrium of the Xanthoquinodins. (B) Interconversion by Heating. (C) Conversion of 
Xanthoquinodin A1 to A3.   
9 
initially in the heterodimerization and subsequently converted to the more stable para-
isomers. 
1.1.3 Selected Bioactivity of Various Anthraquinone–Xanthone Heterodimers 
 A wide variety of bioactivity has been reported among the various members of the 
anthraquinone xanthone heterodimers. The xanthoquinodins, one of the first classes to be 
isolated, was shown to exhibit anticoccidial activity in 1993.22 Xanthoquinodin A1–A3 and 
B1–B2 all shown inhibition of schizont maturation in BHK-21 cells with a minimum effective 
concentration of 0.02 μg/mL. Additionally, cytotoxicity was observed at concentrations 
higher than 2.0 μg/mL for A1 and A3 and B1–B2, and at concentrations higher than 0.2 
μg/mL for xanthoquinodin A2. This indicates that xanthoquinodin A2 is the most cytotoxic 
of the xanthoquinodins tested. Xanthoquinodin A1 has also been shown to have cytotoxicity 
against human tumor cell lines HL-60 (leukemia, IC50 = 6.22 μM), SMMC-7721 
(hepatocellular carcinoma, IC50 = 8.00 μM), A-549 (lung, IC50 = 3.33 μM), MCF-7 (breast 
cancer, IC50 = 14.16 μM), and SW480 (colon cancer, IC50 = 28.82 μM).23  
  The acremonidins have been shown to display moderate antimicrobial activity 
against Gram-positive bacteria, with the most potent congener being acremonidin A (1.1, 
Figure 1.5). In a 2003 report He and coworkers examine the effect of altering the benzylic 
acetate and find improvement when the acetate is replaced with either the isobutyrate 
Figure 1.5: Representative Examples of MIC Values for Acremonidin A and Derivatives.  
10 
(1.31) or the pentanoate (1.32). Interestingly, both analogues performed better in the MIC 
assays than acremonidin A itself.   
 Of the anthraquinone–xanthone heterodimers the beticolins have perhaps the most 
intriguing biological properties. They are also the most studied of the heterodimers as the 
fungus that produces the beticolins, Cercospora beticola Sacc., is responsible for 
Cercosporiose; the leaf spot disease of sugar beets.24 It was shown that beticolin 1 (1.15) and 
the dimagnesium dimer of beticolin 1 (1.17), at the time referred to as cebetins A and B, 
could kill sugar beet cells at a concentration as low as 1 ppm.25 Interestingly, this effect was 
not observed in the absence of light indicating that the beticolins are photoactivated 
phytotoxins.  Additionally, an earlier report by Schlӧsser showed that CBT, which at the time 
was an unknown mixture of beticolins, has both antibiotic and phytotoxic activity.26  
Many of the studies of the biological properties of the beticolins has focused on their 
effect on cell membranes. It was shown that CBT had a harmful effect on K+ uptake, H+ 
extrusion, K+-activated ATPase, and transmembrane polarization of various plant tissues.27 
In another study on the inhibitory effect of beticolin 1 on corn-root-derived plant plasma 
membranes, H+-ATPase was suggested to be the target.28 It was also found that this 
inhibitory effect was not observed on the purified form of the enzyme, suggesting that 
beticolin 1 interacts only with the membrane bound form of the enzyme. The authors further 
suggest that the interaction occurs at the membrane bound, hydrophobic portion of the 
enzyme. This interaction between the beticolins and cell membranes prompted further 
studies on the topic. In one of these studies it was found that the dimagnesium dimer of the 
beticolins is the dominant form at physiological pH.29 Moreover, it was shown by Thibaud 
and coworkers that in the presence of magnesium ions beticolin 0 could assemble into 
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multimeric, nonspecific transmembrane channels through lipid bilayers.30 The authors 
demonstrated that membrane conductance increased in the presence of beticolin 0, and that 
this effect was only observed in the presence of magnesium ions. These nonselective 
channels were permeable to Cl-, K+, Na+, and Ca2+ ions, which can have a deleterious effect on 
intercellular processes. 
1.2 Synthetic efforts towards the Anthraquinone–Xanthone Heterodimers  
1.2.1 Duffault’s Method for the Synthesis of bicyclo[3.2.2]nonanes  
 While there are no previous syntheses of any of the anthraquinone–xanthone 
heterodimers, there have been several synthetic studies aimed at this class of natural 
products. The earliest report is a methodology by Duffault and coworkers that investigated 
the construction of the bicylco[3.2.2]nonane core found in the heterodimers (Scheme 1.3).31  
Their strategy involved reduction of aryl iodide 1.33 to generate the aryl radical that could 
then cyclize to form the desired bicyclo[3.2.2]nonane 1.34. In order to achieve the desired 
bicycle the radical would have to undergo a 7-endo-trig cyclization, whereas a 6-exo-trig 
cyclization would lead to the undesired bicyclo[3.3.1]nonane 1.35. In all substrates 
examined, the authors observed preferential 7-endo-trig cyclization. The origin of the 
selectivity is likely due the electronically biased nature of the alkene, where the aryl radical 
adds to the electron deficient beta position of the α,β-unsaturated ketone. They also 
observed increased yields and a higher degree of selectivity when a methylene was in the 
Scheme 1.3: Duffault’s Bicyclo[3.2.2]nonane Construction. 
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benzylic position opposed to a ketone. While the authors succeed in constructing the desired 
bicycle, they make no attempt to preform the radical 7-endo-trig cyclization on a more 
complex substrate. 
1.2.2 Bräse’s Synthetic Efforts Towards the Beticolins. 
 In Bräse’s studies towards the beticolins he aimed to disconnect the 
bicyclo[3.2.2]nonane core in a similar fashion to Duffault, however, instead of a radical 
cyclization their aim is to use an intramolecular Heck coupling to make the final carbon-
carbon bond of the bicycle (Scheme 1.4).32 To prepare their precursor for the Heck 
cyclization they first converted naphthol 1.37 to aryl aldehyde 1.38 through a benzylation, 
reduction, and oxidation sequence. Grignard addition of 1,1-diiodobenze into the aryl 
aldehyde, followed by demethylation and a series of oxidations, produced naphthoquinone 
Scheme 1.4: Bräse’s Synthetic Efforts Towards the Beticolins. 
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140. Finally, Diels–Alder addition with diene 1.41 yielded the ABC ring system of beticolin 0 
(1.13) as a mixture of diastereomers. While the authors successfully constructed the Heck 
cyclization precursor, they give no examples of attempted Heck reactions to construct the 
bicycle.  
1.2.3 Suzuki’s Synthetic Study Towards Acremoxanthone A 
 Suzuki takes a similar approach to Duffault and Bräse for the construction of the 
bicycle in his synthetic studies towards the anthraquinone–xanthone herterodimers; 
however, he also successfully constructs the functionalized core along with the ABC ring 
system of acremoxanthone A (Schem 1.5).33 Their sequence begins with the alkylation of β-
diketone 1.47, a known compound prepared in one step, followed by elimination to yield 
cyclohexanone 1.49.34 Dihydroxylation followed by ketalization gives cyclohexanone 1.50 
which can then be dehydrogenated to generate enone 1.51. At this stage the authors attempt 
both radical and cross coupling condition for the bicycle formation. While they did not have 
success with Duffault’s radical cyclization conditions, they found that the intramolecular 
Heck reaction afforded the desired 7-endo cyclization product (1.52) in 68% yield, with only 
17% of the undesired 6-exo product (not shown). They then converted the cyclic ketone to 
olefin 1.53 in two steps, followed by hydrolysis of the ketal and subsequent formation of 
cyclic sulfate 1.54. Elimination of the sulfate and acidification gave alcohol 1.55, which was 
then converted to the iodide in two steps. Next, bridgehead lithiation could be achieved with 
three equivalents of tBuLi and subsequent addition to aryl aldehyde 1.60 proceeded in 80% 
yield. Oxime 1.56 was then prepared via oxidation and deallylation as a 1.7 to 1 mixture of Z 
and E isomers respectively. Finally, oxidative conditions generated the nitrile oxide that then 
underwent the 1,3-dipolar cycloaddition to give isoxazoline 1.45 in either 80 or 44% yield 
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depending on the isomer used. This work culminated in the first successful synthesis of the 
ABCDE ring system of acremoxanthone A. This report is also the most recent synthetic study 
towards this class of natural products, and at the time there was yet to be any completed 
syntheses of a member of the anthraquinone–xanthone natural products. 
  
Scheme 1.5: (A) Suzuki’s Retrosynthetic Analysis. (B) Construction of the ABCDE Ring System of Acremoxanthone A. (C) 
Synthesis of Benzaldehyde 1.60. 
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1.3 Total Synthesis of Anthraquinone-Derived Natural Products  
1.3.1 Suzuki’s Total Synthesis of (–)-Euxanmodin B 
 While there are no other reported syntheses or synthetic efforts towards the 
anthraquinone–xanthone heterodimers, there are other natural products resulting from a 
heterodimerization between an anthraquinone and xanthone subunit that do not contain the 
bicyclo[3.2.2]nonane core; some of which have been prepared via total synthesis. One such 
example of a biaryl anthraquinone–xanthone heterodimer is the natural products known as  
euxanmodin B.35 Suzuki and coworkers reported the first total synthesis of (–)-euxanmodin 
Scheme 1.6: Suzuki’s Synthesis of  (–)-Euxanmodin B. 
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B (1.71, Scheme 1.6). Their strategy entailed an enzyme-catalyzed hydrolysis to set the axial 
chirality of the biaryl linkage and generate 1.62.36 This was then taken on through a three-
step sequence involving TBS protection, deallylation/acetylation, and aryl iodination to 
produce 1.63 which, after a series of protecting group manipulation, provided access to aryl 
iodide 1.64. This was then subjected to lithium-halogen exchange, followed by addition to 
benzocyclobutanone 1.65 to generate 1.66 as an inseparable mixture of isomers. After 
deprotection and oxidation to access benzaldehyde 1.67, subsequent Grignard addition of 
aryl iodide 1.68 generated 1.69. Upon heating in mesitylene the cyclobutanone undergoes 
an electrocyclic ring-opening/electrocyclization sequence to form the 
dihydronaphthoquinone (not shown) which is oxidized to the naphthoquinone upon 
prolonged exposure to air furnishing the anthraquinone. Subsequent IBX oxidation afforded 
benzophenone 1.70. Finally, deprotection of the MOM groups, followed by a SNAr cyclization 
to construct the xanthone moiety, and a global demethylation yielded (–)-euxanmodin B 
(1.71). Suzuki’s synthesis highlights some common strategies for the construction of both 
anthraquinones and xanthones.  
1.3.2 Nicolaou’s Total Synthesis of (+)-Rugulosin 
 Some of the most structurally complex anthraquinone dimers are the 
bisanthraquinone natural products, which are derived from biaryl anthraquinone dimers 
that have undergone additional cyclizations to form intriguing caged structures as seen in 
rugulosin (1.81, Scheme 1.7). Nicolaou reported the first total synthesis of (+)-rugulosin, 
alongside (+)-2,2’-epi-cytoskyrin, by utilizing an elegant cascade from simple anthraquinone 
monomers.37 For the synthesis of the monomers the authors first constructed 
cyanophthalide 1.75 and cyclohexanone 1.79, which when subjected to a Hauser–Kraus 
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annulation afforded dihydronaphthoquinone 1.80 in high yield. When subjected to MnO2 
followed by Et3N dihydronaphthoquinone 1.80 underwent the “cytoskyrin cascade” to 
generate the complete caged core of the natural product in a single step. Thus, after 
subsequent removal of the MOM protecting group, the first total synthesis of (+)-rugulosin, 
as well as (+)-2,2’-epi-cytoskyrin through an analogous sequence, in ten steps.  
 
This impressive cascade, which is now referred to as the “cytoskyrin cascade”, was 
studied by Nicolaou and coworkers prior to the completion (+)-rugulosin and has resulted 
in the following proposed mechanism shown in Scheme 1.8. The cascade begins with 
oxidation of dihydronaphthoquinone 1.80 to naphthoquinone 1.82. Subsequent 
tautomerization generates dienol 1.83 which can then undergo a formal [4+2] cycloaddition 
that is believed to be the result of a Michael/oxa-Michael sequence to form 1.84. With the 
addition of excess magnesium dioxide, the ether linkage can be cleaved to generate 
Scheme 1.7: Nicolaou’s Total Synthesis of (+)-Rugulosin. 
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bisquinone 1.87 which, after prolonged heating, undergoes the final two Michael additions 
to complete the caged core of (+)-rugulosin. 
 
1.4 Total Synthesis of Xanthone-Derived Natural Products  
1.4.1 Barton’s Synthesis of Bikaverin 
 Bikaverin was initially isolated by in Nakamura in 1957.38 Following this initial 
report, several studies found a range of interesting biological properties associated with this 
xanthone derived natural product.39 In 1976 Barton and coworkers reported the total 
synthesis of bikaverin, which is one of the earliest total syntheses of a xanthone natural 
Scheme 1.8: Proposed Mechanism of the “Cytoskyrin Cascade”. 
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product.40 Their synthesis began with benzaldehyde 1.88 which was condensed with 
acetonitrile and hydrogenated to generate 1.89. This was then used to acylate orcinol (1.90), 
followed by formation of the chromene ring to form 1.92. Subsequent methylation of the 
phenol, followed by the two-step conversion of the ethyl ester to the acid chloride, and lastly 
Friedel–Crafts cyclization afforded the xanthone ring (1.93). Finally, oxidation followed by 
demethylation yielded bikaverin (1.94).  
Scheme 1.9: Barton’s Synthesis of Bikaverin. 
 
1.4.2 Hosokawa’s Synthesis of Nidulalin A 
 The dihydroxanthone nidulalin A was first isolated by Kawai in 1994 and was later 
found to have potent antitumor activity.41 In 2009 the first total synthesis of this natural 
product was reported by Hosokawa and coworkers.42 Benzophenone 1.97, prepared in two 
steps from diester 1.95, was subjected to protecting group removal, dearomative cyclization, 
and conjugate reduction to generate tricycle 1.98. Reduction followed by demethylation of 
the enol ether in hydrochloric provided the enone (not shown) which was reduced to form 
the allylic alcohol 1.99. Finally, silylation and selenium dioxide oxidation provided racemic 
nidulalin A, which could then be resolved via esterification with (–)-camphanic acid to access 
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both enantiomers. While this route isn’t asymmetric, thus requiring a resolution, it does 
enable construction of the dihydroxanthone fragment with a high degree of 
diastereoselectivity. 
Scheme 1.10: Hosokawa’s Synthesis of Nidulalin A. 
 
 
1.4.3 Nicolaou’s Synthesis of Blennolide C 
 The blennolides are perhaps the most well studied class of tetrahydroxanthone 
natural products, and various research groups have developed strategies to access these 
structures. The first reported synthesis of belnnolide C (1.109, Scheme 1.12) was reported 
in 2008 by Nicolaou and Li, alongside the synthesis of diversonol.43 His synthesis began with 
racemic cyclohexenone 1.101, which was converted to nitrile 1.102 in two steps. A series of 
functional group manipulations provided β-keto ester 1.104 and subsequent bromination 
and reduction yielded alcohol 1.105. Deprotonation of 1.105 followed by lithium-halogen 
exchange and addition to acyl cyanide 1.106 afforded ketone 1.107 after subsequent 
oxidation. Lastly, desilylation and deallylation afforded blennolide C as the minior 
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diastereomer. In the same report Nicolaou also utilized this strategy in the synthesis of 
diversonol.  
 
1.4.4 Tietze’s Synthesis of (–)-Blennolide C 
 Tietze achieved the first enantioselective total synthesis of (–)-blennolide C, as well 
as (–)-gonytolide (1.122, Scheme 1.12), in 2014.44 Beginning with benzaldehyde 1.110, 
which is made in two steps from commercial material, a five-step sequence provided alkene 
1.112. Next, a carbonylative Wacker annulation generated ester 1.113 which could be 
converted to 1.114 in three steps. A diastereoselective dihydroxylation generated diol 1.115 
which was subjected to TBS protection, selective deprotection, and an oxidation to generate 
aldehyde 1.116. Next, a five-step sequence of functional group manipulations provided 
diester 1.118, which was then converted to chromanone 1.119 in three steps. A Dieckmann 
condensation of 1.119 followed by sequential demethylation and desilylation furnished (–)-
blennolide C (1.109). Alternatively, chromanone 1.119 can be desilylated, with 
simultaneous cyclization, to lactone 1.121 followed by demethylation to yield (–)-gonytolide 
Scheme 1.11: Nicolaou’s Synthesis of Blennolide C. 
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(1.122). With this divergent strategy Tietze was able to complete the first asymmetric total 
synthesis of both (–)-blennolide C (1.109) and (–)-gonytolide (1.122). 
Scheme 1.12: Tietze’s Enantioselective Total Synthesis of (–)-Blennolide C and (–)-Gonytolide. 
 
1.4.5 Porco’s Synthesis of Blennolide C 
 In 2014 Porco demonstrates yet another strategy for the construction of 
tetrahydoxanthones in his racemic synthesis of blennolides C and B.45 Starting with ketone 
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1.123, chromone 1.124 is prepared via condensation with dimethyl oxalate. The chromone 
is then converted to the activated siloxybenzopyrylium species with diisopropylsilyl 
ditriflate. Subsequent treatment with 2-trimethylsiloxyfuran, and lastly desilylation, affords 
chromone butanolides 1.126 and 1.127 as a 2:1 mixture. Interestingly, at –78 ˚C the authors 
observe a 20:1 diastereoselectivity favoring 1.127.  Finally, hydrogenation and Dieckmann 
cyclization of the major diastereomer affords blennolide C. While racemic, Porco’s strategy 
allows for rabid assembly of tetrahydroxanthone structures. 
Scheme 1.13: Porco’s Racemic Synthesis of Blennolide C.  
 
 
1.4.6 Porco’s Synthesis of (+) and (–) Rugulotrosin A 
 In 2015 Porco demonstrated the utility of his concise approach to 
tetrahydroxanthones in his synthesis of the dimeric natural product rugulotrosin A (1.133, 
Scheme 1.14).46 After the initial addition of 2-trimethylsiloxyfuran to the activated 
siloxybenzopyrylium species, and subsequent hydrogenation, the authors can perform the 
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Dieckmann cyclization to access tetrahydrofuran 1.130 in only three steps from commercial 
material. Subsequent methylation of the enol and aryl iodination is followed by kinetic 
acylative resolution using HBTM to generate carbonate 1.131 in 46% yield with 99% e.e. 
following recrystallization. When subjected to a Suzuki dimerization, biaryl dimer 1.132 is 
produced in a 27% yield, whereas only 9% of the other atropisomer is formed. Finally, 
deprotection with acid produced (+)-rugulotrosin A (1.133). In an effort to rationalize the 
observed atropselectivity the authors modelled the lowest-energy structures of the diaryl 
Pd(II) intermediate. They find that the three lowest-energy conformers all have a dihedral 
angle (between the phenol bearing carbons of the monomers) that would lead to the 
formation of the naturally occurring atropisomer following stereospecific reductive 
elimination.  
Scheme 1.14: Proco’s Atropselective Synthesis of (+)-Rugulotrosin A.   
 
1.4.7 Porco’s Synthesis of (+)-Gonytolide A 
 In 2018 Porco and coworkers reported the synthesis of the xanthone homodimer 
natural product (+)-gonytolide A (1.137, Scheme 1.15).47 Unlike (+)-rugulotrosin A, (+)-
gonytolide A is a para-para linked dimer consisting of two chromone ester monomers. Initial 
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addition of 2-trimethylsiloxyfuran to the activated siloxybenzopyrylium species, followed by 
desilylation, provides racemic chromanone butenolide 1.134. Asymmetric conjugate 
reduction provides access to (+)-1.135, which can then be recrystallized with of overall yield 
of 38% and 97:3 er. Prior to the oxidative dimerization, (+)-1.135 is brominated to generate 
bromide (+)-1.136. This aryl bromide serves as a blocking group to allow for the selective 
para-para dimerization. Finally, the oxidative coupling is achieved via vanadium(V) 
oxytrifluoride to provide a mixture of (+)-gonytolide A (1.137) and the unnatural 
atropisomer (–)-atrop-gonytolide A after subsequent hydrogenation. While attempts to 
isomerize (–)-atrop-gonytolide A to the natural atropisomer were unsuccessful, this 
approach still provides access to (+)-gonytolide A (1.137) in only five steps from 
chromanone ester 1.124.  
Scheme 1.15: Porco’s Synthesis of (+)-Gonytolide A. 
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Prangé, T.; Neuman, A.; Milat, M.-L.; Blein, J.-P. Acta Crystallogr., B 1995, B51, 308. (e) Milat, 
M.-L.; Blein, J.-P. J. Chromatogr., A 1995, 699, 277. (f) Goudet, C.; Benitah, J.-P.; Milat, M.-L.; 
Sentenac, H.; Thibaud, J.-B. Biophys. J. 1999, 77, 3052. (g) Ducrot, P.-H.; Einhorn, J.; Kerhoas, 
L.; Lallemand, J.-Y.; Milat, M.-L.; Blein, J.-P.; Neuman, A.; Prangé, T. Tetrahedron Lett. 1996, 
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Chapter 2: A Concise Approach to the Anthraquinone–Xanthone 
Heterodimers 
2.1 Model System Studies Towards the Bicyclo[3.2.2]nonane Core 
2.1.1 Conjugate Propargylation Approach 
 At the beginning of our synthetic efforts towards the anthraquinone–xanthone 
heterodimers we initially sought to determine how to construct the bicyclo[3.2.2]nonane 
core using a simplified model system. Thus, our initial target was pentacycle 2.1 (Scheme 
2.1A). Our retrosynthetic analysis involved a late-stage alkenylation to install the alkene 
bridge of the bicycle from tetracycle 2.2. The seven-membered ring would be constructed 
through a Dieckmann cyclization from ester 2.3, which we imagined arising via Negishi 
coupling with a Reformatsky reagent.  
Scheme 2.1: (A) Retrosynthetic Analysis of the Bicyclo[3.2.2]nonane Core. (B) Unsuccessful Conjugate Propargylation. 
 
 The first step in the synthesis began with an aldol condensation/isomerization of 
tetralone 2.5 and benzaldehyde 2.6 to from naphthol 2.7 (Scheme 2.1B). This naphthol could 
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then be oxidized using [bis(trifluoroacetoxy)iodo]benzene (PIFA) to form the desired 
naphthoquinone 2.8. Inspired by work developed by Haruta and coworkers, we planned to 
use allenylstannane 2.12 to effect the conjugate propargylation.1 While we did not expect a 
high degree of regioselectivity for the desired conjugate addition products (2.4), we hoped 
to find a procedure that would allow us to procure enough material to explore the 
subsequent bicycle construction. Therefore, we prepared allenylstannane 2.122 and 
subjected it to Haruta’s conjugate propargylation conditions with naphthoquinone 2.8. 
However, instead of forming the expected 1,4-addition products, we observed only a mixture 
the of 1,2-addition products 2.9 and 2.10. While we explored various Lewis acids for this 
reaction, such as TiCl4, BF3·OEt2, and EtAlCl2, we only observed the undesired 1,2-addition 
products. 
2.1.2 Enolate Propargylation Approach 
 Due to the failed conjugate propargylation, we changed our approach for the 
synthesis of the Dieckmann cyclization precursor (Scheme 2.2A). We imagined ketal 2.13 
would be more accessible and allow us to explore conditions for the Negishi coupling. 
Beginning with naphthol 2.7, an oxidative ketalization with PIFA afforded enone 2.14. While 
standard hydrogenation conditions using hydrogen and palladium on carbon proved 
ineffective for the subsequent reduction, Magnus’ Mn(III) conjugate reduction conditions 
provided ketone 2.15 in good yield.3 Finally, enolate propargylation provided access to aryl 
bromide 2.13; the precursor for the Negishi coupling. Unfortunately, attempted coupling 
with Reformatsky reagent 2.18 proved unsuccessful. Further attempts at performing the 
Negishi coupling on previous intermediates in the sequence were also unproductive 
(Scheme 2.2C). When enone 2.14 was subjected to the coupling conditions, ester 2.19 was 
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formed as the sole product. In the case of naphthol 2.7, the major product was the result of 
an apparent Ullmann coupling. 
Scheme 2.2: (A) Revised Retrosynthetic Analysis. (B) Synthesis of Ketal 2.13. (C) Attempted Negishi Couplings. 
 
2.1.3 Construction of the Cycloheptanone 
 Considering the difficulties associated with the Negishi coupling, we altered our 
approach such that the benzylic ester would be incorporated into the starting material 
(Scheme 2.3A). Thus, beginning with naphthol 2.24, oxidative ketalization yielded enone 
2.25. Next, treatment of isochromanone 2.26 with TMSBr in EtOH yielded benzylic bromide 
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2.27. Using a procedure developed by Knochel we were able to convert 2.27 into the 
organocopper species 2.28 which could be used in a conjugate addition onto enone 2.25.4 
This allowed us to finally explore the Dieckmann cyclization of 2.23. Using tBuOK in tBuOH 
we could affect the desired cyclization to access 2.29. While several oxidation conditions 
failed to reform the enone, a low yielding phenylselenation/oxidative elimination sequence 
allowed us to generate 2.30 which existed as the enol tautomer. Attempts to generate the 
silyl enol ether prior the conjugate propargylation resulted in deprotection to reform the 
quinone (2.31). Based on previous attempts to propargylate quinone species (vide supra) we 
knew that this would not be a viable substrate for the conjugate propargylation.  
Scheme 2.3: (A) Revised Retrosynthetic Analysis. (B) Synthesis of the Cycloheptanone Core. 
 
 
 Our next approach entailed performing the conjugate propargylation prior to the 
Dieckmann cyclization (Scheme 2.4). We began with the same conjugate addition reported 
32 
 
by Knochel,4 however, instead of carrying out the acidic workup to isolate the ketone we 
isolated the intermediate silyl enol ether 2.32 and subjected it to a Saegusa oxidation to 
access enone 2.34. Using allenylstannane 2.12 we attempted the conjugate propargylation, 
which again yielded only 1,2-addition product (2.35). Due to the preference for 1,2-addition, 
we decided to first perform an allylation of enone 2.34 to generate 2.36 for use in a 
subsequent oxy-Cope. Unfortunately, when we subjected 2.36 to anionic oxy-Cope 
conditions we observed only decomposition of the starting material. Alternatively, when we 
attempted a thermal oxy-Cope we saw either no reaction at 160 ˚C in mesitylene or 
deallylation at 180 ˚C in 1,2-dichlorobenzene to produce enone 2.34.  
Scheme 2.4: Attempted Conjugate Propargylation of 2.34 and Attempted Oxy-Cope of 2.36. 
 
 Due to the difficulty performing the oxy-Cope on the system containing the ketal, we 
decided to attempt the same transformation on the corresponding quinone (Scheme 2.5). 
Conjugate addition of organocopper species 2.28 onto naphthoquinone 2.38 yielded 
naphthoquinone 2.39 after subsequent aerobic oxidation which occurs on silica gel during 
isolation. We found that the allylation and oxy-Cope could be achieved in the same step to 
yield ketone 2.40 in good yield. Attempts to perform a Dieckmann cyclization on 2.40 proved 
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unsuccessful. In all cases we observed either no reaction or formation of the undesired aldol 
product 2.41. In an attempt to circumvent the undesired cyclization, we first prepared silyl 
enol ether 2.42 and treated it with tris(dimethylamino)sulfonium difluorotrimethylsilicate 
(TASF). Unfortunately, this yielded 2.43 and 2.44 which both result from the undesired aldol 
annulations.   
Scheme 2.5: Allylation/Oxy-Cope Sequence of Naphthoquinone 2.39, and Unsuccessful Dieckmann Cyclizations. 
 
2.1.4 Alternatives to the Dieckmann Cyclization 
 Due to the difficulties in performing the Dieckmann cyclization on the functionalized 
diketone, we began exploring alternative methods for installing the seven-membered ring. 
Our next approach was inspired by a report from Lee and coworkers in which a terminal 
alkyne 2.45 (Scheme 2.6A) could be treated with rhodium to produce rhodium vinylidene 
2.46 that is converted to ketene 2.47 via oxygen transfer from an N-oxide.5 This ketene can 
then be trapped with a nucleophile. While the report exclusively utilizes heteroatom 
nucleophiles, we anticipated a silyl enol ether may also be a suitable nucleophile.  
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Scheme 2.6: (A) Lee’s Rhodium-Catalyzed Oxygenative Addition to Terminal Alkynes. (B) Synthesis of Silyl Enol Ether 2.53 
and Attempted Cyclization. 
 
 To prepare a precursor for the rhodium-catalyzed oxygenative cyclization we began 
with the conjugate addition of benzylic organocopper species 2.49 into enone 2.25 (Scheme 
2.6B). Instead of isolating the ketal, we hydrolyzed it in situ to isolate quinone 2.50 after 
subsequent oxidation on silica gel. Allylation followed by oxy-Cope then provided aryl iodide 
2.51, which was subjected to a Sonogashira coupling with trimethylsilylacetylene followed 
by desilylation to provide alkyne 2.52. Finally, silyl enol ether formation provided the 
desired cyclization precursor 2.53. Unfortunately, none of the conditions employed afforded 
cyclized product 2.55.  
 To prepare the ketene through a different means we also attempted the Sonogashira 
coupling with tert-butyl ethynyl ether (Scheme 2.7). This would allow us to access the ketene 
via a retro-ene of the tert-butyl ethynyl ether moiety. However, under the coupling 
conditions we only observed products resulting from an intramolecular Heck coupling (2.56 
35 
 
and 2.57). Our final attempt for the construction of the cycloheptanone was a gold-catalyzed 
cyclization onto the terminal alkyne in 2.52. However, when alkyne 2.52 was treated with 
AuCl3 and AgOTf we observed formation 2.58, which arises from a 6-exo-dig cyclization of 
2.52 and subsequent isomerization. Employing IPrAuCl and AgSbF6 in the cyclization had no 
effect on the regioselectivity, and instead generated the 6-exo-dig cyclization product 2.59. 
At this point in our synthetic studies we decided to leave the model system and begin work 
towards the natural product. While we were unable to construct the bicyclo[3.2.2]nonane 
core, the model system did give us a better understanding of the challenges presented by 
such a scaffold.  
Scheme 2.7: Alternative Attempts to Construct the Cycloheptanone. 
 
2.2 Concise Synthesis of the Anthraquinone-Xanthone Core  
2.2.1 Construction of the Benzocycloheptenone  
 Although our synthetic studies on the model system did not allow us to explore 
methods for assembly of the bicyclo[3.2.2]nonane core, they did allow us to determine that 
the formation of the seven-membered ring should not be a convergent point in our synthesis. 
As a result, we revised our retrosynthetic analysis such that construction of the 
benzocycloheptenone preceded formation of the anthraquinone moiety (Scheme 2.8). 
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Furthermore, we chose acremonidin A (2.60), the simplest member of the anthraquinone–
xanthone heterodimers, as the initial target of our synthesis. Our retrosynthetic analysis 
involved a late-stage installation of the benzophenone fragment via aryl bromide 2.61. We 
envisioned the alkene bridge of the bicyclo[3.2.2]nonane core arising from an intramolecular 
aldol/elimination sequence of tetracycle 2.62. Lastly, we planned to prepare the 
anthraquinone via either a Hauser–Kraus annulation between phthalide 2.64 and 
benzocycloheptenone 2.63 or a Diels–Alder using the corresponding siloxyisobenzofuran 
derived from phthalide 2.64. This strategy would allow us to construct the seven-membered 
ring on a simplified system, avoiding the undesired reactivity observed in the model system. 
Scheme 2.8: Retrosynthetic Analysis of Acremonidin A. 
 
 Our initial strategy to construct the benzocycloheptanone was inspired by a method 
reported by Zhang and coworkers.6 In this report, the authors generate N-
alkenoxypyridinium species (2.66, Scheme 2.9A) from terminal alkynes via Au(I) catalysis. 
These intermediates can then react in an SN2’ manner with the aromatic ring to form 
benzene-fused cyclic ketones (2.67). With this reaction in mind, we set out to synthesize a 
terminal alkyne with the desired functionality (Scheme 2.9B). Sulfonation of alkyl bromide 
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2.68, followed by propargylation, yielded sulfone 2.70. This intermediate was then 
benzylated with benzyl bromide 2.71 to generate our desired alkyne (2.72). When subjected 
to Zhang’s conditions we observed rapid formation of 2.73 (Scheme 2.9C), which arises from 
Au(I)-catalyzed cyclization and subsequent elimination of the sulfone. This cyclization 
occurs rapidly, preceding formation of the desired N-alkenoxypyridinium intermediate. This 
is likely a consequence of the highly electron-rich aromatic ring necessary for the 
construction of the anthraquinone-xanthone heterodimers. Indeed, similarly electron-rich 
aromatic rings are not employed in Zhang’s report. While the desired reaction proved 
unsuitable on our substrate, it led us to the realization that if we could access styrene 2.74 
an oxidative ring expansion could provide the desired benzocycloheptanone. However, 
subjection of alkyne 2.72 to (Ph3P)AuCl and AgOTf in DCE produced only 2.73.  
Scheme 2.9: (A) Zhang’s Method for the Synthesis of Benzocycloheptanones. (B) Synthesis of Cyclization Precursor 2.72. 
(C) Formation of Undesired Cyclization Product 2.73. 
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 Construction of the desired styrene (2.79, Scheme 2.10) began with sulfonation of 
bromide 2.68 followed by allylation to provide sulfone 2.75. The requisite benzyl bromide 
2.81 was prepared via a reduction, aryl iodination, and Appel reaction sequence applied to 
benzoic acid 2.80. Benzylation of sulfone 2.75 with 2.81 produced aryl iodide 2.78, which 
was cyclized via an intramolecular Heck coupling to afford the desired styrene (2.79). 
Scheme 2.10: Synthesis of Styrene 2.79. 
 
 The first report of an oxidative ring expansion from an exocyclic styrene to a 
benzocycloheptanone was reported by Taylor in 1977 using thallium(III) nitrate.7 When 
styrene 2.79  was subjected to Taylor’s ring expansion conditions, we observed formation of 
the desired benzocycloheptanone in 29% yield (Scheme 2.11). The mechanism is proposed 
to proceed via initial thallation of the styrene to generate benzylic cation 2.82. After the 
addition of methanol to form 2.83, a semipinacol rearrangement then yields 
Scheme 1.11: Mechanism of the Oxidative Ring Expansion. 
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benzocycloheptanone 2.84. The low yield observed for the oxidative ring expansion of 2.79 
is due in part to the formation of the corresponding naphthalene (cf. 2.73, Scheme 2.9) via 
sulfone elimination and isomerization of the styrene.  
 The final elimination of the sulfone to form the desired benzocycloheptenone (2.63, 
Scheme 2.12) was performed using DBU. While the enone isomer was expected to be the 
major product of the elimination, we found that using DBU yielded exclusively styrene 2.85. 
This distinction was determined via NOESY NMR analysis; however, initially styrene 2.85 
was incorrectly assigned as benzocycloheptenone 2.63. Consequently, styrene 2.85 was 
carried on to the convergent step in the synthesis (vide infra). 
Scheme 2.12: Sulfone Elimination to Generate the Benzocycloheptenone.  
 
2.2.2 Diels–Alder Approach to the Anthraquinone 
 Our initial approach to install the anthraquinone moiety of the anthraquinone–
xanthone heterodimers involved a Diels–Alder cycloaddition between siloxyisobenzofuran 
2.86 and enone 2.63 (Scheme 2.13A). One advantage of this approach is that the endo 
product of the cycloaddition would generate the desired diastereomer of tetracycle 2.62 
after hydrolysis. Synthesis of phthalide 2.87 began with formylation of aryl bromide 2.88 
followed by reduction to benzylic alcohol 2.90 (Scheme 2.13B). Directed lithiation followed 
by addition of the aryl lithium to carbon dioxide and subsequent treatment with acid 
furnished phthalide 2.87. While there are several reports entailing the synthesis and 
isolation of the related siloxyisobenzofurans, attempts to generate the desired 
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siloxyisobenzofuran (2.86) were unsuccessful.8 We initially attributed this to the hydrolytic 
instability of the siloxyisobenzofuran during aqueous workup. However, while monitoring 
the formation of 2.86 by trapping with dimethyl acetylenedicarboxylate (DMAD), it was 
determined that siloxyisobenzofuran 2.86 was unstable at room temperature (Scheme 
2.13C). Since the planned Diels–Alder reaction was expected to require elevated 
temperatures due to the steric congestion of the dieneophile,8b the use of 
siloxyisobenzofuran 2.86 was not feasible for the construction of the anthraquinone.  
Scheme 2.13: (A) Diels–Alder Approach to Tetracycle 2.62. (B) Synthesis of Phthalide 2.87. (C) Monitoring the Conversion 
of Siloxyisobenzofuran Formation by Trapping with DMAD. 
 
2.2.3 Hauser–Kraus Approach to the Anthraquinone 
 The Hauser–Kraus annulation is a well-known method for the construction of 
anthraquinones.9 We planned to utilize this type of annulation to construct tetracycle 2.92 
from benzocycloheptenone 2.63 and cyanophthalide 2.93 (Scheme 2.14A). While 
cyanophthalide 2.93 is a known compound, its reported synthesis is lengthy.10 
Consequently, we devised a new route to access this material (Scheme 2.14B). From 
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benzaldehyde 2.89 we utilized Comins’ method for directed ortho lithiation.11 The 
intermediate aryl lithium was subsequently trapped with carbon dioxide followed by and 
acidic workup to form hydroxyphthalide 2.94. Conversion to cyanophthalide 2.93 was 
accomplished with potassium cyanide followed by acidification. We determined that 
benzaldehyde 2.89 could also be converted to the desired cyanophthalide in a single step 
with the same overall yield; providing a convenient approach to access 2.93. 
Scheme 2.14: (A) Hauser–Kraus Approach to Tetracycle 2.92. (B) Synthesis of Cyanophthalide 2.93.  
 
 With both cyanophthalide 2.93 and benzocycloheptenone 2.85 (Scheme 2.12) in 
hand, we began exploring the Hauser–Kraus annulation. It should be noted that while 
initially testing the Hauser–Kraus annulation, styrene 2.85 was misassigned as enone 2.63 
(Scheme 2.14A) due to the similarities in their 1H NMR spectra. Consequently, styrene 2.85 
was subjected to the annulation with cyanophthalide 2.93 (Scheme 2.15). While no reaction 
was observed at the cryogenic temperatures used for the lithiation of the phthalide, we were 
fortunate to find that at elevated temperatures the desired tetracycle (2.95) was formed in 
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67% yield.12 This indicates that at elevated temperatures styrene 2.85 can isomerize to 
enone 2.63 and subsequently undergo the Hauser–Kraus annulation. A variety of conditions 
were then explored for the hydrolysis of acetal 2.95. It was found that the strongly acidic 
conditions required for hydrolysis also facilitated the desired aldol cyclization, generating 
pentacycle 2.96 in 65% yield.13 
Scheme 2.15: Hauser–Kraus Annulation and Subsequent Transannular Aldol. Yields Determined by NMR.  
 
2.2.4 Second Generation Approach to Pentacycle 2.96 
 While the above route was effective for the construction of the bicyclic core of the 
anthraquinone–xanthone heterodimers, the lengthy synthesis of benzocycloheptenone 2.85, 
along with the low yield and side product formation associated with the thallium-mediated 
ring expansion, warranted development of a more concise approach. To this end, we 
prepared enol ether 2.99 via sequential lithiation-alkylation sequences from sulfone 2.69 
(Scheme 2.16). With the enol ether in hand we were able to explore conditions for the 
desired oxidative cyclization. It was determined that using PIFA in hexafluoroisopropanol 
afforded the desired benzocycloheptanone. Upon treatment with aqueous base, the sulfone 
could be eliminated in the same step to afford benzocycloheptenones 2.85 and 2.63 as a four 
to one mixture respectively. This mixture could then be directly subjected to the Hauser–
Kraus annulation with cyanophthalide 2.93. Additionally, the subsequent hydrolysis and 
transannular aldol could be conducted in the same pot with the addition of concentrated 
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hydrochloric acid in alcoholic solvent. This optimized route allowed us the access pentacycle 
2.96 in just four steps from commercially available material.  
Scheme 2.16: Second Generation Synthesis of Pentacycle 2.96. 
 
 
2.2.5 Iodine(III)-Mediated Arylation of Enol Ethers 
 While there are reports of related oxidative arylations using 1,3-dicarbonyl 
compounds, the conversion of 2.99 to 2.84 represents the first iodine(III)-mediated 
arylation of an enol ether.14 Consequently, we set out to examine the scope of this reaction 
(Table 2.1). As is the case with previously reported iodine(III)-mediated arylations, the use 
of non-nucleophilic solvents with strong hydrogen bond donor ability, such as 
hexafluoroisopropanol (HFIP), was vital to the success of the reaction. Furthermore, both 
(diacetoxyiodo)benzene (PIDA) and PIFA could be employed with varying success 
depending on the substrate used. 
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 We found that this reaction performed well with a range of electron rich aromatic 
systems (e.g. 2.100 and 2.101); however, less electron rich systems gave lower yields of the 
desired benzocycloheptanones. In the case of ketone 2.102, when the corresponding enol 
ether substrate was subjected to the reaction conditions using PIDA it resulted in a one to 
two mixture of desired ketone 2.102 and the corresponding α-acyloxyketone. Furthermore, 
PIFA, a more reactive iodine(III) reagent with less nucleophilic ligands, still afforded a two 
to one mixture of 2.102 and the α-trifluoroacetoxyketone. Although the scope of the 
oxidative cyclization is limited to electron rich aromatic systems, this method provides a 
complementary approach to benzocycloheptanones that cannot be accessed using 
previously reported methods.6 This oxidative cyclization could also be employed in the 
synthesis of benzannulated heterocycles 2.103 and 2.104, and was effective in the 
construction of eight-membered rings such as 2.105.  
Table 2.1: Scope of the Iodine(III)-Mediated Arylation of Enol Ethers.  
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 While the reaction performed well on the methoxy-substituted arenes shown in Table 
2.1, other arenes exhibited a preference for α-acyloxyketone formation (Scheme 2.17). For 
example, 1,3-benzodioxole derivative 2.106 formed products 2.107a and 2.107b 
preferentially regardless of whether PIDA of PIFA were used in the reaction. Likewise, 
naphthalene derivative 2.109 produced α-trifluoroacetoxyketone 2.110 as the sole product 
of the reaction.  
Scheme 2.17: Unsuccessful Arylation Substrates. 
 
 In an attempt to expand the scope of the iodine(III)-mediated arylation, we began 
exploring the cyclization of silyl enol ether 2.111. Unlike the MOM enol ethers, silyl enol 
ethers undergo facile hydrolysis to the corresponding ketone in HFIP. However, PIDA and 
PIFA are not sufficiently activating to conduct the oxidative cyclization in solvents such as 
DCM. To access an iodine(III) reagent with a more electron-deficient iodine center we 
prepared the cationic (bis)pyridinium iodine(III) reagent 2.113. Such cationic hypervalent 
Scheme 2.18: Oxidative Arylation of Silyl Enol Ether 2.111. 
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iodine compounds have been shown to be more reactive than PIDA or PIFA.15 When silyl enol 
ether 2.111 was combined with 2.113 in DCM we did observe formation of the cyclized 
product in low yield; however, this was accompanied by several side products. 
2.2.6 Completing the Core  
 With pentacycle 2.96 in hand, we continued progression to the core of acremonidin 
A (2.60, Scheme 2.19). Only two transformations remained to access the core: elimination of 
the secondary alcohol to form the alkene bridge of the bicycle and reduction of the benzylic 
ketone to generate the final stereocenter in the natural product. While a variety of 
elimination conditions failed to generate the alkene bridge, such as activating the alcohol via 
triflation or under Appel conditions, Chugaev elimination provided alkene 2.114 in 56% 
yield over two steps. The necessity for this elimination to proceed via an Ei mechanism is 
likely due to the rigidity of the bicycle, which precludes the antiperiplanar arrangement 
necessary for an E2 reaction. Additionally, this elimination could be performed in a single 
step using thiocarbonyldiimidazole.  
Scheme 2.19: Elimination of the Secondary Alcohol in 2.96. 
 
 Reduction of the benzylic ketone in 2.114 is complicated by the presence of the 1,3-
diketone. Additionally, it was unclear if we would be able to perform the reduction 
diastereoselectively. At cryogenic temperatures NaBH4 could be employed to reduce only the 
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intended ketone in high yield and diastereoselectivity; however, the diastereomer obtained 
was shown to be undesired benzylic alcohol 2.115 (Scheme 2.20). Analysis of the X-ray 
crystal structure of 2.115 showed that the alkene bridge of the bicycle is in-plane with the 
ring that originally contained the ketone prior to reduction. Additionally, this indicates that 
the adjacent benzylic methylene is perpendicular to the ketone in 2.114. Such 
conformational analysis rationalizes formation of the observed diastereomer. We found that 
sodium dithionite could also be employed to access 2.115 in high yield and diaselectivity.16   
Scheme 2.20: Reduction of 2.114, and X-Ray Crystal Structure of 2.115.  
 
 Attempts to correct the stereochemistry of alcohol 2.115 via a Mitsunobu reaction 
were unsuccessful. In all attempts, only starting material was recovered from the reaction 
mixture. Alternatively, ionizing the benzylic alcohol and traping with various acids proved 
effective in generating the desired stereochemistry (Scheme 2.21). It was determined that 
trapping the benzylic cation with acetic acid, isobutyric acid, or pivalic acid provided the 
corresponding benzylic ester with increasing diastereoselectivity. Specifically, formation of 
the pivalate proceeded with a d.r. of 14:1 favoring the desired diastereomer. This strategy 
was ultimately shown to be unproductive as the resulting benzylic ester is not stable to the 
demethylation conditions required to access the natural product. For example, when 
pivalate 2.118 was subjected to BBr3 the benzylic ester was displaced, generating bromide 
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2.119.17 While unsuccessful, these studies demonstrated that ionization of the benzylic 
alcohol, and subsequent trapping with an acid, was an effective means to access the desired 
stereochemistry. As such, we planned to utilize this reactivity later in the sequence.   
2.2.7 Completing the Synthesis of Acremoxanthone A 
 Our initial strategy to install the benzophenone entailed lithium-halogen exchange of 
aryl bromide 2.115 and addition of the resulting aryllithium to anhydride 2.122 (Scheme 
Scheme 2.21: Correcting the Stereochemistry of Benzylic Alcohol 2.116.  
Scheme 2.22: Unsuccessful Approach to Benzophenone 2.123. 
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2.22).18 While the major product from these reactions was protodehalogenated 2.115, we 
never observed addition of the aryllithium to anhydride 2.122. We attributed this to the 
steric encumbrance of the aryllithium species generated from 2.115.  
 Our second approach for the installation of the benzophenone was to perform a 
carbonylative Stille coupling of aryl bromide 2.115. To this end, aryl stannane 2.126 was 
prepared via directed lithiation and stannylation of benzoic acid 2.124 followed by 
methylation to provide 2.126 (Scheme 2.23A).19 Subsequent attempts to achieve a catalytic 
carbonylative Stille coupling were unsuccessful. Utilization of conditions that have been 
shown to significantly increase the rate of oxidative addition to the aryl bromide, such as 
employing Ph3As or (2-furyl)3P as ligands, for example, also failed to produce benzophenone 
2.128 (Scheme 2.23B).20 In an attempt to understand the feasibility of performing an 
oxidative addition on such an electron-rich and sterically encumbered aryl bromide, 
Scheme 2.23: (A) Synthesis of Aryl Stannane 2.126. (B) Carbonylative Stille Coupling of Aryl Bromide 2.125. 
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stoichiometric quantities of Pd(PPh3)4 were combined with 2.115 in DMA and the reaction 
was progressively heated. At 140 ˚C we observed complete consumption of the aryl bromide 
and formation of arylpalladium species 2.127. Once formed, aryl palladium 2.127 could be 
successfully employed in the carbonylative coupling with stannane 2.126 to generate 
benzophenone 2.128 in 62% yield.  
 With the benzophenone installed we began investigating the ionization of the 
secondary alcohol to access the desired diastereomer. We found that the conditions 
previously employed for the ionization (cf. Scheme 2.21) resulted in decomposition of 2.128. 
To allow for a more facile ionization the benzylic alcohol was displaced with PBr3. Following 
formation of the benzylic bromide, BBr3 could be added to the reaction mixture to achieve 
the demethylation in the same step. However, at –20 ˚C the desired pentaphenol 2.129 was 
not formed. Instead, monomethylated 2.130 was the major product of the demethylation 
(Scheme 2.24). Additionally, benzophenone 2.130 could not be isolated due to its instability 
on silica gel. Increasing the temperature of the reaction with BBr3, or including TBAI as an 
additive, resulted in significant decomposition. Additionally, employing BI3 or AlI3 resulted 
Scheme 2.24: Demethylation of Benzophenone 2.126.  
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in decomposition at cryogenic temperatures. Alternatively, conditions such as PhSH/AlCl3, 
TMSI, BCl3, EtBBr2, or BrB(cat) resulted in various ratios of partially demethylated material. 
As we were unable to access the fully demethylated benzophenone 2.129, which is necessary 
for the synthesis of acremonidin A (2.60, Scheme 2.19), we chose instead to apply this 
approach to acremoxanthone A (2.131). In this context, the presence of the remaining aryl 
methyl ether is advantageous as it could allow for selective formation of the desired 
xanthone. 21  
 With the benzylic bromide installed, the ionization and subsequent trapping with 
acetic acid proceeded smoothly in HFIP to provide acetate 2.132 in greater than 10:1 d.r. 
Finally, xanthone formation, following the procedure reported by Suzuki, afforded 
acremoxanthone A (2.131) in 20% yield over three steps.21 This completed the first total 
synthesis of acremoxanthone A with a longest linear sequence of ten steps.22  
Scheme 2.25: Completing the Synthesis of Acremoxanthone A. 
 
2.3 Conclusion and Outlook 
 This synthesis represents the first total synthesis of any member of the 
anthraquinone–xanthone heterodimers. Future work on this project is aimed at accessing 
other members of the anthraquinone–xanthone heterodimers via this strategy. Along these 
lines we also plan to develop an asymmetric approach to this class of natural products. 
Specifically, developing an asymmetric Hauser-Kraus annulation would provide access to a 
single enantiomer of the bicyclo[3.2.2]nonane core, thus requiring minimal modification to 
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the current strategy (Scheme 2.26A). We anticipate that sulfinamide 2.133 could be 
employed to this end, and the synthesis of this substrate is currently underway.  
 Along with developing an asymmetric synthesis, we also plan to evaluate the 
bioactivity of the of these natural products and their derivatives. With the completion of the 
synthesis of acremoxanthone A, we were able to begin these studies (Scheme 2.26B).23 
Starting with acremoxanthone A, we were able to access analogs 2.134 and 2.135 for 
comparison of their antibiotic activity. While pentanoate derivative 2.135 proved less active 
than acremoxanthone A towards the inhibition of the bacterial strains examined, free alcohol 
2.134 displayed increased activity. We plan on conducting similar analyses as we construct 
the other congeners of the anthraquinone–xanthone heterodimers.  
 
Figure 2.1: (A) Planned Asymmetric Approach to the Heterodimers. (B) MIC Values of Acremoxanthone A and Analogs.  
2.4 Experimental Section 
2.4.1 General Experimental Details 
 All reactions were carried out in flame-dried glassware under positive pressure of dry 
nitrogen unless otherwise noted. Reaction solvents including tetrahydrofuran (THF, Fisher, 
HPLC Grade), dichloromethane (DCM, Fisher, HPLC Grade), and toluene (Fisher, HPLC 
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Grade) were dried by percolation through a column packed with neutral alumina and a 
column packed with a supported copper catalyst for scavenging oxygen (Q5) under positive 
pressure of argon. Hexamethylphosphoramide (HMPA, Oakwood Chemical) was distilled 
from calcium hydride (10% w/v) under vacuum (ca. 0.5 torr) before use. 1,1,1,3,3,3- 
Hexafluoroisopropanol was purchased from Chem-Impex and used as received. Solvents for 
extraction, thin layer chromatography (TLC), and flash column chromatography were 
purchased from Fisher (ACS Grade) and VWR (ACS Grade) and used without further 
purification. Chloroform-d for 1H and 13C NMR analysis were purchased from Cambridge 
Isotope Laboratories and used without further purification. Commercially available reagents 
were used without further purification unless otherwise noted. Reactions were monitored 
by thin layer chromatography (TLC) using precoated silica gel plates (EMD Chemicals, Silica 
gel 60 F254). Flash column chromatography was performed over silica gel (Acros Organics, 
60 Å, particle size 0.04-0.063 mm). 1H NMR and 13C NMR spectra were recorded on Bruker 
DRX-500 (cryoprobe), and Bruker AVANCE600 (cryoprobe) spectrometers using residual 
solvent peaks as internal standards (CHCl3 @ 7.26 ppm 1H NMR, 77.16 ppm 13C NMR). High-
resolution mass spectra (HRMS) were recorded on Waters LCT Premier TOF spectrometer 
with ESI source. 
2.4.2 Experimental Procedures 
 
Phenol 2.7: Tetralone 2.5 (730 mg, 5 mmol) and benzaldehyde 2.6 (925 mg, 5 mmol) were 
combined in a solution of tBuOK (1.12 g, 10 mmol) in tBuOH (75 mL) and heated to reflux 
for 23 h. The reaction mixture was then acidified with aqueous HCl (1 M) and concentrated 
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under reduced pressure to remove tBuOH. The reaction mixture was then extracted ethyl 
acetate, washed with water and brine, dried over anhydrous sodium sulfate, and 
concentrated under reduced pressure. Purification by flash chromatography (gradient 
elution with 5-10% v/v ethyl acetate in hexanes) afforded phenol 2.7 (1.06 g, 68% yield). Rf 
= 0.38 (10% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3): δ 8.19 – 8.13 (m, 1H), 
7.86 – 7.80 (m, 1H), 7.63 (dd, J = 7.9, 1.4 Hz, 1H), 7.54 – 7.48 (m, 2H), 7.46 (d, J = 8.4 Hz, 1H), 
7.25 (d, J = 8.5 Hz, 1H), 7.21 (td, J = 7.5, 1.4 Hz, 1H), 7.15 – 7.07 (m, 2H), 5.36 (s, 1H), 4.27 (s, 
2H). 
 
Quinone 2.8: A solution of [bis(trifluoroacetoxy)iodo]benzene (2.6 g, 6 mmol) in DMF/water 
(2:1, 15 mL) was added to a solution of phenol 2.7 (930 mg, 3 mmol) in DMF/water (2:1, 15 
mL) at room temperature. The reaction mixture was stirred for 5 h and diluted with ethyl 
acetate (50 mL). The organic layer was separated and washed successively with water (three 
times, 75 mL combined) then brine. The resulting solution was dried over anhydrous sodium 
sulfate and concentrated under reduced pressure. Purification by flash chromatography 
(gradient elution with 5-10% v/v ethyl acetate in hexanes) afforded quinone 2.8 (981 mg, 
70 %). Rf = 0.40 (10% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3): δ 8.16 – 8.10 
(m, 1H), 8.06 – 8.00 (m, 1H), 7.76 – 7.69 (m, 2H), 7.62 – 7.56 (m, 1H), 7.33 – 7.25 (m, 2H), 
7.16 (ddd, J = 8.8, 6.3, 2.9 Hz, 1H), 6.41 (s, 1H), 4.05 (d, J = 1.8 Hz, 2H). 
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Alcohols 2.9 and 2.10: To a solution of quinone 2.8 (32.6 mg, 0.1 mmol) in DCM (1 mL) was 
added tributyltin allene 2.122 (45 μL, 0.15 mmol) at –78 ˚C, followed by the addition of a 
solution of TiCl4 in DCM (0.12 mL, 1 M). The reaction mixture was stirred at this temperature 
for 1 h and quenched with aqueous HCl (0.5 M). The resulting biphasic mixture was diluted 
with DCM (10 mL), washed with water and brine, dried over anhydrous sodium sulfate, and 
concentrated under reduced pressure. Purification by flash chromatography (gradient 
elution with 5-20% v/v ethyl acetate in hexanes) afforded alcohol 2.9 (19.5 mg, 53%) and 
2.10 (2.9 mg, 8%). Alcohol 2.9 (contains tributyltin derived imputities): Rf = 0.32 (30% v/v 
ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3) δ 8.03 (dd, J = 7.8, 1.4 Hz, 1H), 7.84 (dd, 
J = 7.9, 1.2 Hz, 1H), 7.64 (td, J = 7.6, 1.5 Hz, 1H), 7.59 (dd, J = 8.0, 1.2 Hz, 1H), 7.46 (td, J = 7.5, 
1.2 Hz, 1H), 7.30 (m, 2H), 7.17 (td, J = 7.6, 2.0 Hz, 1H), 5.80 (d, J = 1.8 Hz, 1H), 4.17 (dd, J = 
17.9, 1.6 Hz, 1H), 3.82 (dd, J = 17.9, 2.0 Hz, 1H), 3.07 – 2.92 (m, 2H), 2.73 (bs, 1H), 1.90 (t, J = 
2.6 Hz, 1H). Alcohol 2.10 (contains tributyltin derived imputities): Rf = 0.35 (30% v/v ethyl 
acetate in hexanes); 1H NMR (500 MHz, CDCl3) δ 8.14 (dd, J = 7.9, 1.4 Hz, 1H), 7.75 (dd, J = 
7.8, 1.2 Hz, 1H), 7.63 (td, J = 7.6, 1.4 Hz, 1H), 7.58 (dd, J = 8.0, 1.3 Hz, 1H), 7.48 (td, J = 7.6, 1.2 
Hz, 1H), 7.34 – 7.27 (m, 2H), 7.12 (td, J = 7.7, 1.8 Hz, 1H), 6.56 (t, J = 1.6 Hz, 1H), 3.97 (dd, J = 
16.5, 1.6 Hz, 1H), 3.89 (dd, J = 16.4, 1.5 Hz, 1H), 2.83 (dd, J = 16.4, 2.7 Hz, 1H), 2.70 (dd, J = 
16.4, 2.7 Hz, 1H), 2.37 (d, J = 42.5 Hz, 1H), 1.93 (t, J = 2.7 Hz, 1H). 
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Ketal 2.14: A solution of phenol 2.7 (313 mg, 1 mmol) in MeCN (3 mL) was added to a 
solution of [bis(trifluoroacetoxy)iodo]benzene (1 g, 2.7 mmol) in ethylene glycol (3 mL) and 
MeCN (4 mL) at 0 ˚C. The reaction mixture was stirred at this temperature for 2 h and 
quenched with saturated aqueous NaHCO3. The biphasic mixture was then diluted with ethyl 
acetate (20 mL), washed with water and brine, dried over anhydrous sodium sulfate, and 
concentrated under reduced pressure. Purification by flash chromatography (gradient 
elution with 5-20% v/v ethyl acetate in hexanes) afforded ketal 2.14 (211 mg, 57%). Rf = 
0.42 (30% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3) δ 8.09 (d, J = 7.8 Hz, 1H), 
7.63 – 7.55 (m, 3H), 7.49 (ddd, J = 8.4, 6.7, 2.0 Hz, 1H), 7.31 – 7.26 (m, 2H), 7.12 (ddd, J = 7.8, 
7.0, 2.1 Hz, 1H), 6.34 (t, J = 1.6 Hz, 1H), 4.33 – 4.27 (m, 2H), 4.19 – 4.13 (m, 2H), 3.90 (d, J = 
1.5 Hz, 2H). 
 
Ketone 2.15: To a solution of ketal 2.14 (121 mg, 0.32 mmol) and Mn(dpm)3 (12 mg, 19 
μmol, 6 mol %) in iPrOH (1 mL) and DCM (0.5 mL) was added PhSiH3 (52 μL, 0.42 mmol) at 
room temperature. The reaction mixture was stirred for 3 h then diluted with ethyl acetate. 
Silica gel was added, and the reaction was concentrated under reduced pressure. Purification 
by flash chromatography (gradient elution with 5-30% v/v ethyl acetate in hexanes) 
afforded ketone 2.15 (109.5 mg, 92%). Rf = 0.63 (30% v/v ethyl acetate in hexanes); 1H NMR 
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(500 MHz, CDCl3) δ 8.06 (dd, J = 7.8, 1.4 Hz, 1H), 7.63 – 7.53 (m, 3H), 7.50 – 7.46 (m, 1H), 7.31 
– 7.26 (m, 2H), 7.10 (td, J = 7.7, 2.0 Hz, 1H), 4.29 – 4.24 (m, 1H), 4.14 – 4.09 (m, 1H), 4.09 – 
4.03 (m, 1H), 3.97 – 3.91 (m, 1H), 3.73 (dd, J = 14.1, 4.8 Hz, 1H), 3.46 – 3.36 (m, 1H), 2.82 (dd, 
J = 14.1, 9.2 Hz, 1H), 2.24 – 2.12 (m, 2H). 
 
Ketone 2.13: To a solution of LDA in THF (0.5 mL, 0.25 M) at –78 ˚C was added ketone 2.15 
(37.4 mg, 0.1 mmol) as a solution in THF (0.5 mL). The reaction mixture was stirred at this 
temperature for 1 h, followed by the addition of propargyl bromide 2.11 (29 μL, 0.3 mmol). 
The resulting mixture was warmed to room temperature and stirred for 16 h, then quenched 
with saturated aqueous NH4Cl, diluted with ethyl acetate (15 mL), washed with water, brine, 
dried over anhydrous sodium sulfate, and concentrated under reduced pressure. 
Purification by flash chromatography (gradient elution with 5-10% v/v ethyl acetate in 
hexanes) afforded ketone 2.13 (14.1 mg, 34%). Rf = 0.20 (10% v/v ethyl acetate in hexanes); 
1H NMR (500 MHz, CDCl3) δ 8.04 (dd, J = 7.8, 1.4 Hz, 1H), 7.60 (td, J = 7.5, 1.4 Hz, 1H), 7.54 
(dd, J = 7.8, 1.4 Hz, 1H), 7.51 – 7.43 (m, 2H), 7.23 (dd, J = 7.8, 1.8 Hz, 1H), 7.12 (td, J = 7.5, 1.3 
Hz, 1H), 7.00 (td, J = 7.6, 1.8 Hz, 1H), 4.26 – 4.18 (m, 4H), 3.60 (d, J = 14.0 Hz, 1H), 3.45 (d, J = 
14.0 Hz, 1H), 2.88 (dd, J = 16.8, 2.7 Hz, 1H), 2.73 (d, J = 14.5 Hz, 1H), 2.63 (dd, J = 16.9, 2.7 Hz, 
1H), 2.24 (d, J = 14.5 Hz, 1H), 2.17 (t, J = 2.6 Hz, 1H). 
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Ester 2.19. To a solution of [BrPd(P(tBu)3)2 (0.5 mg, 1.25 μmol) and ketone 2.14 (18.6 mg, 
50 μmol) in THF (0.1 mL) was added a solution of organozinc 2.1824 in THF (300 μL, 0.15 
mmol, 0.5 M) at room temperature. The reaction mixture was stirred for 1 h then quenched 
with aqueous HCl (1 M), diluted with ethyl acetate, washed with water, brine dried over 
anhydrous sodium sulfate, and concentrated under reduced pressure. Purification by flash 
chromatography (gradient elution with 5-20% v/v ethyl acetate in hexanes) afforded ester 
2.19 (15 mg, 72%). %). Rf = 0.35 (30% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, 
CDCl3) δ 8.05 (d, J = 7.7 Hz, 1H), 7.76 (d, J = 7.9 Hz, 1H), 7.64 – 7.56 (m, 2H), 7.45 (t, J = 7.6 Hz, 
1H), 7.33 – 7.26 (m, 2H), 7.17 (td, J = 7.6, 2.0 Hz, 1H), 5.68 (s, 1H), 4.39 (s, 1H), 4.18 (dd, J = 
18.3, 1.7 Hz, 1H), 4.00 (q, J = 7.1 Hz, 2H), 3.90 (dd, J = 18.3, 2.0 Hz, 1H), 3.19 (d, J = 14.7 Hz, 
1H), 2.86 (d, J = 14.7 Hz, 1H), 1.06 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 183.93, 
170.67, 162.67, 146.33, 136.50, 133.27, 132.84, 132.30, 130.29, 129.01, 128.41, 127.97, 
126.81, 126.45, 125.52, 125.33, 72.18, 61.35, 47.62, 37.83, 13.93. 
 
Arene 2.20. To a solution of phenol 2.7 (15.7 mg, 50 μmol) and Pd(PtBu3)2 (1.3 mg, 2.5 μmol) 
in DMA (0.3 mL) was added organozinc 2.1825 in THF (195 μL, 0.15 mmol, 0.77 M) at room 
temperature. The reaction mixture was then heated to 60 ˚C for 3 h, then stirred at room 
temperature for 36 h, then heated to 65 ˚C for 3 h at which point starting material was 
consumed by TLC. The reaction mixture was then cooled to room temperature, quenched 
with aqueous HCl (1 M), diluted with ethylacetate, washed with water, brine dried over 
anhydrous sodium sulfate, and concentrated under reduced pressure. Purification by flash 
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chromatography (gradient elution with 2-5% v/v ethyl acetate in hexanes) afforded arene 
2.20. Rf = 0.61 (30% v/v ethyl acetate in hexanes); 1H NMR data matched the reported 
spectrum.26  
 
Acetal 2.25: To a solution of [bis(trifluoroacetoxy)iodo]benzene (5.38 g, 12.5 mmol) and 
ethylene glycol (10 mL, 179 mmol) in MeCN (10 mL) at 0 ˚C was added 1-naphthol (720 mg, 
5 mmol) as a solution in MeCN (5 mL). The reaction mixture was stirred at 0 ˚C for 2 h. then 
quenched with satd. aq. NaHCO3, extracted with EtOAc, and washed with brine. The organic 
layer was then dried over anhydrous sodium sulfate and concentrated under reduced 
pressure. Purification by flash chromatography (15% v/v ethyl acetate in hexanes) afforded 
acetal 20 (722 mg, 71%). Rf = 0.26 (30% v/v ethyl acetate in hexanes); 1H-NMR (500 MHz; 
CDCl3): δ 8.06 (d, J = 8.3 Hz, 1H), 7.65-7.60 (m, 2H), 7.50 (ddd, J = 8.0, 6.1, 2.1 Hz, 1H), 6.85 
(d, J = 10.3 Hz, 1H), 6.36 (d, J = 10.3 Hz, 1H), 4.40-4.35 (m, 2H), 4.32-4.27 (m, 2H); 13C NMR 
(126 MHz; CDCl3): δ 184.4, 143.1, 141.1, 133.7, 131.1, 129.9, 129.2, 127.0, 126.7, 100.3, 66.3.  
 
Benzyl bromide 2.27: TMSBr (0.79 mL, 6 mmol, prepared by stirring a mixture of bromine 
and hexamethyldisilane for 2 h at 60 ˚C) was added to a solution of 3-isochromanone (440 
mg, 3 mmol) in EtOH (5 mL). The reaction mixture was stirred at 50 ˚C for 15 h, and then 
excess TMSBr and EtOH were removed under reduced pressure. Flash chromatography 
(15% v/v ethyl acetate in hexanes) afforded 639 mg (2.49 mmol, 83%) of benzyl bromide 
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2.27 as an orange tinted oil: 1H-NMR (600 MHz; CDCl3): Rf = 0.57 (30% v/v ethyl acetate in 
hexanes). 1H NMR spectrum matched that found in the literature.27 1H-NMR (500 MHz; 
CDCl3): δ 7.38-7.36 (m, 1H), 7.31-7.24 (m, 3H), 4.60 (s, 2H), 4.16 (q, J = 7.1 Hz, 2H), 3.79 (s, 
2H), 1.26 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 171.09, 136.37, 133.51, 131.29, 
130.74, 129.24, 128.01, 61.19, 38.45, 31.86, 14.22. 
 
Ester 2.23: Following the procedure reported by Knochel,4 a solution of benzyl bromide 2.27 
(257 mg, 1 mmol) in THF (1 mL) was added dropwise to a solution of Zn powder (98 mg, 1.5 
mmol) in THF (1 mL), which had been activated with 1 drop of 1,2-dibromoethane and 1 
drop of TMSCl and stirred at 65 ˚C for 45 min., at 0 ˚C. The reaction mixture was then stirred 
at 0 ˚C for 2 h and titrated with iodine to determine the concentration (0.39 M). A solution of 
CuCN2LiCl (624 µL, 1 M solution in THF, 0.624 mmol), prepared by combining anhydrous 
LiCl (343 mg, 8.1 mmol) with CuCN (360 mg, 4 mmol) in THF (4 mL) at room temperature, 
was added to the organozinc solution (1.6 mL, 0.39 M solution in THF, 0.624 mmol) at –78 
˚C. The reaction mixture was then warmed to –20 ˚C for 10 min then cooled back down to –
78 ˚C. TMSCl (0.16 mL, 1.25 mmol) was then added to the organocopper solution followed 
by the slow addition of a solution of enone 2.25 (101 mg, 0.5 mmol) in THF (1 mL). The 
reaction mixture was then stirred at –78 ˚C for 1 h, warmed to –25 ˚C, and stirred at this 
temperature for 15 h. The reaction mixture was then quenched at the same temperature with 
saturated aqueous NH4Cl, filtered, extracted with ethyl acetate, and washed with brine. After 
drying over anhydrous sodium sulfate and removal of organic solvents under reduced 
61 
 
pressure, purification by flash chromatography (15% v/v ethyl acetate in hexanes) afforded 
174 mg (0.458 mmol, 92%) of ester 2.23 as a thick yellow/orange oil. Rf = 0.61 (50% v/v 
ethyl acetate in hexanes); 1H-NMR (500 MHz; CDCl3): δ 8.03-8.00 (m, 1H), 7.64-7.57 (m, 2H), 
7.47 (ddd, J = 7.8, 7.1, 1.5 Hz, 1H), 7.24-7.19 (m, 3H), 7.13-7.11 (m, 1H), 4.37-4.34 (m, 1H), 
4.25-4.15 (m, 3H), 4.11 (qd, J = 7.1, 1.5 Hz, 2H), 3.70 (d, J = 15.3 Hz, 1H), 3.64 (d, J = 15.3 Hz, 
1H), 3.27 (dd, J = 13.8, 2.7 Hz, 1H), 2.83-2.72 (m, 2H), 2.69-2.64 (m, 1H), 2.41 (dd, J = 13.8, 
11.1 Hz, 1H), 1.18 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz; CDCl3): δ 197.2, 172.0, 143.1, 138.1, 
134.2, 133.3, 132.3, 131.18, 131.13, 129.5, 127.8, 127.5, 127.2, 125.5, 108.2, 67.1, 65.6, 61.2, 
45.0, 40.4, 38.7, 32.6, 14.5; HRMS (CI) m/z calculated for C23H24O5 [M]+: 380.1624, found: 
380.1608. 
 
Tetracycle 2.29: Anhydrous tBuOH (1 mL) was added to ester 2.23 (43 mg, 0.11 mmol) and 
tBuOK (19 mg, 0.17 mmol) in a dram vial, and the mixture was warmed to 30 ˚C for 15 h. The 
reaction mixture was then quenched with 2N HCl, extracted with ethyl acetate (2x 10 mL), 
washed with brine and dried over anhydrous sodium sulfate. Purification by flash 
chromatography afforded 14.8 mg (0.044 mmol, circa 40%) of acetal 2.29. Compound 2.29 
contaminated with approximately 20% ethyl acetate. There also appears to be other 
impurities in the 13C NMR, which are suspected to arise from the ketone enol tautomer. Rf = 
0.45 (30% v/v ethyl acetate in hexanes); 1H-NMR (500 MHz; CDCl3): δ 16.94 (s, 1H), 8.00-
7.96 (m, 1H), 7.55-7.49 (m, 2H), 7.48-7.45 (m, 1H), 7.20-7.16 (m, 4H), 4.35-4.33 (m, 1H), 
4.22-4.15 (m, 3H), 4.00-3.95 (m, 1H), 3.87 (d, J = 15.5 Hz, 1H), 3.31-3.24 (m, 2H), 3.16 (dd, J 
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= 14.0, 13.4 Hz, 1H); 13C NMR (126 MHz; CDCl3): δ 196.9, 191.8, 140.1, 138.8, 133.3, 132.3, 
130.9, 129.33, 129.29, 127.7, 126.8, 126.6, 123.8, 107.7, 107.3, 66.6, 64.7, 45.2, 44.0, 31.1; 
HRMS (ESI) m/z calculated for C21H18O4Na [M+Na]+: 357.1103, found: 337.1109.  
 
Diketone 2.136: A solution of PhSeCl in DCM (1 mL, 0.21 M) was added to a solution of enol 
2.29 (62.4 mg, 0.187 mmol) and pyridine (17 μL, 0.21 mmol) in DCM (2 mL) at 0 ˚C. The 
reaction was stirred at this temperature for 30 min. then quenched with saturated aqueous 
NaHCO3 (3 mL) and extracted with DCM. The organic phase was then washed with brine, 
dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. 
Purification by flash chromatography afforded diketone 2.136 (24.2 mg, 25%). 1H NMR (500 
MHz, CDCl3) δ 7.62 – 7.56 (m, 3H), 7.50 (d, J = 3.7 Hz, 2H), 7.39 – 7.34 (m, 1H), 7.31 – 7.26 (m, 
3H), 6.90 (t, J = 7.4 Hz, 1H), 6.82 (d, J = 7.5 Hz, 1H), 6.60 (t, J = 7.4 Hz, 1H), 6.52 (d, J = 7.6 Hz, 
1H), 4.38 – 4.31 (m, 1H), 4.25 – 4.16 (m, 3H), 4.05 (d, J = 18.4 Hz, 1H), 3.65 (d, J = 18.4 Hz, 
1H), 3.24 – 3.07 (m, 3H); 13C NMR (126 MHz, CDCl3) δ 202.45, 186.20, 138.83, 138.37, 135.73, 
133.55, 130.51, 130.31, 130.18, 129.55, 129.21, 128.83, 128.55, 127.40, 127.00, 126.94, 
124.81, 105.41, 68.20, 66.13, 64.84, 51.67, 48.49, 33.05. 
 
Enol 2.30. To a solution of diketone 2.136 (24.2 mg, 50 μmol) in DCM (1 mL) at 0 ˚C was 
added H2O2 (14 μL, 0.12 mmol). The reaction mixture was stirred for 15 min. followed by the 
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addition of another portion of H2O2 (14 μL, 0.12 mmol). After an additional 20 min. at 0 ˚C 
the reaction was quenched by the addition of saturated aqueous Na2S2O3, extracted with 
DCM, washed with brine, dried over anhydrous magnesium sulfate, and concentrated under 
reduced pressure. Purification by flash chromatography afforded enol 2.30 (7 mg, 42 %). 
Spectra contain ca. 5% of 2.29. 1H NMR (499 MHz, CDCl3) δ 16.62 (s, 1H), 8.01 (dd, J = 7.8, 
1.3 Hz, 1H), 7.74 (dd, J = 7.8, 1.4 Hz, 1H), 7.59 (td, J = 7.6, 1.3 Hz, 1H), 7.48 (td, J = 7.6, 1.3 Hz, 
1H), 7.36 – 7.28 (m, 5H), 4.27 – 4.17 (m, 4H), 3.69 (s, 2H); 13C NMR (126 MHz, CDCl3) δ 189.02, 
177.74, 139.34, 134.40, 133.83, 133.24, 131.35, 130.91, 129.43, 129.31, 129.05, 128.97, 
127.20, 126.59, 124.01, 123.68, 107.05, 105.59, 45.50. 
 
Quinone 2.31: A solution of enol 2.30 (7 mg, 21 μmol), TBSCl (3.2 mg, 21 μmol), and 
imidazole (3 mg, 42 μmol) was stirred at room temperature for 16 h followed by the addition 
of TBSOTf (5 μL, 21 μmol) and Et3N (6 μL, 42 μmol). The reaction mixture was then stirred 
for an additional 16 h and quenched with saturated aqueous NaHCO3, extracted with DCM, 
washed with brine, dried over anhydrous magnesium sulfate, and concentrated under 
reduced pressure. Purification by flash chromatography afforded enol 2.31. 1H NMR (600 
MHz, CDCl3) δ 16.58 (s, 1H), 8.31 (d, J = 7.7 Hz, 1H), 8.23 (d, J = 7.7 Hz, 1H), 7.95 (s, 1H), 7.76 
(t, J = 7.5 Hz, 1H), 7.71 (t, J = 7.5 Hz, 1H), 7.51 (d, J = 7.6 Hz, 1H), 7.46 (t, J = 7.4 Hz, 1H), 7.39 
– 7.33 (m, 2H), 3.82 (s, 2H); 13C NMR (151 MHz, CDCl3) δ 191.98, 184.69, 170.64, 137.07, 
134.44, 134.01, 133.51, 133.26, 133.10, 131.45, 131.30, 131.27, 131.17, 129.29, 127.66, 
127.64, 126.33, 108.69, 47.33. 
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Ketone 2.34: A solution of benzyl bromide 2.27 (750 mg, 2.9 mmol) in THF (3 mL) was added 
dropwise to a solution of Zn powder (286 mg, 4.4 mmol) in THF (3 mL), which had been 
activated with 1 drop of 1,2-dibromoethane and 1 drop of TMSCl and stirred at 65 ˚C for 45 
min., at 0 ˚C. The reaction mixture was then stirred at 0 ˚C for 2 h and titrated with iodine to 
determine the concentration (0.36 M). A solution of CuCN2LiCl (2.3 mL, 1 M solution in THF, 
2.3 mmol), prepared by combining anhydrous LiCl (343 mg, 8.1 mmol) with CuCN (360 mg, 
4 mmol) in THF (4 mL) at room temperature, was added to the organozinc solution (6.4 mL, 
0.36 M solution in THF, 2.3 mmol) at –78 ˚C. The reaction mixture was then warmed to –20 
˚C for 10 min then cooled back down to –78 ˚C. TMSCl (0.58 mL, 4.56 mmol) was then added 
to the organocopper solution followed by the slow addition of a solution of enone 2.25 (368 
mg, 1.82 mmol) in THF (3 mL). The reaction mixture was then stirred at –78 ˚C for 1 h, 
warmed to –20 ˚C, and stirred at this temperature for 1 h. Et3N (0.76 mL 5.46 mmol) was 
then added and the reaction mixture was quenched at the same temperature with a solution 
of NH4Cl/NH4OH (3:1, 6 mL), extracted with diethyl ether, and washed with water and brine. 
After drying over anhydrous sodium sulfate and removal of organic solvents under reduced 
pressure afforded silyl enol ether 2.32 (1.008 g), which was used in the next step without 
further purification. Pd(OAc)2 (430 mg, 1.91 mmol) was added to a solution of silyl enol ether 
2.32 in MeCN (20 mL) and the reaction mixture was stirred at room temperature for 16 h 
then filtered through celite and concentrated under reduced pressure. Purification by flash 
chromatography (gradient elution with 5–20% v/v ethyl acetate in hexanes) afforded ketone 
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2.34 (544 mg, 1.44 mmol). Rf = 0.3 (30% v/v ethyl acetate in hexanes); 1H NMR (499 MHz, 
CDCl3) δ 8.04 – 8.00 (m, 1H), 7.63 – 7.58 (m, 1H), 7.57 – 7.53 (m, 1H), 7.50 – 7.45 (m, 1H), 
7.31 – 7.24 (m, 3H), 7.23 – 7.19 (m, 1H), 5.67 (t, J = 1.9 Hz, 1H), 4.54 – 4.46 (m, 2H), 4.46 – 
4.38 (m, 2H), 4.09 (q, J = 7.1 Hz, 2H), 3.82 (d, J = 1.9 Hz, 2H), 3.56 (s, 2H), 1.20 (t, J = 7.2 Hz, 
3H); 13C NMR (126 MHz, CDCl3) δ 183.96, 171.61, 160.02, 143.06, 135.30, 133.60, 132.94, 
131.60, 131.12, 130.37, 129.16, 128.34, 127.86, 127.70, 126.50, 125.59, 102.87, 67.17, 60.91, 
38.62, 33.48, 14.20. 
 
Alcohol 2.36: AllylB(pin) (42.2 μL, 0.225 mmol) was added to a solution of ketone 2.34 (57 
mg, 0.15 mmol) in xylenes (1 mL). The reaction mixture was heated to 140 ˚C for 3 h, then 
cooled to room temperature. The reaction mixture was loaded directly onto silica gel for 
purification by flash chromatography (gradient elution with 5-20% v/v ethyl acetate in 
hexanes) which afforded alcohol 2.36 (52 mg, 83%). Rf = 0.41 (30% v/v ethyl acetate in 
hexanes); 1H NMR (499 MHz, CDCl3) δ 7.61 (dd, J = 7.8, 1.4 Hz, 1H), 7.48 (dd, J = 7.8, 1.4 Hz, 
1H), 7.38 (td, J = 7.5, 1.6 Hz, 1H), 7.33 (td, J = 7.5, 1.5 Hz, 1H), 7.29 – 7.25 (m, 3H), 7.25 – 7.20 
(m, 1H), 5.70 – 5.58 (m, 1H), 5.35 (t, J = 1.8 Hz, 1H), 5.06 – 4.95 (m, 2H), 4.56 – 4.48 (m, 1H), 
4.30 – 4.19 (m, 2H), 4.15 (td, J = 8.2, 6.5 Hz, 1H), 4.05 – 3.95 (m, 1H), 3.85 – 3.76 (m, 1H), 3.75 
– 3.63 (m, 2H), 3.57 (dd, J = 17.0, 2.0 Hz, 1H), 3.51 (d, J = 15.7 Hz, 1H), 2.54 – 2.45 (m, 2H), 
1.12 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 172.26, 142.63, 138.83, 137.48, 136.45, 
135.92, 133.44, 133.37, 131.45, 130.93, 128.42, 127.55, 127.27, 127.10, 125.90, 125.00, 
118.67, 103.74, 70.40, 68.01, 64.67, 60.82, 48.65, 38.38, 32.89, 14.10. 
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Quinone 2.39: TMSCl (0.683 mL, 5.38 mmol) was added to a solution of organocopper 2.28 
in THF (6.4 mL, 2.69 mmol, 0.42 M, prepared as above) at –78 ˚C, followed by the addition of  
a solution of naphthoquinone 2.38 (340 mg, 2.15 mmol) in THF (3 mL). The reaction mixture 
was stirred at this temperature for 1.5 h then warmed to –20 ˚ C for 16 h. The reaction mixture 
was then quenched with aqueous HCl (6 mL, 2 M), extracted with diethyl ether, washed with 
brine, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. 
Purification by flash chromatography (gradient elution with 5–15% v/v ethyl acetate in 
hexanes) afforded quinone 2.39 (367 mg, 55%). Rf = 0.45 (30% v/v ethyl acetate in hexanes); 
1H NMR (500 MHz, CDCl3) δ 8.16 – 8.11 (m, 1H), 8.06 – 8.01 (m, 1H), 7.77 – 7.70 (m, 2H), 7.33 
– 7.29 (m, 1H), 7.29 – 7.26 (m, 2H), 7.20 – 7.16 (m, 1H), 6.37 (t, J = 1.8 Hz, 1H), 4.05 (q, J = 7.1 
Hz, 2H), 3.97 (d, J = 1.9 Hz, 2H), 3.60 (s, 2H), 1.17 (t, J = 7.2 Hz, 3H); 13C NMR (126 MHz, CDCl3) 
δ 185.02, 184.99, 171.19, 150.50, 135.73, 135.27, 133.90, 133.83, 133.30, 132.23, 132.11, 
131.28, 130.98, 127.99, 127.74, 126.76, 126.21, 61.06, 38.98, 32.92, 14.13. 
 
Diketone 2.40: AllylB(pin) (51 μL, 0.18 mmol) was added to a solution of quinone 2.39 (60.3 
mg, 0.18 mmol) in xylenes (1 mL). The resulting solution was heated to 100 ˚C for 7 h, 
followed by the addition of water (16 μL) then heating to 140 ˚C for 16 h. The reaction 
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mixture was then cooled to room temperature and loaded directly onto silica gel for 
purification by flash chromatography (gradient elution with 5–10% v/v ethyl acetate in 
hexanes) which afforded diketone 2.40 (52 mg, 77%). Rf = 0.53 (30% v/v ethyl acetate in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 8.11 (dd, J = 7.6, 1.4 Hz, 1H), 7.90 (dd, J = 7.6, 1.5 Hz, 
1H), 7.73 (td, J = 7.5, 1.5 Hz, 1H), 7.68 (td, J = 7.4, 1.5 Hz, 1H), 7.16 – 7.03 (m, 4H), 5.79 – 5.68 
(m, 1H), 5.17 – 5.04 (m, 2H), 4.10 (q, J = 7.2 Hz, 2H), 3.62 (d, J = 15.5 Hz, 1H), 3.55 (d, J = 15.5 
Hz, 1H), 3.41 (d, J = 14.5 Hz, 1H), 3.00 (d, J = 16.4 Hz, 1H), 2.95 – 2.85 (m, 2H), 2.74 (dd, J = 
13.7, 6.4 Hz, 1H), 2.22 (dd, J = 13.8, 8.3 Hz, 1H), 1.22 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, 
CDCl3) δ 199.47, 196.42, 171.46, 135.29, 134.91, 134.39, 134.23, 134.19, 133.75, 132.62, 
131.77, 130.90, 127.55, 127.28, 125.93, 120.22, 60.98, 53.91, 46.59, 42.82, 39.10, 38.87, 
14.20. 
 
Silyl enol ether 2.42 and 2.137. To a solution of diketone 2.40 (22 mg, 58 μmol) in DCM (0.6 
mL) was added Et3N (21 μL, 0.15 mmol) followed by TBSOTf (27 μL, 0.12 mmol). The 
reaction was stirred at room temperature 20 h, followed by the addition of water (0.5 mL). 
After an additional 3 h, the reaction was quenched with saturated aqueous NaHCO3, 
extracted with diethyl ether, washed with brine, dried over anhydrous magnesium sulfate, 
and concentrated under reduced pressure. Purification by flash chromatography on silica 
that has been washed with a 5% v/v solution of Et3N in hexanes (elution with 1% v/v ethyl 
acetate in hexanes) afforded a 3.3:1 mixture of 2.42 and 2.137. 1H NMR (500 MHz, C6D6) δ 
8.38 (dd, J = 8.0, 1.3 Hz, 3H), 7.91 (ddd, J = 11.5, 7.8, 1.4 Hz, 4H), 7.74 (dd, J = 7.9, 1.2 Hz, 1H), 
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7.31 (d, J = 7.7 Hz, 4H), 7.07 (ddd, J = 7.8, 7.2, 1.4 Hz, 1H), 6.85 – 6.78 (m, 4H), 6.78 – 6.71 (m, 
4H), 6.74 – 6.63 (m, 11H), 6.59 (dt, J = 7.4, 1.0 Hz, 1H), 5.93 – 5.83 (m, 1H), 5.77 – 5.65 (m, 
3H), 5.12 – 5.04 (m, 1H), 5.06 – 5.00 (m, 3H), 5.01 – 4.95 (m, 5H), 4.74 (s, 3H), 4.26 – 4.11 (m, 
8H), 4.03 – 3.95 (m, 1H), 3.90 – 3.82 (m, 1H), 3.70 (d, J = 12.6 Hz, 1H), 3.08 (dd, J = 13.3, 5.7 
Hz, 1H), 2.89 (ddt, J = 13.4, 6.0, 1.4 Hz, 3H), 2.84 – 2.74 (m, 8H), 2.69 (dd, J = 13.9, 1.8 Hz, 3H), 
2.44 – 2.31 (m, 1H), 2.22 – 2.12 (m, 6H), 1.11 (s, 31H), 0.22 (s, 3H), 0.10 (s, 10H), -0.10 (s, 
3H), -0.14 (s, 10H); 13C NMR (126 MHz, CDCl3) δ 199.20, 198.46, 171.21, 169.53, 148.35, 
145.80, 137.72, 136.34, 134.95, 134.59, 134.28, 133.96, 132.88, 132.59, 132.35, 132.18, 
131.92, 131.01, 128.46, 127.99, 127.61, 127.40, 127.24, 127.15, 126.82, 126.76, 126.29, 
126.25, 124.78, 118.33, 75.46, 74.82, 67.42, 61.99, 60.44, 60.20, 53.35, 48.63, 48.20, 46.94, 
46.33, 44.96, 44.54, 43.55, 25.91, 25.82, 18.39, 13.80, -1.64, -1.83, -2.80.  
 
Tetracycles 2.44 and 2.43. To a solution of silyl enol ether 2.42 (16 mg, 25 μmol) in THF 
(0.25 mL) was added tris(dimethylamino)sulfonium difluorotrimethylsilicate (7 mg, 25 
μmol) as a solution in THF (0.25 mL) at –78 ˚C. After 2 h the reaction was warmed to –50 ˚C 
and MeCN (0.5 mL) was added to dissolve TASF and the reaction was stirred for an additional 
hour before being warmed to room temperature. The reaction mixture was stirred for 16 h 
at this temperature, then quenched with water, extracted with ether, washed with brine, 
dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. 
Purification by flash chromatography (gradient elution with 5–10% v/v ethyl acetate in 
hexanes) afforded tetracycles 2.44 (6 mg, 64%) and 2.43 (2 mg, 21%). Tetracycle 2.44: Rf = 
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0.56 (30% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3) δ 8.03 (dd, J = 7.7, 1.4 Hz, 
1H), 7.60 (td, J = 7.5, 1.4 Hz, 1H), 7.56 (dd, J = 7.8, 1.4 Hz, 1H), 7.43 (td, J = 7.4, 1.4 Hz, 1H), 
7.23 (t, J = 8.8 Hz, 3H), 7.16 (t, J = 7.4 Hz, 1H), 6.96 (d, J = 7.8 Hz, 1H), 5.80 (ddt, J = 17.3, 10.0, 
7.5 Hz, 1H), 5.40 (s, 1H), 5.12 (dd, J = 9.9, 1.9 Hz, 1H), 5.03 – 4.96 (m, 1H), 4.20 – 4.08 (m, 2H), 
4.02 (s, 1H), 3.34 (d, J = 17.1 Hz, 1H), 2.74 (d, J = 19.1 Hz, 1H), 2.62 – 2.45 (m, 3H), 2.00 (dd, J 
= 13.9, 8.0 Hz, 1H), 1.10 (t, J = 7.2 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 196.64, 175.11, 
146.78, 134.66, 133.87, 133.23, 133.21, 131.24, 130.98, 130.14, 127.94, 127.92, 127.42, 
127.12, 126.52, 125.30, 119.49, 73.82, 61.76, 55.33, 43.09, 41.98, 38.39, 36.40, 14.10. 
Tetracycle 2.43: Rf = 0.45 (30% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3) δ 
8.00 (dd, J = 7.7, 1.5 Hz, 1H), 7.93 (dd, J = 7.9, 1.2 Hz, 1H), 7.67 (td, J = 7.6, 1.5 Hz, 1H), 7.44 
(td, J = 7.5, 1.2 Hz, 1H), 7.26 – 7.14 (m, 3H), 7.03 (d, J = 7.6 Hz, 1H), 5.92 (dddd, J = 17.0, 9.9, 
8.1, 7.1 Hz, 1H), 5.14 (dd, J = 10.0, 1.9 Hz, 1H), 4.97 (dd, J = 17.0, 1.6 Hz, 1H), 4.32 (s, 1H), 3.60 
(dq, J = 10.8, 7.1 Hz, 1H), 3.53 (dd, J = 18.2, 1.8 Hz, 1H), 3.39 (dq, J = 10.8, 7.2 Hz, 1H), 3.25 (d, 
J = 16.8 Hz, 1H), 2.67 (d, J = 16.9 Hz, 1H), 2.59 (s, 1H), 2.49 (d, J = 18.3 Hz, 1H), 2.34 (dd, J = 
14.2, 7.8 Hz, 1H), 2.18 (dd, J = 13.8, 7.0 Hz, 1H), 0.77 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, 
CDCl3) δ 196.83, 171.97, 144.67, 133.90, 133.41, 133.10, 131.70, 129.82, 129.07, 128.32, 
127.58, 126.75, 126.60, 126.41, 120.02, 61.28, 60.80, 43.56, 42.92, 40.62, 35.86, 29.77, 13.55. 
 
Quinone 2.50: To a solution of organocopper 2.49 in THF (2.47 mmol, 6.5 mL, 0.38 M), which 
was prepared using the same procedure used in the preparation of 2.28, was added TMSCl 
(0.63 mL, 4.94 mmol) and ketal 2.25 (400 mg, 1.98 mmol) at –78 ˚C. The reaction mixture 
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was stirred at this temperature for 1 h then warmed to –20 ˚C. After 1 h at –20 ˚C the reaction 
mixture was treated with aqueous HCl (4M) and heated to 50 ˚C for 16 h, at which point it 
was neutralized by pouring slowly into saturated aqueous NaHCO3, extracted with diethyl 
ether, washed with water, brine, dried over anhydrous magnesium sulfate, and concentrated 
under reduced pressure. Purification by flash chromatography (gradient elution with 1–5% 
v/v ethyl acetate in hexanes) afforded quinone 2.50 (635 mg, 86%). 1H NMR (499 MHz, 
CDCl3) δ 8.18 – 8.14 (m, 1H), 8.08 – 8.03 (m, 1H), 7.89 (dd, J = 7.9, 1.3 Hz, 1H), 7.78 – 7.72 (m, 
2H), 7.35 (td, J = 7.5, 1.3 Hz, 1H), 7.29 – 7.26 (m, 1H), 7.00 (td, J = 7.7, 1.8 Hz, 1H), 6.37 (t, J = 
1.8 Hz, 1H), 4.06 (d, J = 1.9 Hz, 2H); 13C NMR (126 MHz, CDCl3) δ 185.00, 184.85, 149.42, 
140.05, 139.82, 135.72, 133.91, 133.83, 132.19, 132.14, 131.02, 129.04, 128.87, 126.78, 
126.25, 101.31, 40.40. 
 
Diketone 2.51: AllylB(pin) (0.23 mL, 1.2 mmol) added to a solution of quinone 2.50 (300 mg, 
0.8 mmol) in xylenes (4.5 mL) and heated to 100 ˚C for 16 h. Water (72 μL, 4 mmol) was then 
added to the reaction mixture and the resulting solution was heated to 140 ˚C for 6 h, then 
cooled to room temperature and loaded directly onto silica gel for purification by flash 
chromatography (gradient elution with 1–5% v/v ethyl acetate in hexanes) which afforded 
diketone 2.51 (312 mg, 93%). Rf = 0.45 (15% v/v ethyl acetate in hexanes); 1H NMR (500 
MHz, CDCl3) δ 8.14 (d, J = 7.8 Hz, 1H), 7.93 (d, J = 6.9 Hz, 1H), 7.79 (d, J = 8.0 Hz, 1H), 7.75 (t, 
J = 7.5 Hz, 1H), 7.70 (t, J = 7.4 Hz, 1H), 7.15 (d, J = 4.0 Hz, 2H), 6.88 – 6.79 (m, 1H), 5.83 – 5.68 
(m, 1H), 5.18 – 5.01 (m, 2H), 3.62 (d, J = 14.2 Hz, 1H), 3.13 (t, J = 15.3 Hz, 2H), 2.93 (d, J = 16.4 
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Hz, 1H), 2.74 (dd, J = 14.0, 6.7 Hz, 1H), 2.33 (dd, J = 14.0, 8.0 Hz, 1H); 13C NMR (126 MHz, 
CDCl3) δ 199.13, 196.39, 140.17, 140.08, 134.98, 134.43, 134.26, 134.23, 132.48, 131.32, 
128.67, 128.33, 127.77, 125.98, 120.18, 103.49, 54.46, 46.40, 45.17, 42.98.  
 
Alkyne 2.138: To a solution of diketone 2.51 (312 mg, 0.75 mmol), Cl2Pd(PPh3)2 (16 mg, 23 
μmol), CuI (14 mg, 75 μmol), and Et3N (0.42 mL, 3 mmol) in MeCN (7.5 mL) was added 
trimethylsilyl acetylene (125 μL, 0.9 mmol). The resulting solution was stirred at room 
temperature for 1h then filtered through celite and concentrated under reduced pressure. 
Purification by flash chromatography (elution with 1% v/v ethyl acetate in hexanes) 
afforded alkyne 2.138 (195 mg, 67%). Rf = 0.53 (15% v/v ethyl acetate in hexanes); 1H NMR 
(500 MHz, CDCl3) δ 8.12 (d, J = 6.2 Hz, 1H), 7.93 (d, J = 7.5 Hz, 1H), 7.74 (td, J = 7.5, 1.5 Hz, 
1H), 7.69 (td, J = 7.4, 1.4 Hz, 1H), 7.40 (dd, J = 7.3, 1.8 Hz, 1H), 7.18 – 7.04 (m, 3H), 5.84 – 5.70 
(m, 1H), 5.10 (dd, J = 10.2, 1.9 Hz, 1H), 5.04 (dd, J = 17.0, 1.7 Hz, 1H), 3.47 (d, J = 13.7 Hz, 1H), 
3.21 (d, J = 13.7 Hz, 1H), 3.10 (d, J = 16.5 Hz, 1H), 2.94 (d, J = 16.5 Hz, 1H), 2.73 (dd, J = 14.0, 
6.7 Hz, 1H), 2.29 (dd, J = 14.0, 8.0 Hz, 1H), 0.29 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 199.29, 
196.61, 139.16, 134.99, 134.34, 134.24, 134.10, 132.87, 132.76, 130.97, 128.52, 127.64, 
126.72, 125.92, 124.53, 119.80, 104.44, 98.98, 54.43, 46.41, 42.68, 39.74, -0.01.  
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Alkyne 2.52: To a solution of alkyne 2.138 (193 mg, 0.5 mmol) in THF (15 mL) was added 
TBAF (0.6 mL, 1 M in THF, 0.6 mmol) and the reaction was stirred at room temperature for 
10 min, then quenched with water, extracted with diethyl ether, washed with brine, dried 
over anhydrous magnesium sulfate, and concentrated under reduced pressure. Purification 
by flash chromatography (elution with 5% v/v ethyl acetate in hexanes) afforded alkyne 
2.52 (119 mg, 76%). 1H NMR (500 MHz, CDCl3) δ 8.12 (dd, J = 7.6, 1.5 Hz, 1H), 7.94 (dd, J = 
7.6, 1.5 Hz, 1H), 7.74 (td, J = 7.5, 1.6 Hz, 1H), 7.69 (td, J = 7.4, 1.5 Hz, 1H), 7.43 (dd, J = 7.9, 1.6 
Hz, 1H), 7.23 – 7.09 (m, 3H), 5.80 – 5.69 (m, 1H), 5.11 (dd, J = 9.5, 1.5 Hz, 1H), 5.04 (dd, J = 
17.0, 1.6 Hz, 1H), 3.45 (d, J = 13.7 Hz, 1H), 3.23 (d, J = 13.7 Hz, 1H), 3.19 (s, 1H), 3.10 (d, J = 
16.4 Hz, 1H), 2.95 (d, J = 16.5 Hz, 1H), 2.75 (dd, J = 14.0, 6.6 Hz, 1H), 2.27 (dd, J = 14.0, 8.1 Hz, 
1H); 13C NMR (126 MHz, CDCl3) δ 199.20, 196.68, 139.21, 134.98, 134.34, 134.31, 134.11, 
133.19, 132.81, 131.08, 128.78, 127.71, 126.84, 125.93, 123.47, 119.86, 82.81, 81.79, 54.29, 
46.53, 42.41, 39.79.  
 
Silyl enol ether 2.53: TIPSOTf (101 μL, 0.375 mmol) added to a solution of alkyne 2.52 (118 
mg, 0.375 mmol) and Et3N (68 μL, 0.488 mmol) in DCM (1.5 mL) and the reaction mixture 
was stirred at room temperature for 16 h, followed by the addition of another equivalent of 
TIPSOTf. The reaction mixture was then stirred for an additional 1 h and poured into 
saturated aqueous NaHCO3, extracted with diethyl ether, washed with brine, dried over 
anhydrous magnesium sulfate, and concentrated under reduced pressure. Purification by 
flash chromatography using silica gel that had been treated with a solution of 1% v/v Et3N 
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in hexanes (elution with 1% v/v eethyl acetate in hexanes) afforded silyl enol ether 2.53 
(123 mg, 70 %). Rf = 0.59 (15% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3) δ 
8.06 (dd, J = 7.7, 1.5 Hz, 1H), 7.65 (dd, J = 7.9, 1.3 Hz, 1H), 7.57 (td, J = 7.6, 1.4 Hz, 1H), 7.41 – 
7.34 (m, 2H), 7.07 – 6.97 (m, 3H), 5.69 – 5.58 (m, 1H), 5.34 (s, 1H), 5.03 (dd, J = 17.0, 1.9 Hz, 
1H), 4.98 – 4.92 (m, 1H), 3.52 (d, J = 13.4 Hz, 1H), 3.34 (d, J = 13.6 Hz, 1H), 3.27 (s, 1H), 2.73 
(ddd, J = 13.4, 7.3, 1.2 Hz, 1H), 2.37 (ddd, J = 13.3, 7.4, 1.3 Hz, 1H), 1.26 – 1.17 (m, 3H), 1.08 
(d, J = 7.7 Hz, 9H), 0.99 (d, J = 7.6 Hz, 9H); 13C NMR (126 MHz, CDCl3) δ 202.17, 145.09, 140.79, 
137.65, 134.24, 133.13, 132.82, 130.43, 129.71, 128.63, 127.96, 126.86, 126.17, 123.09, 
122.73, 118.57, 112.22, 83.22, 81.08, 54.95, 46.09, 41.38, 18.19, 18.10, 12.80. 
 
Sulfone 2.69.  A mixture of bromide 2.68 (18.1 g, 0.100 mol, Acros #213540250), sodium 
sulfinate (20.5 g, 0.125 mol), and DMF (50 mL) was stirred at room temperature for 48 h. 
The mixture was diluted with water (500 mL) and extracted with DCM (two times, 400 mL 
combined). The combined organic layers were washed with water, brine, and dried over 
anhydrous MgSO4. The solution was concentrated under reduced pressure, and the crude 
product was triturated with hexanes. The resulting solid was dried under reduced pressure 
to afford 17.6 g (73% yield) of sulphone 2.69 as a white microcrystalline solid.28 Rf = 0.42 
(50% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3): δ 7.91 (m, 2 H), 7.56 (m, 2 H), 
7.65 (m, 1 H), 4.95 (t, 2 H, J = 4.0 Hz), 3.80–3.92 (m, 4 H), 3.22 (m, 2 H), 2.07 (m, 2 H).  
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Alkyne 2.70. nBuLi (0.71 mL, 2.54 M in hexanes, 1.8 mmol) was added to a solution of 
sulphone 2.69 (440 mg, 1.8 mmol) in THF (9 mL) and the resulting solution was stirred at    
–78 ˚ C for 20 min, followed by the addition of propargyl bromine (0.26 mL, 80% v/v in PhMe, 
2.7 mmol). The reaction mixture was warmed to room temperature for 16 h and poured into 
water, extracted with diethyl ether, washed with brine, dried over anhydrous magnesium 
sulfate, and concentrated under reduced pressure. Purification by flash chromatography 
(gradient elution with 10–30% v/v ethyl acetate in hexanes) afforded alkyne 2.70 (136 mg, 
27%). Rf = 0.46 (50% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.91 (dd, J = 
8.3, 1.3 Hz, 2H), 7.70 – 7.63 (m, 1H), 7.60 – 7.53 (m, 2H), 5.13 (t, J = 4.9 Hz, 1H), 3.96 – 3.88 
(m, 2H), 3.88 – 3.79 (m, 2H), 3.43 – 3.35 (m, 1H), 2.79 – 2.69 (m, 2H), 2.32 (dt, J = 14.4, 4.8 
Hz, 1H), 2.15 (ddd, J = 14.4, 8.2, 4.8 Hz, 1H), 1.93 (t, J = 2.7 Hz, 1H); 13C NMR (126 MHz, CDCl3) 
δ 137.16, 134.10, 129.30, 129.28, 101.77, 78.54, 71.72, 64.99, 64.90, 59.09, 31.45, 18.97. 
 
Sulfone 2.72. nBuLi (0.104 mL, 2.53 M in hexanes, 0.26 mmol) was added to a solution of 
alkyne 2.70 (68 mg, 0.24 mmol) in THF (1.4 mL) at –78 ˚C. After 1 h at this temperature a 
solution of benzyl bromide 2.71 (60 mg, 0.26 mmol) in THF (1 mL) was added. After an 
additional 30 min at –78 ˚C the reaction mixture was warmed to room temperature and 
stirred for another 3 h then quenched with water, extracted with ethyl acetate, washed with 
brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. 
Purification by flash chromatography (gradient elution with 5–15% v/v ethyl acetate in 
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hexanes) afforded sulfone 2.72 (63.6 mg, contaminated with 10 mol% 2.70, 58%); 1H NMR 
(499 MHz, CDCl3) δ 7.99 (dd, J = 8.5, 1.3 Hz, 2H), 7.69 – 7.64 (m, 1H), 7.58 – 7.53 (m, 2H), 6.55 
(d, J = 2.3 Hz, 2H), 6.35 (t, J = 2.3 Hz, 1H), 5.32 (dd, J = 5.2, 4.0 Hz, 1H), 3.93 – 3.88 (m, 2H), 
3.84 – 3.79 (m, 2H), 3.75 (s, 6H), 3.38 (d, J = 13.5 Hz, 1H), 3.17 (d, J = 13.5 Hz, 1H), 2.92 (ddd, 
J = 18.1, 2.7, 0.8 Hz, 1H), 2.52 (dd, J = 18.1, 2.8 Hz, 1H), 2.27 (dd, J = 15.4, 4.1 Hz, 1H), 2.03 – 
1.98 (m, 2H). 
 
Naphthalene 2.73. HFIP (0.2 mL) was added to a round bottom flask charged with Ph3PAuCl 
(1 mg, 2 μmol), AgNTf2 (0.7 mg, 1.7 μmol), pyridine-N-oxide (33 mg, 0.35 mmol), and HNTf2 
(11.2 mg, 40 μmol) followed by the addition of sulfone 2.72 (15 mg, 35 μmol) in HFIP (0.2 
mL). The reaction mixture was stirred for 25 min, then concentrated under reduced 
pressure. Purification by flash chromatography (elution with 20% v/v ethyl acetate in 
hexanes) afforded naphthalene 2.73 (8.5 mg, 85%). Rf = 0.65 (50% v/v ethyl acetate in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 7.39 (s, 1H), 6.97 (s, 1H), 6.68 (d, J = 2.4 Hz, 1H), 6.42 
(d, J = 2.4 Hz, 1H), 5.13 (t, J = 4.9 Hz, 1H), 4.00 – 3.94 (m, 2H), 3.93 – 3.77 (m, 8H), 3.02 (d, J = 
4.9 Hz, 2H), 2.82 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 159.29, 157.60, 137.05, 135.51, 134.24, 
128.37, 125.55, 120.11, 104.79, 98.90, 97.98, 65.06, 55.33, 55.27, 40.62, 24.93.  
 
76 
 
Sulfone 2.75. nBuLi (0.8 mL, 2.51 M in hexanes, 2.2 mmol) was added to sulfone 2.69 (485 
mg, 2 mmol) in THF (9 mL) and HMPA (0.77 mL, 4.4 mmol) at –78 ˚C. After 1 h at this 
temperature the solution was transferred via cannula to a solution of allyl bromide (0.19 mL, 
2.2 mmol) in THF (9 mL) at –78 ˚C. After 1 h the reaction was quenched by the addition of 
water and warmed to room temperature, extracted with ethyl acetate, washed with brine, 
dried over anhydrous sodium sulfate, and concentrated under reduced pressure. 
Purification by flash chromatography (elution with 15% v/v ethyl acetate in hexanes) 
afforded sulfone 2.75 (484 mg, 86%). 1H NMR (499 MHz, CDCl3) δ 7.90 (dd, J = 8.4, 1.4 Hz, 
2H), 7.68 – 7.64 (m, 1H), 7.57 (t, J = 7.6 Hz, 2H), 5.81 – 5.70 (m, 1H), 5.12 – 5.01 (m, 3H), 3.92 
– 3.84 (m, 2H), 3.85 – 3.77 (m, 2H), 3.33 (tt, J = 7.3, 5.0 Hz, 1H), 2.67 – 2.60 (m, 1H), 2.44 – 
2.35 (m, 1H), 2.21 (dt, J = 14.7, 5.1 Hz, 1H), 1.92 (ddd, J = 14.6, 7.0, 5.3 Hz, 1H). 
 
Benzyl alcohol 2.139: BH3·SMe2 (9 mL, 2 M in THF, 18 mmol) was added slowly to a solution 
of benzoic acid 2.80 (2.35 g, 9 mmol) in THF (36 mL) and the reaction mixture was heated 
to 40 ˚C for 16 h, then cooled to 0 ˚C and quenched with aqueous HCl (1 M), extracted with 
ethyl acetate, washed with brine, dried over anhydrous magnesium sulfate, and 
concentrated under reduced pressure. Purification by flash chromatography (gradient 
elution with 30–70% v/v ethyl acetate in hexanes) afforded benzyl alcohol 2.139 (2 g, 91%). 
Rf = 0.56 (40% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3) δ 6.60 (s, 2H), 4.68 
(d, J = 6.1 Hz, 2H), 3.91 (s, 6H), 1.83 – 1.67 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 157.21, 
141.72, 103.02, 99.72, 65.27, 56.53.  
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Aryl iodide 2.140: TFA (31 μL, 0.4 mmol) was added to a solution of benzyl alcohol 2.139 
(320 mg, 1.3 mmol) and NIS (293 mg, 1.3 mmol) in MeCN (4 mL) in a round bottom flask 
wrapped in foil. The reaction mixture was stirred at room temperature for 5 h, followed by 
the addition of another equivalent of NIS. The resulting solution was stirred for 16 h, then 
poured into water, extracted with ethyl acetate, washed with saturated aqueous Na2S2O3, 
then brine, dried over anhydrous magnesium sulfate, and concentrated under reduced 
pressure. Purification by flash chromatography (gradient elution with 20–50% v/v ethyl 
acetate in hexanes) afforded aryl iodide 2.140 (460 mg, 95%). 1H NMR (500 MHz, CDCl3) δ 
6.96 (s, 1H), 4.67 (d, J = 6.2 Hz, 2H), 3.93 (s, 3H), 3.87 (s, 3H), 2.06 (t, J = 6.2 Hz, 1H); 13C NMR 
(126 MHz, CDCl3) δ 157.69, 157.13, 143.58, 107.49, 105.32, 83.91, 69.40, 60.58, 56.74.  
 
Benzyl bromide 2.81: NBS (1.65 g, 9.26 mmol) added slowly to a solution of aryl iodide 2.140 
(2.87 g, 7.72 mmol) and Ph3P (2.43 g, 9.26 mmol) in DCM (30 mL) at 0 ˚C and the reaction 
mixture was then warmed to room temperature. After stirring for 5 h at this temperature 
the reaction mixture was poured into water, extracted with ethyl acetate, washed with 
saturated aqueous Na2S2O3, then brine, dried over anhydrous magnesium sulfate, and 
concentrated under reduced pressure. Purification by flash chromatography (gradient 
elution with 15–30% v/v ethyl acetate in hexanes) afforded benzyl bromide 2.81 (2.98 g, 89 
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%). 1H NMR (600 MHz, CDCl3) δ 6.87 (s, 1H), 4.62 (s, 2H), 3.92 (s, 3H), 3.88 (s, 3H); 13C NMR 
(151 MHz, CDCl3) δ 158.03, 157.53, 140.79, 109.35, 106.99, 87.92, 60.56, 56.77, 38.90. 
 
Sulfone 2.78. nBuLi (2.74 mL, 2.48 M in hexanes, 6.79 mmol) was added to a solution of 
sulfone 2.75 (1.74 g, 6.17 mmol) and HMPA (2.6 mL, 14.9 mmol) in THF (30 mL) at –78 ˚C. 
The reaction mixture was stirred at this temperature for 1 h then transferred via cannula to 
a solution of benzyl bromide 2.81 (2.96 g, 6.79 mmol) in THF (30 mL) at –78 ˚ C. The resulting 
solution was stirred at this temperature for 1 h then quenched with water, extracted with 
ethyl acetate, washed with brine, dried over anhydrous sodium sulfate, and concentrated 
under reduced pressure. Purification by flash chromatography (gradient elution with 20–
35% v/v ethyl acetate in hexanes) afforded sulfone 2.78 (3.51 mg, containing 8 mol% 
sulfone 2.75, 86%). Rf = 0.40 (40% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3) 
δ 8.03 (d, J = 8.1 Hz, 2H), 7.70 (t, J = 7.4 Hz, 1H), 7.65 – 7.61 (m, 2H), 7.28 (s, 1H), 5.79 – 5.69 
(m, 1H), 5.44 (dd, J = 5.7, 3.3 Hz, 1H), 5.06 – 4.98 (m, 2H), 4.00 – 3.84 (m, 7H), 3.77 (s, 3H), 
3.68 (d, J = 14.1 Hz, 1H), 3.53 (d, J = 14.1 Hz, 1H), 2.63 – 2.56 (m, 1H), 2.50 – 2.43 (m, 1H), 
2.29 (dd, J = 15.9, 3.3 Hz, 1H), 2.18 (dd, J = 16.0, 5.7 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 
157.47, 157.04, 139.72, 135.76, 134.08, 132.31, 131.25, 129.26, 119.45, 111.26, 105.48, 
101.34, 92.06, 68.82, 65.15, 64.41, 60.38, 56.68, 41.05, 37.70, 36.58. 
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Styrene 2.79. A solution of sulfone 2.78 (1.93 g, 3 mmol), K2CO3 (1.24 g, 9 mmol), and Ph3P 
(315 mg, 1.2 mmol) in MeCN (50 mL) was sparged with argon for 30 min, followed by the 
addition of Pd(OAc)2 (67 mg, 0.3 mmol). The reaction mixture was heated to 50 ˚C for 18 h, 
then filtered through a plug of silica gel and concentrated under reduced pressure. 
Purification by flash chromatography (gradient elution with 20–35% v/v ethyl acetate in 
hexanes) afforded styrene 2.79 (1.14 g, 75%). Rf = 0.35 (40% v/v ethyl acetate in hexanes);  
1H NMR (600 MHz, CDCl3) δ 7.95 – 7.93 (m, 2H), 7.68 (t, J = 7.5 Hz, 1H), 7.59 (t, J = 7.8 Hz, 
2H), 6.47 (s, 1H), 6.13 (t, J = 1.7 Hz, 1H), 5.42 (dd, J = 6.1, 3.5 Hz, 1H), 5.22 (s, 1H), 3.87 (s, 
3H), 3.79 – 3.72 (m, 4H), 3.67 (s, 3H), 3.30 (s, 2H), 2.79 (d, J = 13.4 Hz, 1H), 2.61 (d, J = 13.5 
Hz, 1H), 2.12 (dd, J = 15.7, 3.5 Hz, 1H), 1.97 (dd, J = 15.6, 6.1 Hz, 1H); 13C NMR (126 MHz, 
CDCl3) δ 156.55, 156.02, 135.21, 135.04, 134.12, 134.09, 130.76, 130.63, 129.20, 129.13, 
120.87, 117.69, 108.24, 106.68, 101.36, 64.85, 64.38, 63.46, 59.32, 56.46, 40.52, 36.02, 33.86; 
HRMS (ESI) m/z calculated for C23H25BrO6SNa [M+Na]+: 531.0453, found: 531.0442. 
 
Benzocycloheptanone 2.84: Tl(NO3)3 (83 mg, 0.187 mmol) was added to a solution of 
styrene 2.79 (95 mg, 0.187 mmol) in MeOH (2 mL). The reaction mixture was stirred at room 
temperature for 2 h then filtered through celite, diluted with ethyl acetate, washed with 
saturated aqueous NaHCO3, then brine, dried over anhydrous sodium sulfate, and 
concentrated under reduced pressure. Purification by flash chromatography (elution with 
25% v/v ethyl acetate in hexanes) afforded benzocycloheptanone 2.84 (28.1 mg, 29%). Rf = 
0.31 (50% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3): δ 7.94 (d, 2 H, J = 7.6 Hz), 
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7.71 (t, 1 H, J = 7.4 Hz), 7.61 (t, 2 H, J = 7.7 Hz), 6.85 (s, 1 H), 5.20 (t, 1 H, J = 4.5 Hz), 3.92 (s, 3 
H), 3.85 (m, 7 H), 3.74 (s, 3 H), 3.34 (d, 1 H, J = 14.8 Hz), 2.70 (d, 1 H, J = 14.6 Hz), 2.43 (d, 1 
H, J = 14.7 Hz), 2.06 (dd, 1 H, J = 15.2, 4.1 Hz), 1.83 (dd, 1 H, J = 15.2, 5.0 Hz); 13C NMR (125 
MHz, CDCl3): δ 204.0, 156.0, 155.9, 135.6, 134.5, 134.2, 130.9, 129.3, 121.7, 111.3, 106.5, 
100.5, 66.2, 64.8, 64.6, 61.5, 56.6, 46.1, 41.0, 40.5, 34.8; HRMS (ESI) calculated for 
C23H25BrO7SNa [M+Na]+: 547.0402, found: 547.0388. 
 
Styrene 2.85. DBU (72 μL, 0.48 mmol) added to a solution of benzocycloheptanone 2.84 (195 
mg, 0.37 mmol) in THF (13 mL). The reaction mixture was stirred at room temperature for 
15 min and concentrated under reduced pressure. Purification by flash chromatography 
(elution with 20% v/v ethyl acetate in hexanes) afforded styrene 2.85 (110.5 mg, 75%). Rf = 
0.55 (60% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3): δ 6.69 (s, 1 H), 6.60 (s, 1 
H), 5.00 (t, 1 H, J = 4.5 Hz), 3.96 (m, 2 H), 3.88 (s, 2 H), 3.85 (m, 2 H), 3.76 (s, 3 H), 3.64 (s, 2 
H), 3.08 (s, 2 H), 2.64 (d, 2 H, J = 4.5 Hz); 13C NMR (125 MHz, CDCl3): δ 210.4, 156.1, 155.3, 
137.5, 134.7, 129.4, 119.7, 107.5, 106.5, 103.3, 65.0, 61.7, 56.5, 48.6, 43.6, 42.2; HRMS (ESI) 
calculated for C17H19BrO5Na [M+Na]+: 405.0313, found: 405.0306. 
 
Phthalide 2.87.  A solution of nBuLi (27.0 mL of 2.60 M solution in hexanes, 70.0 mmol) was 
added dropwise to a stirred solution of bromide 2.88 (8.5 mL, 58.4 mmol) in THF (120 mL) 
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at –78 °C. The reaction mixture was stirred 20 min and treated dropwise with DMF (13.5 mL, 
175 mmol). The resulting solution was warmed up to room temperature and diluted with 
water (100 mL). The resulting mixture was extracted with diethyl ether, and the organic 
layer was washed with water, brine, and dried over anhydrous magnesium. The solution was 
concentrated under reduced pressure and the residue was distilled under reduced pressure 
(0.3 Torr; distillation flask at 100 °C) to afford 8.7 g (99% yield) of aldehyde 2.89 as a beige 
liquid.29 NaBH4 was added to a solution of aldehyde 2.89 (640 mg, 4.26 mmol) in MeOH (40 
mL) and stirred at room temperature for 1.5 h. The reaction mixture was then cooled to 0 ˚C, 
quenched with water, concentrated under reduced pressure to remove MeOH, extracted 
with ethyl acetate, washed with brine, dried over anhydrous magnesium sulfate, and 
concentrated under reduced pressure to afford analytically pure alcohol 2.90 (642 mg, 
99%).30 nBuLi (4.21 mL, 2.50 M, 10.53 mmol) was added to a solution of alcohol 2.90 (640 
mg, 4.21 mmol) in Et2O (10 mL) at room temperature. The reaction mixture was then heated 
to 35 ˚C for 4 h, then cooled to –78 ˚C and dry ice (large excess) was added. The reaction 
mixture was then warmed to room temperature and stirred for 1 h before quenching with 
aqueous HCl (2 M) and stirring at room temperature for 16 h. The reaction mixture was then 
extracted with ethyl acetate, washed with brine, dried over anhydrous sodium sulfate, and 
concentrated under reduced pressure. Purification by flash chromatography (gradient 
elution with 20–55% ethyl acetate in hexanes) afforded phthalide 2.87 (567 mg, 77%). 1H 
NMR (500 MHz, CDCl3) δ 6.81 (s, 1H), 6.72 (s, 1H), 5.18 (s, 2H), 3.97 (s, 3H), 2.46 (s, 3H); 13C 
NMR (126 MHz, CDCl3) δ 169.25, 158.48, 149.82, 147.96, 114.28, 111.60, 111.02, 68.63, 
55.95, 22.50.  
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Cyanophthalide 2.93. A solution of nBuLi (4.9 mL of 2.45 M solution in hexanse, 12.0 mmol) 
was added dropwise to a stirred solution of N,N,N-trimethylethylenediamine (1.56 mL, 12.0 
mmol) in diethyl ether (20 mL) at –20 °C. The resulting solution was treated with aldehyde 
47 (1.50 g, 10.0 mmol), and the reaction mixture was stirred 1 h. A solution of nBuLi (4.9 mL 
of 2.45 M solution in hexanse, 12.0 mmol) was added dropwise to the stirred reaction 
mixture at –20 °C, and the resulting solution was warmed up to room temperature. After 1 
h, the reaction mixture was cooled to –78 °C and treated with a large excess of dry ice. The 
resulting slurry was warmed up to room temperature and treated with a solution of KCN (3.0 
g, 46.2 mmol) in water (80 mL). The resulting mixture was cooled to 0 °C and treated with a 
concentrated aqueous solution of HCl (12.5 mL). The resulting solution was warmed up to 
room temperature and stirred 24 h. The resulting mixture was extracted with ethyl acetate 
(two times, 150 mL combined), and the combined organic layers were washed with brine, 
dried over anhydrous MgSO4, and concentrated under reduced pressure. Purification by 
flash chromatography (elution with 50% v/v ethyl acetate in hexanes) afforded 0.98 g (48% 
yield) of cyanophthalide 2.93 as a while solid.31 Rf = 0.44 (50% v/v ethyl acetate in hexanes); 
1H NMR (500 MHz, CDCl3): δ 7.01 (s, 1 H), 6.87 (s, 1 H), 5.93 (s, 1 H), 4.01 (s, 3 H), 2.53 (s, 3 
H). 
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Benzyl bromide 2.98.  Phosphorous tribromide (4.7 mL, 0.05 mol) was added dropwise to a 
stirred suspension of benzyl alcohol 2.141 (25.0 g, 0.10 mol) in diethyl ether (500 mL) at 0 
°C. The reaction mixture was warmed up to room temperature and stirred 15 h. The resulting 
solution was added slowly to the vigorously stirred saturated aqueous solution of NaHCO3 
(500 mL). The mixture was stirred 30 min, and the layers were separated. The aqueous layer 
was extracted with diethyl ether, and the combined organic layers were washed with brine 
and dried over anhydrous MgSO4. The solution was concentrated under reduced pressure 
and the crude product was azeotroped with toluene to afford 31.1 g (99% yield) of benzyl 
bromide 2.98 as a white solid.32 Rf = 0.30 (10% v/v ethyl acetate in hexanes); 1H NMR (500 
MHz, CDCl3): δ 6.60 (s, 2 H), 4.45 (s, 2 H), 3.91 (s, 6 H).  
 
Enol ether 2.99.  A solution of nBuLi (2.0 mL of 2.65 M solution in hexanes, 5.3 mmol) was 
added dropwise to a stirred solution of sulfone 2.69 (1.2 g, 5.0 mmol) in THF (16 mL) at –78 
°C. The reaction mixture was stirred 45 min and treated with anhydrous HMPA (1.80 mL, 
10.4 mmol). The resulting solution was stirred 15 min and treated with allyl chloride 2.97 
(0.75 mL, 6.0 mmol). The reaction mixture was warmed up to room temperature and stirred 
1 h. The resulting solution was cooled to –78 °C and treated dropwise with a solution of nBuLi 
(2.3 mL of 2.65 M solution in hexanes, 6.0 mmol). The reaction mixture was stirred 45 min 
and treated with anhydrous HMPA (2.1 mL, 12.0 mmol). The resulting solution was stirred 
15 min and treated with a solution of benzyl bromide 2.98 (2.5 g, 8.0 mmol) in THF (8 mL). 
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The reaction mixture was warmed up to room temperature and stirred 2 h. The resulting 
solution was diluted with water (100 mL) and extracted with diethyl ether (two times, 200 
mL combined). The combined organic layers were washed with water, brine, and dried over 
anhydrous MgSO4. The solution was concentrated under reduced pressure. Purification by 
flash chromatography (elution with 30% v/v ethyl acetate in hexanes) afforded 2.7 g (95% 
yield) of enol ether 2.99 as a beige waxy solid. For prolonged storage, enol ether 2.99 could 
be converted to its solvate with benzene (2.4:1.0 molar ration of benzene to 2.99; according 
to 1H NMR analysis) according to the following procedure. A solution of enol ether 2.99 (ca. 
0.1 M) in benzene was crystallized at –20 °C. Upon warming to room temperature, a 
suspension of colorless microcrystalline solvate was formed. The solids were collected by 
filtration and dried under reduced pressure. The supernatant was concentrated under 
reduced pressure, and the procedure was repeated with the material recovered from the 
supernatant (>90% recovery of the solvate can be achieved after three cycles). Rf = 0.51 
(50% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3): δ 7.87 (m, 2 H), 7.64 (m, 1 H), 
7.53 (m, 2 H), 6.73 (s, 2 H), 5.31 (t, 1 H, J = 4.2 Hz), 4.89 (d, 1 H, J = 6.1 Hz), 4.82 (d, 1 H, J = 
6.1 Hz), 4.26 (d, 1 H, J = 2.2 Hz), 4.18 (d, 1 H, J = 2.1 Hz), 3.93 (m, 2 H), 3.85 (s, 6 H), 3.83 (m, 
2 H), 3.62 (d, 1 H, J = 14.0 Hz), 3.36 (s, 3 H), 3.19 (d, 1 H, J = 14.0 Hz), 2.85 (d, 1 H, J = 14.9 Hz), 
2.57 (d, 1 H, J = 15.0 Hz), 2.18 (dd, 1 H, J = 16.1, 4.5 Hz), 2.09 (dd, 1 H, J = 16.0, 4.0 Hz); 13C 
NMR (125 MHz, CDCl3): δ 156.7, 156.0, 137.0, 136.2, 133.8, 131.1, 128.8, 108.8, 101.4, 99.7, 
94.4, 90.8, 68.5, 64.9, 64.8, 56.9, 56.6, 39.6, 38.9, 37.7; HRMS (ESI) calculated for 
C25H31BrO8SNa [M+Na]+: 593.0821, found: 593.0825. 
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Enones 2.85 and 2.63.  A solution of enol ether 2.99 (2.7 g, 4.75 mmol) in MeCN (9 mL) was 
added dropwise to a solution of PIFA (3.1 g, 7.15 mmol) in HFIP (40 mL) at 0 ˚C over the 
course of 10 min. The resulting solution was stirred 30 min and diluted with a saturated 
aqueous solution of NaHCO3 (200 mL) containing 5% w/v of Na2SO3. The resulting mixture 
was warmed up to room temperature, stirred vigorously for 4 h, and concentrated to ca. 50% 
of initial volume under reduced pressure. The resulting emulsion was extracted with diethyl 
ether (two times, 200 mL combined). The combined organic layers were washed with brine, 
dried over anhydrous MgSO4, and concentrated under reduced pressure. with hexanes. The 
layers were separated, and the organic layer was washed with water, then brine, dried over 
anhydrous sodium sulfate, and concentrated under reduced pressure. Purification by flash 
chromatography (elution with 25% v/v ethyl acetate in hexanes) afforded 1.45 g (80% yield) 
of a 1:4 mixture of enones 2.63 and 2.85, respectively, as a yellow oil. Data for enone 2.63: 
Rf = 0.37 (60% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3): δ 6.59 (s, 1 H), 5.92 
(s, 1 H), 5.02 (t, 1 H, J = 4.5 Hz), 3.97 (m, 2 H), 3.93 (s, 2 H), 3.88 (s, 3 H), 3.87 (m, 2 H), 3.78 
(s, 3 H), 3.75 (s, 2 H), 2.67 (d, 2 H, J = 4.5 Hz); 13C NMR (125 MHz, CDCl3): δ 194.8, 156.3,, 
155.9, 155.5, 140.2, 131.1, 120.0, 108.4, 105.8, 103.1, 65.1, 61.9, 56.6, 45.7, 43.3, 41.2; HRMS 
(ESI) calculated for C17H19BrO5Na [M+Na]+: 405.0313, found: 405.0306. 
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Pentacycle 2.96. A solution of LiHMDS (318 mg, 1.90 mmol) in DME (3.5 mL) was added to 
a solution of cyanophthalide 2.93 (430 mg, 2.12 mmol) in DME (3.5 mL) at –45 ˚C. The 
reaction mixture was stirred for 30 min followed by the addition of a solution of enones 2.85 
and 2.63 (270 mg, 0.705 mmol) in DME (3.5 mL). The resulting mixture was heated to 60 ˚C 
for 30 min. The reaction mixture was then cooled to 0 ˚C and a solution of concentrated 
aqueous HCl (1.5 mL) in iPrOH (1.5 mL) was added slowly. The resulting solution was heated 
to 70 ºC for 1 h, then cooled to room temperature and diluted with water (50 mL). The 
resulting mixture was extracted with ethyl acetate (two times, 100 mL combined), and the 
combined organic layers were washed with brine, dried with anhydrous MgSO4, and 
concentrated under reduced pressure. Purification by flash chromatography (elution with 
20-50% v/v ethyl acetate in hexanes) afforded 248 mg (68% yield, d. r. = 7:1) of pentacycle 
296 as an amorphous yellow solid. Rf = 0.42 (50% v/v ethyl acetate in hexanes); 1H NMR 
(major diastereomer, 500 MHz, CDCl3): δ 15.94 (s, 1 H), 7.62 (s, 1 H), 7.11 (s, 1 H), 6.30 (s, 1 
H), 4.55-4.51 (m, 1 H), 4.28 (m, 1 H), 3.97 (s, 3 H), 3.88 (s, 3 H), 3.77 (s, 3 H), 3.13 (d, 1 H, J = 
17.0 Hz), 3.04 (d, 1 H, J = 17.0 Hz), 2.89 (dd, 1 H, J = 15.1, 8.3 Hz), 2.48 (s, 3 H), 1.96 (d, 1 H, J 
= 15.1 Hz); 13C NMR (major diastereomer, 125 MHz, CDCl3): δ 199.4, 196.9, 170.3, 160.0, 
156.1, 156.1, 145.4, 136.3, 133.5, 121.3, 120.5, 119.5, 118.7, 109.7, 107.8, 105.9, 70.9, 62.1, 
56.9, 56.4, 51.5, 46.0, 45.3, 39.4, 22.2; HRMS (ESI) calculated for C25H23BrO7Na [M+Na]+: 
537.0525, found: 537.0516. 
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Ketone 2.84.  A solution of enol ether 2.99 (76.2 mg, 0.1 mmol) in MeCN (0.5 mL) was added 
dropwise to a solution of PIDA (40.3 mg, 0.125 mmol) in HFIP (1.5 mL) at 0 ˚C. The resulting 
solution was stirred 10 min and diluted with a saturated aqueous solution of 5% w/v of 
Na2S2O4. The resulting mixture was warmed to room temperature and concentrated under 
reduced pressure to remove HFIP. The resulting mixture was taken up in ethyl acetate, 
washed with water, then brine, dried over anhydrous MgSO4, and concentrated under 
reduced pressure. Purification by flash chromatography (elution with 25-30% v/v ethyl 
acetate in hexanes) afforded 46.2 mg (88% yield) of ketone 2.84 as a white solid. See above 
for spectra. 
 
Sulfone 2.143.  A solution of (3,5-dimethoxyphenyl)acetic acid (1.07 g, 5.48 mmol) in THF 
(10 mL) was added to a stirred suspension of LAH (312 mg, 8.22 mmol) in THF (35 mL). 
After one hour at room temperature the reaction was cooled to 0 ˚C and excess LAH was 
destroyed via the slow addition of 1 mL of water. The mixture was then poured into 1N 
aqueous HCl, extracted with ethyl acetate, and the organic phase was washed with brine, 
dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to yield 
997 mg of crude material. This material was then taken up in dichloromethane (11 mL) and 
CBr4 (2.00 g, 6.03 mmol) was added. The reaction mixture was then cooled to 0 ˚C, and Ph3P 
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(1.58 g, 6.03 mmol) was added slowly. The reaction mixture was then warmed to room 
temperature and stirred for 30 min., after which the solution was poured into water, 
extracted with ethyl acetate, washed with brine, dried with anhydrous magnesium sulfate 
and concentrated under reduced pressure. This crude material was then taken up in cold 
hexanes (70 mL) and diethyl ether (10 mL) and filtered to remove most of the Ph3PO from 
the mixture. The filtrate was then concentrated under reduced pressure. Purification by flash 
chromatography (elution with 2–4% v/v ethyl acetate in hexanes) afforded 1.18 g (88% 
yield) of the bromide as a clear oil.33 The bromide was then taken up in DMF (5 mL), NaSO2Ph 
(951 mg, 5.8 mmol) was added and the reaction mixture was heated to 80 ˚C. After 1 hr at 
this temperature the reaction mixture was cooled to room temperature, diluted with ethyl 
acetate (100 mL), washed with water (four times, 50 mL each), then brine, dried with 
anhydrous MgSO4, and concentrated under reduced pressure. Purification by flash 
chromatography (elution with 10-35% v/v ethyl acetate in hexanes) afforded 1.10 g (74% 
yield) of sulfone 2.143 as a white solid. Rf = 0.43 (40% v/v ethyl acetate in hexanes); 1H NMR 
(500 MHz, CDCl3): δ 7.94 (d, 2 H, J = 7.2 Hz), 7.67 (t, 1 H, J = 7.5 Hz), 7.58 (t, 2 H, J = 7.7 Hz), 
6.30 (t, 1 H, J = 2.2 Hz), 6.25 (d, 2 H, J = 2.2 Hz), 3.74 (s, 6 H), 3.35 (m, 2 H), 2.98 (m, 2 H); 13C 
NMR (125 MHz, CDCl3): δ 161.2, 139.9, 139.2, 133.9, 129.5, 128.2, 106.5, 98.9, 57.6, 55.5, 
29.2; HRMS (ESI) calculated for C16H18O4SNa [M+Na]+: 329.0823, found: 329.0829. 
 
Enol ether 2.144. A solution of nBuLi (0.23 mL of 2.4 M solution in hexanes, 0.55 mmol) was 
added dropwise to a stirred solution of sulfone 2.143 (153 mg, 0.5 mmol) in THF (2.5 mL) 
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and HMPA (0.19 mL, 1.1 mmol) at –78 °C. After stirring for 30 min. at this temperature the 
reaction mixture was transferred via cannula to a solution of chloride 2.97 (0.08 mL, 0.65 
mmol) in THF (2.5 mL) at –78 ˚C. The reaction was then warmed to room temperature and 
quenched with water (0.5 mL), extracted with ethyl acetate, washed with water (three times, 
30 mL each), then brine, dried with anhydrous MgSO4, and concentrated under reduced 
pressure. Purification by flash chromatography (elution with 15-20% v/v ethyl acetate in 
hexanes) afforded 158 mg (75% yield) of enol ether 2.144 as a clear oil containing 4.8 wt. % 
of sulfone 2.133. Rf = 0.43 (40% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3): δ 
7.88 (d, 2 H, J = 7.3 Hz), 7.61 (t, 1 H, J = 7.5 Hz), 7.51 (t, 2 H, J = 7.7 Hz), 6.24 (t, 1 H, J = 2.2 Hz), 
6.21 (d, 1 H, J = 2.2 Hz), 4.65 (d, 1 H, J = 6.1 Hz), 4.63 (d, 1 H, J = 6.1 Hz) , 4.07 (d, 1 H, J = 2.1 
Hz), 4.00 (d, 1 H, J = 1.9 Hz), 3.70 (m, 7 H), 3.26 (m, 4 H), 2.77 (m, 2 H), 2.37 (dd, 1 H, J = 14.6, 
8.5 Hz); 13C NMR (125 MHz, CDCl3): δ 160.8, 155.6, 139.9, 138.3, 133.7, 129.11, 129.06, 107.3, 
98.6, 93.9, 88.1, 62.9, 56.4, 55.4, 34.5, 34.4; HRMS (ESI) calculated for C21H25O6SNa [M+Na]+: 
429.1348, found: 429.1358. 
 
Ketone 2.100.  A solution of enol ether 2.144 (40.0 mg, containing 4.8 wt% sulfone 2.143, 
0.09 mmol) in MeCN (0.5 mL) was added dropwise to a solution of PIDA (37.6 mg, 0.117 
mmol) in HFIP (1.5 mL) at 0 ˚C. The resulting solution was stirred 10 min and diluted with a 
saturated aqueous solution of 5% w/v of Na2S2O4. The resulting mixture was warmed to 
room temperature and concentrated under reduced pressure to remove HFIP. The resulting 
mixture was taken up in ethyl acetate, washed with water, then brine, dried over anhydrous 
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MgSO4, and concentrated under reduced pressure. Purification by flash chromatography 
(elution with 15-20% v/v ethyl acetate in hexanes) afforded 29.7 mg (89% yield) of ketone 
2.100 as a white solid. Rf = 0.42 (50% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, 
CDCl3): δ 7.90 (d, 2 H, J = 7.3 Hz), 7.69 (t, 1 H, J = 7.5 Hz), 7.59 (t, 2 H, J = 7.7 Hz), 6.41 (d, 1 H, 
J = 2.3 Hz), 6.39 (d, 1 H, J = 2.3 Hz), 3.86 (d, 1 H, J = 16.3 Hz), 3.80 (s, 3 H), 3.77 (s, 3 H), 3.65 
(d, 1 H, J = 16.3 Hz), 3.42 (m, 2 H), 3.33 (m, 1 H), 2.87 (dd, 1 H, J = 12.9, 8.7 Hz), 2.56 (dd, 1 H, 
J = 12.7, 4.9 Hz); 13C NMR (125 MHz, CDCl3): δ 204.3, 159.9, 157.8, 137.5, 136.7, 134.3, 129.5, 
129.1, 114.0, 106.7, 98.0, 61.5, 55.8, 55.5, 42.2, 40.0, 31.4; HRMS (ESI) calculated for 
C19H20O5SNa [M+Na]+: 383.0929, found: 383.0931. 
 
Sulfone 2.146.  A solution of (3,4,5-trimethoxyphenyl)acetic acid 2.145 (579 mg, 2.56 mmol) 
in THF (5 mL) was added to a stirred suspension of LAH (171 mg, 4.5 mmol) in THF(20 mL). 
After one hour at room temperature the reaction was cooled to 0 ˚C and excess LAH was 
destroyed via the slow addition of 1 mL of water. The mixture was then poured into 1 N 
aqueous HCl, extracted with ethyl acetate, and the organic phase was washed with brine, 
dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to yield 
493 mg of crude material. This material was then taken up in dichloromethane (6 mL) and 
CBr4 (839 mg, 2.53 mmol) was added. The reaction mixture was then cooled to 0 ˚C, and Ph3P 
(664 mg, 2.53 mmol) was added slowly. The reaction mixture was then warmed to room 
temperature and stirred for 2 h, after which the solution was poured into water, extracted 
with ethyl acetate, washed with brine, dried with anhydrous magnesium sulfate and 
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concentrated under reduced pressure. This crude material was then taken up in cold hexanes 
(70 mL) and diethyl ether (10 mL) and filtered to remove most of the Ph3PO from the 
mixture. The filtrate was then concentrated under reduced pressure. The crude bromide was 
then taken up in DMF (5 mL), NaSO2Ph (755 mg, 4.6 mmol) was added and the reaction 
mixture was heated to 80 ˚C. After 16 hr at this temperature the reaction mixture was cooled 
to room temperature, diluted with ethyl acetate, washed with water (four times, 30 mL 
each), then brine, dried with anhydrous MgSO4, and concentrated under reduced pressure. 
Purification by flash chromatography (elution with 15-35% v/v ethyl acetate in hexanes) 
afforded 388 mg (50% yield) of sulfone 2.146 as a white solid. Rf = 0.37 (50% v/v ethyl 
acetate in hexanes); 1H NMR (500 MHz, CDCl3): δ 7.94 (d, 2 H, J = 7.2 Hz), 7.67 (t, 1 H, J = 7.5 
Hz), 7.58 (t, 2 H, J = 7.7 Hz), 6.32 (s, 2 H), 3.81 (s, 6 H), 3.79 (s, 3 H), 3.36 (m, 2 H), 3.01 (m, 2 
H); 13C NMR (125 MHz, CDCl3): δ 153.5, 139.2, 137.0, 133.8, 133.1, 129.4, 128.2, 105.5, 60.9, 
57.7, 56.2, 29.1; HRMS (ESI) calculated for C17H20O5SNa [M+Na]+: 359.0929, found: 
359.0920. 
 
Enol ether 2.147. A solution of nBuLi (0.475 mL of 2.47 M solution in hexanes, 1.17 mmol) 
was added dropwise to a stirred solution of sulfone 2.146 (303 mg, 0.902 mmol) in THF (4.5 
mL) and HMPA (0.408 mL, 2.35 mmol) at –78 °C. After stirring for 30 min at this temperature 
the reaction mixture was transferred via cannula to a solution of chloride 2.97 (0.147 mL, 
1.17 mmol) in THF (4.5 mL) at –78 ˚C. The reaction was then warmed to room temperature, 
stirred for 1 h, and quenched with water (0.5 mL), extracted with ethyl acetate, washed with 
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water (three times, 30 mL each), then brine, dried with anhydrous MgSO4, and concentrated 
under reduced pressure. Purification by flash chromatography (elution with 20-30% v/v 
ethyl acetate in hexanes) afforded 370 mg (94% yield) of enol ether 2.147 as a clear oil. Rf = 
0.37 (50% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3): δ 7.87 (m, 2 H), 7.61 (m, 
1 H), 7.51 (m, 2 H), 6.28 (s, 2 H), 4.67 (d, 1 H, J = 6.0 Hz), 4.66 (d, 1 H, J = 6.0 Hz), 4.08 (d, 1 H, 
J = 2.2 Hz), 4.01 (d, 1 H, J = 2.1 Hz) , 3.78 (s, 3 H), 3.77 (s, 6 H), 3.70 (m, 1 H), 3.28 (m, 4 H), 
2.80 (m, 2 H), 2.37 (dd, 1 H, J = 14.5, 8.8 Hz); 13C NMR (125 MHz, CDCl3): δ 155.6, 153.1, 138.4, 
136.8, 133.8, 133.3, 129.1, 129.0, 106.3, 94.0, 88.1, 63.1, 60.9, 56.5, 56.2, 34.6, 34.5; HRMS 
(ESI) calculated for C22H28O7SNa [M+Na]+: 459.1454, found: 459.1461. 
 
Ketone 2.101.  A solution of enol ether 2.147 (37.8 mg, 0.087 mmol) in MeCN (0.5 mL) was 
added dropwise to a solution of PIFA (46.5 mg, 0.108 mmol) in HFIP (1.5 mL) at 0 ˚C. The 
resulting solution was stirred 10 min and diluted with a saturated aqueous solution of 5% 
w/v of Na2S2O4. The resulting mixture was warmed to room temperature and concentrated 
under reduced pressure to remove HFIP. The resulting mixture was taken up in ethyl acetate, 
washed with water, then brine, dried over anhydrous MgSO4, and concentrated under 
reduced pressure. Purification by flash chromatography (elution with 15-25% v/v ethyl 
acetate in hexanes) afforded 24 mg (71% yield) of ketone 2.101 as a white solid. Rf = 0.37 
(50% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3): δ 7.89 (m, 2 H), 7.70 (m, 1 H), 
7.60 (m, 2 H), 6.61 (s, 1 H), 3.86 (s, 3 H), 3.84 (m, 4 H), 3.81 (s, 3 H), 3.69 (d, 1 H, J = 15.4 Hz), 
3.40 (m, 3 H), 2.90 (m, 1 H), 2.56 (m, 1 H); 13C NMR (125 MHz, CDCl3): δ 203.5, 152.8, 151.6, 
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142.1, 136.7, 134.4, 131.3, 129.6, 129.2, 119.6, 109.7, 61.9, 61.6, 61.1, 56.3, 43.3, 41.0, 31.5; 
HRMS (ESI) calculated for C20H22O6SNa [M+Na]+: 413.1035, found: 413.1043. 
 
Sulfone 2.149.  A solution of (3-methoxyphenyl)acetic acid 2.148 (499 mg, 3.00 mmol) in 
THF (5 mL) was added to a stirred suspension of LAH (171 mg, 4.5 mmol) in THF(20 mL). 
After one hour at room temperature the reaction was cooled to 0 ˚C and excess LAH was 
destroyed via the slow addition of 1 mL of water. The mixture was then poured into 1 N 
aqueous HCl, extracted with ethyl acetate, and the organic phase was washed with brine, 
dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to yield 
468 mg of crude material. This material was then taken up in dichloromethane (7 mL) and 
CBr4 (1.12 g, 3.38 mmol) was added. The reaction mixture was then cooled to 0 ˚C, and Ph3P 
(887 mg, 3.38 mmol) was added slowly. The reaction mixture was then warmed to room 
temperature and stirred for 2 h, after which the solution was poured into water, extracted 
with ethyl acetate, washed with brine, dried with anhydrous magnesium sulfate and 
concentrated under reduced pressure. This crude material was then taken up in cold hexanes 
(70 mL) and diethyl ether (10 mL) and filtered to remove most of the Ph3PO from the 
mixture. The filtrate was then concentrated under reduced pressure. The crude bromide was 
then taken up in DMF (6 mL), NaSO2Ph (985 mg, 6.00 mmol) was added and the reaction 
mixture was heated to 80 ˚C. After 16 hr at this temperature the reaction mixture was cooled 
to room temperature, diluted with ethyl acetate, washed with water (four times, 30 mL 
each), then brine, dried with anhydrous MgSO4, and concentrated under reduced pressure. 
Purification by flash chromatography (elution with 5–15% v/v ethyl acetate in hexanes) 
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afforded 386 mg (45% yield) of sulfone 2.149 as a white solid. Rf = 0.43 (40% v/v ethyl 
acetate in hexanes); 1H NMR (500 MHz, CDCl3): δ 7.94 (m, 2 H), 7.67 (m, 1 H), 7.58 (m, 2 H), 
7.18 (t, 1 H, J = 7.9 Hz), 6.74 (m, 1 H), 6.70 (m, 1 H), 6.65 (m, 1 H), 3.76 (s, 3 H), 3.36 (m, 2 H), 
3.02 (m, 2H); 13C NMR (125 MHz, CDCl3): δ 160.1, 139.21, 139.15, 133.9, 130.0, 129.5, 128.2, 
120.7, 114.3, 112.4, 57.6, 55.4, 28.9; HRMS (ESI) calculated for C15H16O3SNa [M+Na]+: 
299.0718, found: 299.0720. 
 
Enol ether 2.150. A solution of n-BuLi (0.476 mL of 2.47 M solution in hexanes, 1.17 mmol) 
was added dropwise to a stirred solution of sulfone 2.149 (250 mg, 0.905 mmol) in THF (4.5 
mL) and HMPA (0.409 mL, 2.35 mmol) at –78 °C. After stirring for 30 min at this temperature 
the reaction mixture was transferred via cannula to a solution of chloride 2.97 (0.147 mL, 
1.17 mmol) in THF (4.5 mL) at –78 ˚C. The reaction was then warmed to room temperature, 
stirred for 1 h, and quenched with water (0.5 mL), extracted with ethyl acetate, washed with 
water (three times, 30 mL each), then brine, dried with anhydrous MgSO4, and concentrated 
under reduced pressure. Purification by flash chromatography (elution with 5-15% v/v ethyl 
acetate in hexanes) afforded 384 mg (83% yield) of enol ether 2.150 as a clear oil. Rf = 0.43 
(40% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3): δ 7.88 (m, 2 H), 7.61 (m, 1 H), 
7.51 (m, 2 H), 7.10 (t, 1 H, J = 7.9 Hz), 6.68 (m, 1 H), 6.66 (m, 1 H), 6.61 (t, 1 H, J = 2.0 Hz), 4.62 
(d, 1 H, J = 6.1 Hz), 4.60 (d, 1 H, J = 6.1 Hz), 4.06 (d, 1 H, J = 2.2 Hz), 3.99 (d, 1 H, J = 2.2 Hz), 
3.74 (s, 3 H), 3.71 (m, 1 H), 3.30 (dd, 1 H, J = 14.7, 5.1 Hz), 3.26 (s, 3 H), 2.80 (m, 2 H), 2.36 
(dd, 1 H, J = 14.5, 8.6 Hz); 13C NMR (125 MHz, CDCl3): δ 159.7, 155.6, 139.2, 138.3, 133.7, 
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129.4, 129.14, 129.08, 121.6, 115.0, 112.0, 110.1, 93.9, 88.1, 63.0, 56.4, 55.3, 34.6, 34.2; HRMS 
(ESI) calculated for C20H24O5SNa [M+Na]+: 399.1242, found: 399.1243. 
 
Ketone 2.102.  A solution of enol ether 2.150 (40.0 mg, 0.106 mmol) in MeCN (0.5 mL) was 
added dropwise to a solution of PIFA (57.0 mg, 0.133 mmol) in HFIP (1.5 mL) at 0 ˚C. The 
resulting solution was stirred 10 min and diluted with a saturated aqueous solution of 5% 
w/v of Na2S2O4. The resulting mixture was warmed to room temperature and concentrated 
under reduced pressure to remove HFIP. The resulting mixture was taken up in ethyl acetate, 
washed with water, then brine, dried over anhydrous MgSO4, and concentrated under 
reduced pressure. Purification by flash chromatography (elution with 5–10% v/v ethyl 
acetate in hexanes) afforded 15 mg (43% yield, r.r. = ca. 16:1) of ketone 2.102 as a white 
solid. Rf = 0.31 (40% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3): δ 7.91 (m, 2 
H), 7.70 (m, 1 H), 7.60 (m, 2 H), 7.04 (d, 1 H, J = 8.2 Hz), 6.78 (d, 1 H, J = 2.6 Hz), 6.75 (dd, 1 H, 
J = 8.2, 2.7 Hz), 3.89 (d, 1 H, J = 15.2 Hz), 3.79 (s, 3 H), 3.47 (d, 1 H, J = 15.3 Hz), 3.40 (m, 3 H), 
2.86 (m, 1 H), 2.62 (dd, 1 H, J = 13.6, 4.6 Hz); 13C NMR (125 MHz, CDCl3): δ 203.2, 159.4, 
136.65, 136.58, 134.3, 130.8, 129.5, 129.1, 125.3, 116.1, 113.1, 61.5, 55.4, 48.7, 42.6, 31.5; 
HRMS (ESI) calculated for C18H18O4SNa [M+Na]+: 353.0823, found: 353.0825. 
 
Sulfonamide 2.151. K2CO3 (414 mg, 3 mmol) was added to a solution of bromide 2.71 (462 
mg, 2 mmol, prepared according to a known procedure34) and p-toluenesulfonamide (1.37 
96 
 
g, 8 mmol), in acetone (20 mL) and heated to reflux. After 22 h the reaction mixture was 
cooled to room temperature, filtered, and concentrated under reduced pressure. Purification 
by flash chromatography (elution with 10-25% v/v ethyl acetate in hexanes) afforded 360 
mg (56% yield) of sulfonamide 2.151 as a beige solid. Rf = 0.44 (40% v/v ethyl acetate in 
hexanes); 1H NMR (500 MHz, CDCl3): δ 7.76 (d, 2 H, J = 8.3 Hz), 7.31 (d, 2 H, J = 8.0 Hz), 6.34 
(t, 1 H, J = 2.2 Hz), 6.32 (d, 2 H, J = 2.1 Hz), 4.58 (t, 1 H, J = 5.5 Hz), 4.07 (d, 2 H, J = 6.1 Hz), 
3.73 (s, 6 H), 2.44 (s, 3 H); 13C NMR (125 MHz, CDCl3): δ 161.2, 143.7, 138.7, 137.1, 129.9, 
127.4, 105.8, 100.1, 55.5, 47.6, 21.7; HRMS (ESI) calculated for C16H19NO4SNa [M+Na]+: 
344.0933, found: 344.0937. 
 
Enol ether 2.152. A solution of 2.151 (350 mg, 1.09 mmol) in DMF (2.5 mL) was added to a 
suspension of NaH (29 mg, 1.2 mmol) in DMF (1 mL) at 0 ˚C. After 20 min. chloride 2.97 (0.15 
mL, 1.2 mmol) was added as a solution in DMF (1 mL), and the reaction was heated to 50 ˚C 
for 2 h. The reaction mixture was then cooled to room temperature, diluted with ethyl 
acetate, washed with water (four times, 30 mL each), then brine, dried with anhydrous 
MgSO4, and concentrated under reduced pressure. Purification by flash chromatography 
(elution with 5-15% v/v ethyl acetate in hexanes) afforded 437 mg (95% yield) of enol ether 
2.152 as a clear oil. Rf = 0.53 (40% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3): 
δ 7.77 (d, 2 H, J = 8.4 Hz), 7.28 (d, 2 H, J = 8.5 Hz), 6.42 (d, 2 H, J = 2.3 Hz), 6.36 (t, 1 H, J = 2.3 
Hz), 4.65 (s, 2 H), 4.33 (s, 2 H), 4.24 (d, 1 H, J = 2.3 Hz), 4.08 (d, 1 H, J = 2.3 Hz) , 3.82 (s, 2 H), 
3.74 (s, 6 H), 3.22 (s, 3 H), 2.42 (s, 3 H); 13C NMR (125 MHz, CDCl3): δ 161.0, 154.9, 143.1, 
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138.5, 138.2, 129.4, 127.7, 106.5, 100.0, 93.7, 89.1, 56.2, 55.5, 50.6, 49.4, 21.6; HRMS (ESI) 
calculated for C21H27NO6SNa [M+Na]+: 444.1457, found: 444.1460. 
 
Ketone 2.103.  A solution of enol ether 2.152 (38 mg, 0.09 mmol) in MeCN (0.5 mL) was 
added dropwise to a solution of PIDA (36 mg, 0.123 mmol) in HFIP (1.5 mL) at 0 ˚C. The 
resulting solution was stirred 10 min and diluted with a saturated aqueous solution of 5% 
w/v of Na2S2O4. The resulting mixture was warmed to room temperature and concentrated 
under reduced pressure to remove HFIP. The resulting mixture was taken up in ethyl acetate, 
washed with water, then brine, dried over anhydrous MgSO4, and concentrated under 
reduced pressure. Purification by flash chromatography (elution with 15-20% v/v ethyl 
acetate in hexanes) afforded 29 mg (86% yield) of ketone 2.103 as a white solid. Rf = 0.45 
(40% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3): δ 7.68 (d, 2 H, J = 8.4 Hz), 7.32 
(d, 2 H, J = 8.1 Hz), 6.36 (d, 1 H, J = 2.3 Hz), 6.22 (d, 1 H, J = 2.3 Hz), 4.57 (s, 2 H), 3.95 (s, 2 H), 
3.89 (s, 2 H), 3.77 (s, 3 H), 3.76 (s, 3 H), 2.43 (s, 3 H); 13C NMR (125 MHz, CDCl3): δ 205.3, 
159.7, 158.5, 144.1, 135.5, 135.4, 130.1, 127.3, 112.0, 104.1, 98.2, 57.5, 56.0, 55.5, 52.9, 37.9, 
21.7; HRMS (ESI) calculated for C19H21NO5SNa [M+Na]+: 398.1038, found: 398.1042. 
 
Enol ether 2.155. A solution of benzoic acid 2.153 (911 mg, 5 mmol) in THF (10 mL) was 
added to a stirred suspension of LAH (285 mg, 7.5 mmol) in THF (15 mL). After one hour at 
98 
 
room temperature the reaction was cooled to 0 ˚C and excess LAH was destroyed via the slow 
addition of 1 mL of water. The mixture was then poured into 1 N aqueous HCl, extracted with 
ethyl acetate, and the organic phase was washed with brine, dried over anhydrous 
magnesium sulfate, and concentrated under reduced pressure to yield 835 mg of benzyl 
alcohol 2.154.32 A solution of 2.154 (185 mg, 1.1 mmol) in DMF (3 mL) was added to a 
suspension of NaH (26 mg, 1.1 mmol) in DMF (1 mL) at 0 ˚C. After 20 min. chloride 2.97 (0.13 
mL, 1 mmol) was added as a solution in DMF (2 mL), and the reaction was heated to 50 ˚C 
for 20 h. The reaction mixture was then cooled to room temperature, diluted with ethyl 
acetate, washed with water (four times, 30 mL each), then brine, dried with anhydrous 
MgSO4, and concentrated under reduced pressure. Purification by flash chromatography 
(elution with 5-10% v/v ethyl acetate in hexanes) afforded 220 mg (82% yield) of enol ether 
2.155 as a clear oil. Rf = 0.44 (30% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3): 
δ 6.52 (d, 2 H, J = 2.3 Hz), 6.39 (t, 1 H, J = 2.5 Hz), 5.01 (s, 2 H), 4.51 (s, 2 H), 4.39 (d, 1 H, J = 
2.1 Hz), 4.34 (d, 1 H, J = 2.1 Hz), 3.96 (s, 2 H), 3.79 (s, 6 H), 3.44 (2, 3 H); 13C NMR (125 MHz, 
CDCl3): δ 161.0, 156.9, 140.7, 105.5, 99.9, 93.9, 87.7, 72.2, 70.5, 56.3, 55.5; HRMS (ESI) 
calculated for C14H20O5Na [M+Na]+: 291.1208, found: 291.1207. 
 
Ketone 2.104.  A solution of enol ether 2.155 (34.0 mg, 0.127 mmol) in MeCN (0.63 mL) was 
added dropwise to a solution of PIDA (51 mg, 0.158 mmol) in HFIP (1.9 mL) at 0 ˚C. The 
resulting solution was stirred 10 min and diluted with a saturated aqueous solution of 5% 
w/v of Na2S2O4. The resulting mixture was warmed to room temperature and concentrated 
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under reduced pressure to remove HFIP. The resulting mixture was taken up in ethyl acetate, 
washed with water, then brine, dried over anhydrous MgSO4, and concentrated under 
reduced pressure. Purification by flash chromatography (elution with 5-10% v/v ethyl 
acetate in hexanes) afforded 21 mg (75% yield) of ketone 2.104 as a white solid. Rf = 0.38 
(30% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3): δ 6.36 (d, 1 H, J = 2.3 Hz), 6.12 
(d, 1 H, J = 2.2 Hz), 5.02 (s, 2 H), 4.16 (s, 2 H), 4.09 (s, 2 H), 3.79 (s, 3 H), 3.78 (s, 3 H); 13C NMR 
(125 MHz, CDCl3): δ 210.0, 159.6, 158.5, 138.3, 110.7, 101.4, 97.8, 76.5, 75.1, 56.0, 55.4, 37.4; 
HRMS (ESI) calculated for C12H14O4Na [M+Na]+: 245.0790, found: 245.0798. 
 
Enol ether 2.157. A solution of (3,5-dimethoxyphenyl)acetic acid 2.142 (589 mg, 3 mmol) 
in THF (10 mL) was added to a stirred suspension of LAH (171 mg, 4.5 mmol) in THF (15 
mL). After one hour at room temperature the reaction was cooled to 0 ˚C and excess LAH was 
destroyed via the slow addition of 1 mL of water. The mixture was then poured into 1N 
aqueous HCl, extracted with ethyl acetate, and the organic phase was washed with brine, 
dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to yield 
835 mg of benzylic alcohol 2.156.35 A solution of 2.156 (181 mg, 1 mmol) in DMF (3 mL) 
was added to a suspension of NaH (26 mg, 1.1 mmol) in DMF (1 mL) at 0 ˚C. After 20 min. 
chloride 2.97 (0.138 mL, 1.1 mmol) was added as a solution in DMF (2 mL), and the reaction 
was heated to 50 ˚C for 15 h. The reaction mixture was then cooled to room temperature, 
diluted with ethyl acetate, washed with water (four times, 50 mL each), then brine, dried 
with anhydrous MgSO4, and concentrated under reduced pressure. Purification by flash 
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chromatography (elution with 2.5–5% v/v ethyl acetate in hexanes) afforded 178 mg (63% 
yield) of enol ether 2.157 as a clear oil. Rf = 0.34 (20% v/v ethyl acetate in hexanes); 1H NMR 
(500 MHz, CDCl3): δ 6.39 (d, 2 H, J = 2.3 Hz), 6.32 (t, 1 H, J = 2.3 Hz), 5.00 (s, 2 H), 4.35 (d, 1 
H, J = 2.1 Hz), 4.29 (d, 1 H, J = 2.1 Hz), 3.94 (s, 2 H), 3.78 (s, 6 H), 3.68 (t, 2 H, J = 7.2), 3.42 (s, 
3 H), 2.86 (t, 2 H, J = 7.2); 13C NMR (125 MHz, CDCl3): δ 161.9, 157.0, 141.4, 107.2, 98.4, 93.8, 
87.4, 71.44, 71.37, 56.3, 55.4, 36.7; HRMS (ESI) calculated for C15H22O5Na [M+Na]+: 
305.1365, found: 305.1367. 
 
Ketone 2.105.  A solution of enol ether 2.157 (30.9 mg, 0.109 mmol) in MeCN (0.5 mL) was 
added dropwise to a solution of PIDA (44.0 mg, 0.137 mmol) in HFIP (1.5 mL) at 0 ˚C. The 
resulting solution was stirred 10 min and diluted with a saturated aqueous solution of 5% 
w/v of Na2S2O4. The resulting mixture was warmed to room temperature and concentrated 
under reduced pressure to remove HFIP. The resulting mixture was taken up in ethyl acetate, 
washed with water, then brine, dried over anhydrous MgSO4, and concentrated under 
reduced pressure. Purification by flash chromatography (elution with 5% v/v ethyl acetate 
in hexanes) afforded 14 mg (54% yield) of ketone 2.105 as a white solid. Rf = 0.33 (30% v/v 
ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3): δ 6.38 (d, 1 H, J = 2.5 Hz), 6.32 (d, 1 H, J 
= 2.5 Hz), 3.97 (m, 4 H), 3.91 (s, 2 H), 3.81 (s, 3 H), 3.80 (s, 3 H), 3.01 (m, 2 H); 13C NMR (125 
MHz, CDCl3): δ 210.7, 159.9, 159.4, 141.4, 113.7, 106.8, 97.1, 77.7, 76.5, 56.0, 55.5, 39.2, 38.0; 
HRMS (ESI) calculated for C13H17O4 [M+H]+: 237.1127, found: 237.1120. 
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Enol ether 2.158. To a solution of K2CO3 (498 mg, 3.6 mmol), KI (25 mg, 0.15 mmol), and 
dimethyl malonate (0.345 mL, 3 mmol) in MeCN (6 mL) was added enol ether 2.97 (0.395 
mL, 3.15 mmol) and the reaction mixture was stirred at 70 ˚C. After 16 h at this temperature, 
the reaction mixture was filtered through celite and concentrated under reduced pressure. 
Purification by flash chromatography (gradient elution with 2.5–10% v/v ethyl acetate in 
hexanes) afforded enol ether 2.158 (250 mg, 36%). Rf = 0.47 (30% v/v ethyl acetate in 
hexanes); 1H NMR (500 MHz, CDCl3) δ 4.91 (s, 2H), 4.17 (d, J = 2.2 Hz, 1H), 4.07 (d, J = 2.2 Hz, 
1H), 3.74 (s, 6H), 3.70 (d, J = 7.7 Hz, 1H), 3.40 (s, 3H), 2.73 (d, J = 7.7 Hz, 2H); 13C NMR (126 
MHz, CDCl3) δ 169.26, 156.68, 93.74, 86.62, 56.19, 52.59, 50.03, 34.53. 
 
Enol ether 2.106. A solution of enol ether 2.158 (123 mg, 0.48 mmol) in THF (1 mL) was 
added to a suspension of NaH (13.8 mg, 0.58 mmol) in THF (1 mL) at 0 ˚C and the reaction 
mixture was warmed to room temperature. After 20 min the reaction mixture was cooled to 
0 ˚C followed by the addition of a solution of bromide 2.15936 (103.5 mg, 0.48 mmol) in THF 
(1 mL). The reaction mixture was then warmed to room temperature and stirred for 15 h, 
then quenched with water, extracted with ethyl acetate, washed with brine, dried over 
anhydrous magnesium sulfate, and concentrated under reduced pressure. Purification by 
flash chromatography afforded enol ether 2.106 (122 mg, 63%). Rf = 0.44 (30% v/v ethyl 
acetate in hexanes); 1H NMR (500 MHz, CDCl3) δ 6.73 – 6.67 (m, 2H), 6.63 (dd, J = 7.9, 1.7 Hz, 
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1H), 5.92 (s, 2H), 4.92 (s, 2H), 4.29 (d, J = 2.1 Hz, 1H), 4.10 (d, J = 2.1 Hz, 1H), 3.70 (s, 6H), 
3.45 (s, 3H), 3.23 (s, 2H), 2.75 (s, 2H); 13C NMR (126 MHz, CDCl3) δ 171.10, 156.65, 147.47, 
146.51, 129.80, 123.42, 110.60, 108.05, 100.91, 94.01, 88.72, 58.32, 56.54, 52.35, 37.44, 
37.34. 
 
Sulfone 2.161. Bromide 2.16037 (1.175g, 5 mmol) was then taken up in DMF (10 mL), 
NaSO2Ph (1.23 g, 7.5 mmol) was added and the reaction mixture was heated to 80 ˚C. After 
16 hr at this temperature the reaction mixture was cooled to room temperature, diluted with 
ethyl acetate, washed with water (four times, 30 mL each), then brine, dried with anhydrous 
MgSO4, and concentrated under reduced pressure. Purification by flash chromatography 
(elution with 5–15% v/v ethyl acetate in hexanes) afforded 513 mg (35% yield) of sulfone 
2.161. 1H NMR (500 MHz, CDCl3) δ 8.03 – 7.98 (m, 2H), 7.87 – 7.83 (m, 1H), 7.80 (dd, J = 8.6, 
1.4 Hz, 1H), 7.73 (d, J = 8.2 Hz, 1H), 7.71 – 7.67 (m, 1H), 7.61 (dd, J = 8.3, 7.2 Hz, 2H), 7.52 – 
7.46 (m, 2H), 7.36 (dd, J = 8.2, 7.0 Hz, 1H), 7.27 (d, J = 7.5 Hz, 1H), 3.57 – 3.40 (m, 4H). 
 
Enol ether 2.109. A solution of nBuLi (0.470 mL of 2.47 M solution in hexanes, 1.16 mmol) 
was added dropwise to a stirred solution of sulfone 2.161 (2564mg, 0.891 mmol) in THF 
(4.5 mL) and HMPA (0.404 mL, 2.32 mmol) at –78 °C. After stirring for 30 min at this 
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temperature the reaction mixture was transferred via cannula to a solution of chloride 2.97 
(0.145 mL, 1.16 mmol) in THF (4.5 mL) at –78 ˚C. The reaction was then warmed to room 
temperature, stirred for 1 h, and quenched with water (0.5 mL), extracted with ethyl acetate, 
washed with water (three times, 30 mL each), then brine, dried with anhydrous MgSO4, and 
concentrated under reduced pressure. Purification by flash chromatography (elution with 5-
10% v/v ethyl acetate in hexanes) afforded 295 mg (83% yield) of enol ether 2.109 as a clear 
oil. Rf = 0.41 (25% v/v ethyl acetate in hexanes); 1H NMR (500 MHz, CDCl3) δ 7.91 – 7.86 (m, 
3H), 7.82 – 7.78 (m, 1H), 7.68 (dd, J = 6.4, 3.0 Hz, 1H), 7.61 – 7.57 (m, 1H), 7.51 – 7.43 (m, 
4H), 7.32 – 7.28 (m, 2H), 4.32 (d, J = 6.1 Hz, 1H), 4.27 (d, J = 6.1 Hz, 1H), 3.99 – 3.93 (m, 2H), 
3.86 (d, J = 2.3 Hz, 1H), 3.83 (d, J = 2.3 Hz, 1H), 3.19 – 3.12 (m, 1H), 3.04 (s, 3H), 2.81 (dd, J = 
14.9, 5.1 Hz, 1H), 2.43 (dd, J = 14.9, 7.3 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 155.42, 138.11, 
133.88, 133.59, 132.76, 131.81, 128.96, 128.92, 128.44, 127.88, 126.28, 125.63, 125.17, 
123.26, 93.57, 87.55, 61.22, 56.08, 34.45, 32.31. 
 
Ketone 2.110. A solution of enol ether 2.109 (37.5 mg, 95 μmol) in MeCN (0.5 mL) was added 
to a solution of PIFA (50.8 mg, 0.118 mmol) in HFIP (1.5 mL) at 0 ˚C. After 10 min at this 
temperature the reaction mixture was diluted with a saturated aqueous solution of 5% w/v 
of Na2S2O4. The resulting mixture was warmed to room temperature and concentrated under 
reduced pressure to remove HFIP. The resulting mixture was taken up in ethyl acetate, 
washed with water, then brine, dried over anhydrous MgSO4, and concentrated under 
reduced pressure to afford 41.5 mg (94% yield) of ketone 2.110. 1H NMR (500 MHz, CDCl3) 
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δ 7.97 – 7.93 (m, 2H), 7.81 (d, J = 8.1 Hz, 1H), 7.75 – 7.69 (m, 2H), 7.60 (d, J = 7.9 Hz, 2H), 7.47 
– 7.41 (m, 2H), 7.40 – 7.36 (m, 1H), 7.34 (dd, J = 8.3, 7.0 Hz, 1H), 7.22 (d, J = 6.9 Hz, 1H), 4.76 
(d, J = 16.5 Hz, 1H), 4.65 (d, J = 16.4 Hz, 1H), 4.34 – 4.26 (m, 1H), 3.69 (dd, J = 14.2, 4.0 Hz, 
1H), 3.21 – 3.11 (m, 2H), 2.55 (dd, J = 17.4, 4.2 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 196.72, 
137.21, 134.31, 134.03, 131.54, 131.33, 129.53, 129.21, 128.87, 128.66, 127.79, 126.78, 
126.07, 125.28, 122.49, 69.47, 60.44, 35.76, 31.96. 
 
 
Ketone 2.114. 1,2-Dichlorobenzene (8 mL) was added to a round bottom flask containing 
2.96 (392 mg, 0.761 mmol) and 1, 1’-thiocarbonyldiimidazole (271 mg, 1.52 mmol). The 
resulting solution was heated to 140 ˚C for 2 h, then cooled to room temperature. The 
reaction mixture was loaded directly onto a column. Purification by flash chromatography 
(elution with 20% v/v ethyl acetate in hexanes) afforded 201 mg (53 % yield) of ketone 
2.114 as a flakey yellow solid. Rf = 0.50 (40% v/v ethyl acetate in hexanes); 1H NMR (500 
MHz, CDCl3): δ 15.15 (s, 1 H), 7.66 (s, 1 H), 7.12 (s, 1 H), 6.65 (dd, 1 H, J = 8.6, 1.0 Hz), 6.46 
(dd, 1 H, J = 8.6, 6.9 Hz), 6.24 (s, 1 H), 4.62 (dd, 1 H, J = 6.9, 1.0 Hz), 3.97 (s, 3 H), 3.91 (s, 3 H), 
3.75 (s, 3 H,), 3.06 (d, 1 H, J = 16.7 Hz), 2.94 (d, 1 H, J = 16.7 Hz), 2.49 (s, 3 H); 13C NMR (125 
MHz, CDCl3): δ 200.9, 197.1, 166.8, 159.7, 155.9, 155.8, 145.1, 136.3, 133.1, 131.8, 131.6, 
122.0, 121.6, 119.6, 118.6, 110.7, 106.2, 105.6, 62.2, 56.9, 56.5, 50.1, 45.6, 39.5, 22.2; HRMS 
(ESI) calculated for C25H21BrO6Na [M+Na]+: 519.0419, found: 519.0427. 
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Benzyl alcohol 2.115.  A solution of sodium hydrosulfite (239 mg, 1.37 mmol) and sodium 
bicarbonate (277 mg, 3.29 mmol) in water (6 mL) was added to a solution of 2.114 in DMF 
(12 mL) at 80 ˚C. The reaction mixture was stirred at 80 ˚C for 1.5 h, then cooled to room 
temperature and diluted with water (50 mL). The resulting solution was extracted with ethyl 
acetate (two times, 150 mL combined). The combined organic layers were washed with 
water (four times, 50 mL each) then brine, and dried with anhydrous MgSO4. Concentration 
under reduced pressure afforded 273 mg (ca. 100%) of benzyl alcohol 2.115 as an 
amorphous yellow solid. Benzyl alcohol 2.115 could be crystallized by slow evaporation 
from benzene to yield yellow crystals suitable for x-ray crystallographic analysis. Rf = 0.30 
(40% v/v ethyl acetate in hexanes); 1H NMR (600 MHz, CDCl3): δ 14.77 (s, 1 H), 7.19 (s, 1 H), 
6.77 (s, 1 H), 6.44 (dd, 1 H, J = 8.4, 6.8 Hz), 6.40 (dd, 1 H, J = 8.4, 1.0 Hz), 6.26 (s, 1 H), 5.01 (d, 
1 H, J = 4.2 Hz), 4.56 (dd, 1 H, J = 6.8, 1.0 Hz), 3.90 (s, 3 H), 3.88 (s, 3 H), 3.72 (s, 3 H), 2.98 (d, 
1 H, J = 16.8 Hz), 2.65 (d, 1 H, J = 16.8 Hz), 2.45 (s, 3 H), 2.42-2.38 (br s, 1 H); 13C NMR (150 
MHz, CDCl3): δ 201.1, 168.6, 159.3, 155.6, 155.5, 144.9, 142.1, 137.2, 134.2, 132.1, 122.8, 
118.1, 113.7, 112.5, 111.6, 105.8, 104.6, 73.0, 62.1, 56.3, 56.2, 45.4, 42.5, 29.7, 22.4; HRMS 
(ESI) calculated for C25H25BrO6Na [M+Na]+: 521.0576, found: 521.0577. 
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Ester 2.118. TsOH·H2O (88 mg, 0.46 mmol) added to a solution of benzyl alcohol 2.115 (230 
mg, 0.46 mmol) in pivalic anhydride (0.4 mL) in pivalic acid (7 mL) at 70 ˚C and the resulting 
solution was heated to 80 ˚C for 2 h followed by the addition of pivalic anhydride (50 μL). 
After an additional 15 min at 80 ˚C the reaction mixture was diluted with ethyl acetate, 
washed with water, brine, dried over anhydrous magnesium sulfate, and concentrated under 
reduced pressure to afford pure ester 2.118 (268 mg, quant.). Rf = 0.58 (40% v/v ethyl 
acetate in hexanes); 1H NMR (500 MHz, CDCl3) δ 14.79 (bs, 1H), 6.99 (s, 1H), 6.83 (s, 1H), 
6.37 (dd, J = 8.6, 6.9 Hz, 1H), 6.22 (s, 1H), 5.99 (d, J = 8.6 Hz, 1H), 5.89 (s, 1H), 4.58 (d, J = 7.0 
Hz, 1H), 3.91 (s, 4H), 3.89 (s, 4H), 3.73 (s, 3H), 2.81 (d, J = 16.7 Hz, 1H), 2.64 (d, J = 16.7 Hz, 
1H), 2.42 (s, 3H), 1.07 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 198.65, 177.96, 169.98, 159.44, 
155.61, 155.56, 144.78, 136.92, 136.82, 131.87, 131.70, 124.36, 123.24, 114.90, 114.46, 
111.24, 105.01, 73.73, 62.13, 56.32, 56.20, 44.91, 41.51, 39.09, 34.69, 27.10, 26.98, 22.08; 
HRMS (ESI) calculated for C30H31BrO7Na [M+Na]+: 605.1151, found: 605.1147. 
 
Arylstannane 2.126. Regioselective stannylation of 2.124 followed a related methylation 
procedure from Myers and co-workers.18 A solution of nBuLi (10.3 mL of a 2.67 M solution 
in hexanes, 27.45 mmol) was added to a solution of 2,2,6,6-tetramethylpiperidine (4.63 mL, 
27.45 mmol) in THF (10 mL) at 0 ˚C. The resulting solution was stirred for 30 min, followed 
by the addition of a solution of 2,5-dimethoxybenzoic acid (2.124, 1 g, 5.49 mmol) in THF 
(10 mL). The reaction mixture was stirred at 0 ˚C for 2 h then cooled to –20 ˚C. A solution of 
trimethyltin chloride (33 mL of a 1 M solution in hexanes, 33 mmol) was added and the 
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resulting mixture was stirred at –20 ˚C for 30 min, then quenched with saturated aqueous 
NH4Cl, and extracted with ethyl acetate. The combined organic layers were washed with 
water, then brine, dried with anhydrous MgSO4, concentrated under reduced pressure and 
used in the subsequent step without further purification. The crude acid 2.125 was taken up 
in benzene (40 mL) and MeOH (20 mL) followed by the addition of 
trimethylsilyldiazomethane (5.5 mL of a 2 M solution in hexanes, 11 mmol). The reaction 
mixture was stirred at room temperature for 1.5 h, and then quenched with AcOH (2 mL) 
and concentrated under reduced pressure. Purification by flash chromatography (elution 
with 5% v/v ethyl acetate in hexanes) afforded 1.73 g (88 % yield over two steps) of 
arylstannane 2.126 as a viscous yellow oil. Rf = 0.30 (10% v/v ethyl acetate in hexanes); 1H 
NMR (600 MHz, CDCl3): δ 6.86 (d, 1 H, J = 8.9), 6.62 (d, 1 H, J = 8.9), 3.87 (s, 3 H), 3.79 (s, 3 H), 
3.74 (s, 3 H), 0.24 (s, 9 H, J(117/119Sn,H) = 57.6, 54.6 Hz); 13C NMR (150 MHz, CDCl3): δ 169.1, 
158.0, 151.4, 131.3, 131.0, 113.1, 111.6, 56.8, 56.2, 52.4, –7.1 (J(117/119Sn,C) = 368, 352 Hz); 
HRMS (ESI) calculated for C13H20O4SnNa [M+Na]+: 383.0284, found: 383.0270. 
 
Ketone 2.128. A solution of 2.115 (103 mg, 0.206 mmol) in DMA (2.5 mL) was added to a 
Schlenk flask containing tetrakis(triphenylphosphine)palladium(0) (262 mg, 0.277 mmol). 
The reaction mixture was heated to 140 ˚C for 40 min. The resulting solution was then 
transferred to a vial containing 2.126 (213 mg, 0.618 mmol) and copper iodide (196 mg, 
1.03 mmol). The reaction vessel was then loaded into a parr bomb and pressurized to 150 
psi with CO. The parr bomb was then heated to 60 ˚C for 14 h, cooled to room temperature, 
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and depressurized. The reaction mixture was then filtered through celite with ethyl acetate 
(40 mL), washed with water (two times, 50 mL each), then brine, dried with anhydrous 
MgSO4, and concentrated under reduced pressure. Purification by flash chromatography 
(elution with 20-50% v/v acetone in hexanes) afforded 82 mg (62 % yield) of 2.128 as a 
yellow solid. Rf = 0.35 (50% v/v acetone in hexanes); 1H NMR (600 MHz, CDCl3): δ 14.85 (s, 
1 H), 7.19 (s, 1 H), 7.01 (d, 1 H, J = 9.1 Hz), 6.89 (d, 1 H, J = 9.1 Hz), 6.78 (s, 1 H), 6.43 (dd, 1 H, 
J = 8.4, 6.8 Hz), 6.39 (dd, 1 H, J = 8.4, 1.0 Hz), 6.25 (s, 1 H), 5.00 (d, 1 H, J = 6.7 Hz), 4.49 (dd, 1 
H, J = 6.8, 1.0 Hz), 3.92 (s, 3 H), 3.82 (s, 3 H), 3.81 (s, 3 H), 3.73 (s, 3 H), 3.54 (s, 3 H), 3.48 (s, 
3 H), 3.03 (d, 1 H, J = 17.1 Hz), 2.70 (d, 1 H, J = 17.1 Hz), 2.45 (s, 3 H), 2.34 (d, 1 H, J = 6.7 Hz); 
13C NMR (150 MHz, CDCl3): δ 201.4, 191.7, 169.0, 167.9, 159.4, 156.7, 156.1, 153.2, 150.7, 
145.0, 142.4, 140.6, 134.4, 132.4, 129.1, 125.0, 123.8, 121.7, 118.4, 116.2, 115.0, 113.9, 112.6, 
111.4, 106.2, 73.0, 64.4, 57.2, 57.0, 56.3, 56.2, 52.6, 44.4, 42.6, 30.3, 22.5; HRMS (ESI) 
calculated for C36H34O11Na [M+Na]+: 665.1999, found: 665.1992. 
 
Acremoxanthone A (2.131). A solution of PBr3 (150 μL of a 1 M solution in DCM, 150 μmol) 
was added to a solution of 2.128 (65.0 mg, 101 μmol) in DCM (2 mL) at 0 ˚C. The reaction 
mixture was warmed to room temperature and stirred for 15 h. The resulting solution was 
then cooled to –78 ˚C, followed by the addition of BBr3 (1.5 mL of a 1 M solution in DCM, 1.5 
mmol). The reaction was then warmed to –20 ˚ C for 2.5 h, and then quenched with water (0.4 
mL), extracted with ethyl acetate, washed with water, then brine, dried with anhydrous 
MgSO4, and concentrated under reduced pressure. The crude material was carried on 
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without further purification. NaOAc (8.2 mg, 100 μmol) was added to the crude material in 
AcOH (3 mL) and HFIP (9 mL). The reaction mixture was stirred at 60 ˚C for 2 h, and then 
concentrated under reduced pressure. The crude product was then taken up in ethyl acetate 
and washed with 1 N HCl, water, then brine. The organic layer was then dried with 
anhydrous MgSO4, concentrated under reduced pressure, and used in the subsequent step 
without further purification. A solution of crude acetate 2.132 in DMSO (5 mL) was added to 
a Schlenk flask containing anhydrous Cs2CO3 (326 mg, 1 mmol) and the resulting solution 
was heated to 50 ˚C. After 30 min the reaction mixture was cooled to room temperature, 
diluted with ethyl acetate, washed with 1 N HCl, water (three times, 50 mL each), then brine, 
dried with anhydrous MgSO4, then concentrated under reduced pressure. The crude material 
was then taken up in PhH and filtered through a plug of glass wool. This material was 
subjected to preparative thin layer chromatography (55% v/v acetone in hexanes). A 
solution of the resulting sample of 2.131 in ethyl acetate was washed with 1 N aqueous HCl, 
water, and brine. The resulting solution was dried over anhydrous MgSO4 and concentrated 
under reduced pressure to afford 11.1 mg (20 % over three steps, containing ca. 4% w/w 
Ph3PO) of 2.131 as a yellow solid. Rf = 0.40 (50% v/v acetone in hexanes); 1H NMR (500 MHz, 
CDCl3): δ 14.14 (br s, 1 H), 12.80 (s, 1 H), 11.57 (s, 1 H), 7.64 (br s, 1 H), 7.42 (d, 1 H, J = 9.2 
Hz), 7.35 (d, 1 H, J = 9.3 Hz), 6.91 (s, 1 H), 6.81 (s, 1 H), 6.49 (s, 1 H), 6.48 (dd, 1 H, J = 8.5, 6.5 
Hz), 6.12 (dd, 1 H, J = 8.5, 0.9 Hz), 6.01 (s, 1 H), 4.93 (dd, 1 H, J = 6.6, 0.9 Hz), 3.99 (s, 3 H), 
2.93 (d, 1 H, J = 17.7 Hz), 2.80 (d, 1 H, J = 17.7 Hz), 2.39 (s, 3 H), 2.01 (s, 3 H); 13C NMR (150 
MHz, CDCl3): δ 186.3, 185.9, 180.2, 170.6, 169.2, 161.9, 157.9, 154.1, 152.9, 150.8, 147.9, 
146.5, 136.6, 132.6, 132.0, 125.9, 123.3, 122.5, 119.5, 118.6, 117.5, 113.5, 112.8, 109.9, 107.3, 
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105.3, 73.1, 53.3, 41.7, 37.3, 35.3, 22.2, 21.3; HRMS (ESI) calculated for C33H24O11Na [M+Na]+: 
619.1216, found: 619.1216. 
Comparison of 1H NMR data for synthetic acremoxanthone A (2.131) to literature values38,39 
(CDCl3; δ, ppm) 
Synthetic 2.131 Natural 2.131 (ref. 38) Natural 2.131 (ref. 39) 
14.14 (br s, 1 H) 14.15 (br s, 1 H) – 
12.80 (s, 1 H) 12.81 (s, 1 H) 12.79 (s, 1 H) 
11.57 (s, 1 H) 11.62 (s, 1 H) 11.57 (s, 1 H) 
7.64 (br s, 1 H) 7.72 (br s, 1 H) – 
7.42 (d, 1 H, J = 9.2 Hz) 7.38 (d, 1 H, J = 9.1 Hz) 7.41 (d, 1 H, J = 9.25 Hz) 
7.35 (d, 1 H, J = 9.3 Hz) 7.34 (d, 1 H, J = 9.1 Hz) 7.34 (d, 1 H, J = 9.25 Hz) 
6.91 (s, 1 H) 6.93 (s, 1 H) 6.91 (s, 1 H) 
6.81 (s, 1 H) 6.82 (s, 1 H) 6.80 (s, 1 H) 
6.49 (s, 1 H) 6.47 (s, 1 H) 6.48 (s, 1 H) 
6.48 (dd, 1 H, J = 8.5, 6.5 Hz) 6.49 (dd, 1 H, J = 8.5, 6.7 Hz) 6.48 (dd, 1 H, J = 8.5, 6.6 Hz) 
6.12 (dd, 1 H, J = 8.5, 0.9 Hz) 6.13 (dd, 1 H, J = 8.4, 0.6 Hz) 6.11 (dd, 1 H, J = 8.5, 1.1 Hz) 
6.01 (s, 1 H) 6.02 (s, 1 H) 6.00 (s, 1 H) 
4.93 (dd, 1 H, J = 6.6, 0.9 Hz) 4.94 (dd, 1 H, J = 6.6, 0.6 Hz) 4.93 (dd, 1 H, J = 6.6, 1.1 Hz) 
3.99 (s, 3 H) 4.01 (s, 3 H) 3.98 (s, 3 H) 
2.93 (d, 1 H, J = 17.7 Hz) 2.93 (d, 1 H, J = 17.7 Hz) 2.93 (d, 1 H, J = 17.8 Hz) 
2.80 (d, 1 H, J = 17.7 Hz) 2.80 (d, 1 H, J = 17.7 Hz) 2.80 (d, 1 H, J = 18.1 Hz) 
2.39 (s, 3 H) 2.40 (s, 3 H) 2.39 (s, 3 H) 
2.01 (s, 3 H) 2.03 (s, 3 H) 2.01 (s, 3 H) 
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Comparison of 13C NMR data for synthetic acremoxanthone A (2.131) to literature values38,39 
(CDCl3; δ, ppm) 
Synthetic 2.131 Natural 2.131 (ref. 38) Natural 2.131 (ref. 39) 
186.3 186.1 186.8 
185.9 185.9 186.1 
180.2 180.2 180.0 
170.6 170.6 170.5 
169.2 169.0 169.0 
161.9 161.8 161.8 
157.9 157.8 157.7 
154.1 154.0 153.9 
152.9 152.3 152.7 
150.8 150.6 150.7 
147.9 147.8 147.7 
146.5 146.5 146.4 
136.6 136.5 136.4 
132.6 132.5 132.9 
132.0 131.9 131.8 
125.9 125.7 125.7 
123.3 123.2 123.2 
122.5 122.0 122.3 
119.5 119.4 119.4 
118.6 118.4 118.4 
117.5 117.4 117.4 
113.5 114.2 113.4 
112.8 112.7 112.7 
109.9 109.8 109.8 
107.3 107.0 107.1 
105.3 105.2 105.2 
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73.1 73.1 73.0 
53.3 53.2 53.1 
41.7 41.6 41.6 
37.3 37.6 37.6 
35.3 35.2 35.2 
22.2 22.1 22.1 
21.3 21.2 21.1 
 
 
Benzyl alcohol 2.134: K2CO3 (2 mg, 13.4 μmol) was added to a solution of acremoxanthone 
A (2.131) (2 mg, 3.4 μmol) in MeOH (0.5 mL) and the reaction mixture was heated to 50 ˚C 
for 3 h, quenched with aqueous HCl (1 M), extracted with ethyl acetate, washed with brine, 
dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to 
afford benzyl alcohol 2.134. 1H NMR (600 MHz, CDCl3) δ 14.31 (s, 1H), 12.85 (s, 1H), 11.66 
(s, 1H), 7.48 (d, J = 9.2 Hz, 1H), 7.41 (d, J = 9.4 Hz, 1H), 6.87 (s, 1H), 6.86 (s, 1H), 6.63 – 6.55 
(m, 2H), 6.53 (s, 1H), 5.01 (d, J = 6.3 Hz, 1H), 4.65 (s, 1H), 4.05 (s, 3H), 2.94 (d, J = 17.5 Hz, 
1H), 2.81 (d, J = 17.5 Hz, 1H), 2.46 (s, 3H). HRMS (ESI) calculated for C31H22O10Na [M+Na]+: 
577.1111, found: 577.1127. 
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Pentanoate 2.135. A solution of PBr3 (54 μL of a 1 M solution in DCM, 54 μmol) was added 
to a solution of 2.128 (23.0 mg, 36 μmol) in DCM (0.7 mL) at 0 ˚C. The reaction mixture was 
warmed to room temperature and stirred for 17 h. The resulting solution was then cooled to 
–78 ˚C, followed by the addition of BBr3 (0.537 mL of a 1 M solution in DCM, 0.537 mmol). 
The reaction was then warmed to –20 ˚C for 2 h, and then quenched with MeOH (0.150 mL), 
extracted with ethyl acetate, washed with water, then brine, dried with anhydrous MgSO4, 
and concentrated under reduced pressure. The crude material was carried on without 
further purification. NaH (12 mg, 0.5 mmol) was added to valeric acid (10 mL). After stirring 
for 10 min at room temperature 0.3 mL of this solution was added to the crude bromide in 
HFIP (1 mL). The reaction mixture was stirred at 60 ˚C for 2 h, and then concentrated under 
reduced pressure. The crude product was then taken up in ethyl acetate and washed with 1 
N HCl, water, then brine. The organic layer was then dried with anhydrous MgSO4, 
concentrated under reduced pressure, and used in the subsequent step without further 
purification. A solution of the crude pentanoate in DMSO (2.5 mL) was added to a Schlenk 
flask containing anhydrous Cs2CO3 (114 mg, 0.35 mmol) and the resulting solution was 
heated to 50 ˚C. After 45 min the reaction mixture was cooled to room temperature, diluted 
with ethyl acetate, washed with 1 N HCl, water (three times), then brine, dried with 
anhydrous MgSO4, then concentrated under reduced pressure. This material was subjected 
to preparative thin layer chromatography (75% v/v acetone in hexanes). A solution of the 
resulting sample of 2.135 in ethyl acetate was washed with 1 N aqueous HCl, water, and 
brine. The resulting solution was dried over anhydrous MgSO4 and concentrated under 
reduced pressure to afford 2.131. 1H NMR (600 MHz, CDCl3) δ 14.20 (s, 1H), 12.86 (s, 1H), 
11.64 (s, 1H), 7.60 (d, J = 34.9 Hz, 1H), 7.49 (d, J = 9.2 Hz, 1H), 7.41 (d, J = 9.2 Hz, 1H), 6.98 – 
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6.95 (m, 1H), 6.86 (s, 1H), 6.55 (s, 1H), 6.53 (dd, J = 8.4, 6.6 Hz, 1H), 6.16 (d, J = 8.4 Hz, 1H), 
6.07 (s, 1H), 4.99 (d, J = 6.6 Hz, 1H), 4.04 (s, 3H), 2.99 (d, J = 17.3 Hz, 1H), 2.86 (d, J = 17.5 Hz, 
1H), 2.44 (s, 3H), 2.35 – 2.24 (m, 2H), 0.91 (t, J = 7.4 Hz, 3H). HRMS (ESI) calculated for 
C36H29O11 [M–H]–: 637.1710, found: 637.1736. 
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Chapter 3: Indium(III)-Catalyzed Alkenylation of Silyl Enol Ethers 
3.1 Introduction and Examples of Related Alkenylations 
3.1.1 Introduction 
 Our interest in Lewis acid-mediated reactions of silyl enol ethers stemmed from a 
need to conduct an intermolecular alkenylation of ketone 3.1 en route to the 
hexahydroindene core of the paxilline indole diterpenes (Scheme 3.1). While many methods 
exist for the α-alkenylation of ketones, there are few examples that involve ketones bearing 
two different enolizable positions. During the synthesis of emindole SB (3.4) our lab 
determined that stoichiometric indium(III) bromide could affect the α-alkenylation of silyl 
enol ether 3.2, producing the corresponding alkenylated ketone 3.3.1 This success prompted 
further investigation into this transformation. 
Scheme 3.1: Stoicheometric Alkenylation of Silyl Enol Ether 3.2. 
 
3.1.2 Palladium-Catalyzed Alkenylation of Ketones 
 One of the earliest reports of the alkenylation of a ketone was Migita’s palladium- 
catalyzed coupling of tributyltin enolates with vinyl halides (Scheme 3.2).2 Beginning with 
enol acetates, such as 3.5, the corresponding tin enolate is generated in situ using tributyltin 
methoxide. In the presence of a palladium catalyst, these tin enolates can then be coupled to 
vinyl halides producing β,γ-unsaturated ketones (3.6). While this reaction was efficient at 
coupling unhindered tin enolates, more substituted substrates afforded poor yields of the 
corresponding β,γ-unsaturated ketones, specifically those resulting in the formation of 
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quaternary centers. For example, when enol acetate 3.7 was employed in the cross-coupling, 
ketone 3.8 was formed in only 8% yield. 
Scheme 3.2: Migita’s Alkenylation of Tributyltin Enolates.  
 
 Another early example of the alkenylation of enolates via palladium catalysis was 
reported by Buchwald in 2001.3 In this report, sodium enolates are prepared in situ from 
ketones bearing a single enolizable position and coupled with vinyl halides (Scheme 3.3). 
Unlike Migita’s report, Buchwald’s method can be used for the construction of quaternary 
centers. Additionally, the authors are able to conduct asymmetric alkenylations using chiral 
monodentate phosphine ligands. 
Scheme 3.3: Buchwald’s Asymmetric Alkenylation of Sodium Enolates. 
 
 In 2007 Huang and coworkers report a palladium catalyzed coupling of lithium 
enolates that is similar to the report by Buchwald. While the authors do not demonstrate 
asymmetric cross-couplings, they are able to perform the alkenylation of oxindole 3.13.  
Scheme 3.4: Huang’s Alkenylation of Oxindole 3.13.  
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 In 2015 Helquist and coworkers developed the first nickel-catalyzed alkenylation of 
ketone enolates.4 This coupling utilizes in situ generated lithium enolates in cross-couplings 
with a range of diverse alkenyl halides. Notably, this coupling can be performed with a 
variety of ketones under low-temperature conditions, making it a milder alkenylation than 
those reported previously.  
Scheme 3.5: Helquist’s Ni-Catalyzed Alkenylation of Ketone Enolates. 
 
 In 2006 Hartwig and coworkers reported a coupling of enolates generated from silyl 
enol ether precursors.5 This strategy allows for the coupling of ketones bearing two different 
enolizable positions. While most of the couplings in this report employ aryl halides as the 
coupling partners, the authors also demonstrate its utility for alkenylation (Scheme 3.6). 
Subjecting silyl enol ether 3.18 to the coupling conditions with α-bromostyrene 3.19 
afforded β,γ-unsaturated ketone 3.20 in 66% yield.  
Scheme 3.6: Hartwig’s Alkenylation of Silyl Enol Ethers. 
 
3.1.3 Intramolecular Lewis Acid-Mediated Alkenylation of Ketones 
 Other than palladium-catalyzed cross-coupling reactions, the other method for 
performing ketone alkenylations is through the Lewis acid-mediated addition of the 
corresponding enol ether to alkynes. The first example of such a reaction was reported by 
Conia in 1985.6 Using Hg(II) salts, the authors are able to conduct intramolecular 
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alkenylations of silyl enol ethers. This method can be used for generating quaternary centers 
as seen in the alkenylation of silyl enol ether 3.21 and 3.23 (Scheme 3.7). The result of these 
cyclizations is a formal ene reaction, generating β,γ-unsaturated ketones 3.22 and 3.24. 
Scheme 3.7: Conia’s Hg(II)-Mediated Intramolecular Alkenylation of Silyl Enol Ethers. 
 
 In 1999 Yamamoto reported a related intramolecular alkenylation of silyl enol ethers 
using Al(III) Lewis acids.7 However, this reaction results in an endo-cyclization, affording 
internal alkenes such as 3.26 (Scheme 3.8A). This is a consequence of the variation in the 
mechanism of the alkenylation. For example, in Conia’s Hg(II)-mediated cyclization the 
carbometallation occurs via syn-addition to the alkyne. Evidence of this is seen in the 
stereospecific deuteration of the vinylmercurial intermediate, resulting in the formation of 
3.27 (Scheme 3.8B). Similarly, when Yamamoto and coworkers quench the intermediate 
vinylaluminum species with deuterium oxide they observe formation of 3.28, indicating and 
anti-addition to the alkyne.  
Scheme 3.8: (A) Yamamoto’s Aluminum-Mediated Alkenylation. (B) Products of Deuterium Quench of Conia (3.27) and 
Yamamoto’s (3.28) Vinylmetal Intermediates. 
 
 Iwasawa has a series of reports detailing the development of his W(CO)6-mediated 
intramolecular alkenylation of silyl enol ethers.8 Notably, this reaction can be performed 
with catalytic amounts of Lewis acid. The authors find that photoirradiation enhances the 
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rate of the reaction, presumably by facilitating the rate of dissociation of the amine from 
W(CO)5(amine) complexes. Additionally, this reaction can form both the exo- and endo-
cyclization products depending on the amine and solvent used in the reaction. For example, 
when silyl enol ether 3.29 is subjected to the reaction with DABCO in THF the exo-cyclization 
product 3.30 is formed preferentially (Scheme 3.9). Alternatively, when nBu3N is used in 
PhMe the major product is silyl enol ether 3.31, resulting from an endo-cyclization. Under 
the reaction conditions the authors are also able to isolate the silyl enol ether products. The 
ability of this reaction to access either the exo- or endo-cyclization products depending on 
the conditions makes it a useful method for the alkenylation of silyl enol ethers. 
 Of the various pi Lewis acids employed in intramolecular alkenylations, gold catalysis 
is the most common. Echavarren utilizes AuCl3 to perform the alkenylation of methyl vinyl 
ethers (3.32) in methanol to access the corresponding dimethyl acetal (3.33, Scheme 
3.10A).9 Toste employs Au(I) catalysis to perform the intramolecular alkenylation of silyl 
enol ethers with a high degree of exo-selectivity (Scheme 3.10B).10 The method can generate 
quaternary centers, such as in β,γ-unsaturated ketone 3.35, in good yields. Barriault and 
coworkers developed a Au(I) catalyst capable of achieving the alkenylation of silyl enol ether 
3.36 with a high degree of endo-selectivity to access endocyclic alkenes such as 3.37 
Scheme 3.9: Iwasawa’s W(CO)6-Mediated Intramolecular Alkenylation of Silyl Enol Ethers  
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(Scheme 3.10C).11 As demonstrated by Sawamura, Au(I) catalysis can also be used in the 
formation of medium-sized rings such as 3.39 (Scheme 3.10D).12 
3.1.4 Intermolecular Lewis Acid-Mediated Alkenylation of Ketones 
While π Lewis acids have been employed in a variety of intramolecular alkenylations 
of enol ethers, there are relatively few examples of their use in intermolecular alkenylations. 
The only previous report detailing an intermolecular alkenylation of silyl enol ethers is 
Yamaguchi’s Ga(III)-mediated ethenylation.13 This method utilizes superstoicheometric 
GaCl3 and trimethylsilylacetylene to alkenylate fully substituted silyl enol ethers (Scheme 
3.11). This report also demonstrates the ethenylation of methylcyclohexanone-derived silyl 
enol ether 3.42, showing it’s utility it the alkenylation of ketones bearing multiple enolizable 
positions.  
Scheme 3.11: Yamaguchi’s Ga(III)-Mediated Intermolecular Ethenylation. 
 
Scheme 3.10: (A) Echavarren’s AuCl3-Catalyzed Alkenylation of Vinyl Methyl Ethers. (B) Toste’s Alkenylation of Silyl 
Enol Ethers. (C) Barriault’s Endo-Selective Alkenylation of Silyl Enol Ethers. (D) Sawamura’s Alkenylation Method for the 
Construction of Medium-Sized Rings. 
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 The only previously reported example of a catalytic intermolecular alkenylation is 
Nakamura’s In(III)-catalyzed alkenylation of activated methylene compounds.14 While 
catalytic, this method does require harsh conditions to achieve the desired alkenylation. For 
example, to alkenylate β-ketoester 3.44 with phenylacetylene the reaction must be heated 
neat to 140 ˚C for 10 hours (Scheme 3.12). However, under these conditions the authors can 
obtain 3.45 in 92% yield. Interestingly, all reactions generated 1,1-disubstituted alkenes 
with exclusive regioselectivity with only one exception. When β-ketoester 3.44 is 
alkenylated using (dimethylphenylsilyl)acetylene the regioselectivity is completely reversed 
and the authors obtain silane 3.44 in 80% yield.  
Scheme 3.12: Nakamura’s In(III)-Catalyzed Alkenylation of Activated Methylene Compounds. 
 
 In 2009, Baba reported the In(III)-mediated intermolecular alkenylation of ketene 
silyl acetals.15 Using one equivalent of InBr3, ketene silyl acetal 3.47 can be alkenylated with 
phenylacetylene to produce ester 3.48 in 99% yield (Scheme 3.13). Along with the 
alkenylation, the report demonstrates that the intermediate vinylindium species can 
undergo transmetalation with Pd(0) and subsequently be cross-coupled with aryl halides to 
access products such as 3.49.  
Scheme 3.13: Baba’s In(III)-Mediated Intermolecular Alkenylation of Ketene Silyl Acetals. 
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3.1.5 Planned Catalytic Pathway for the Alkenylation of Silyl Enol Ethers 
 Given the current lack of methods for achieving intermolecular α-alkenylations with 
a high degree of selectivity for the more substituted alpha position, as well as the synthetic 
utility of a method that provides access to quaternary centers, we decided to further 
investigate the alkenylation utilized in the synthesis of emindole SB (3.4, Scheme 3.1). To 
begin developing this method we first aimed to render the transformation catalytic. In the 
stoichiometric route (Scheme 3.14) the initial carboindation, forming siloxocarbenium 3.52, 
is followed by desilylation to form vinylindium intermediate 3.53. Subsequent 
protodemetallation generates the β,γ-unsaturated ketone product 3.54. We theorized that 
instead of desilylation, oxocarbenium 3.52 could undergo deprotonation to generate silyl 
enol ether 3.55, which, after protodemetallation, would produce the 2-siloxy-1,4-diene 
product 3.56 and regenerate the π Lewis acid catalyst. The result of such a sequence is a 
formal ene reaction that would produce a silyl enol ether that is useful for further 
functionalization. 
Scheme 3.14: Initial Proposed Catalytic Pathway Leading to Formation of Silyl Enol Ether 3.56.  
 
3.2 The Catalytic Intermolecular Alkenylation of Silyl Enol Ethers with Alkynes 
3.2.1 Screening Conditions for the Intermolecular Alkenylation  
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 To begin developing this intermolecular alkenylation we first screened various 
conditions to determine the most effective system for achieving this transformation. We 
chose silyl enol ether 3.57 as the model substrate for screening conditions based on our 
previous success using 2-methyl cyclopentanone derived silyl enol ethers (Scheme 3.1). 
Initially we evaluated conditions similar to those previously reported with Au(I)9 and 
In(III)14 catalyzed alkenylations, however, these proved unsuccessful in achieving the 
desired alkenylation (Table 3.1, entries 1 and 2).16 Using a different Au(I) precatalyst, along 
with NaBArF as a halide scavenging additive, we were able to observe the formation of a 
small amount of the desired 2-siloxy-1,4-diene 3.58, which was accompanied by some of the 
desilylated product 3.59 (entry 3). Additionally, we observed formation of allene 3.60, 
which we believe arises from initial regioisomeric attack on the alkyne to form intermediate 
Scheme 3.15: Proposed Formation of Allene 3.60. 
Table 3.1: Evaluation of Reaction Conditions. 
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3.62 followed by an intramolecular hydride transfer (Scheme 3.15). Based on our previous 
success using indium complexes, as well as the work of Baba15 and Corey,17 we examined the 
effects of various In(III) catalysts (entries 4- 6). InBr3 generated 3.58 as the major product, 
along with trace amounts of ketone 3.59, allene 3.60, and the product of regioisomeric attack 
on the alkyne (3.61). InI3 gave comparatively much lower yields, and InCl3 proved to be 
significantly less reactive. The incorporation of a halide scavenging additive lead to a 
decrease in reactivity with InBr3 (entry 7). It was found that lowering the reaction 
temperature decreased formation of allene 3.60 and the regioisomeric product 3.61 while 
still forming 3.58 in good yields (entry 8). It should be noted that TMS and TBS enol ethers 
were too labile, and only TIPS enol ethers yielded the desired product 3.58 with relatively 
small amounts of ketone 3.59 observed. Furthermore, chlorinated solvents, specifically 1,2- 
dichloroethane, provided the best results while ethers or aromatic solvents hindered the 
desired reactivity. 
3.2.2 Substrate Scope of the Intermolecular Alkenylation  
 Having determined a functional set of conditions, we next investigated the scope of 
the intermolecular alkenylation (Table 3.2).18 We found that the presence of aromatic 
functionality was permitted (3.63), as well as chlorides (3.64), protected alcohols (3.65), 
and surprisingly even esters (3.66). Nitriles, however, completely suppressed product 
formation. Conjugated alkynes were also suitable for the formal ene reaction (3.67 and 
3.68), although they required more forcing conditions. We also found that this 
transformation was able to form quaternary centers, bearing no methyl substituents, in 
comparable yields (3.69 and 3.70). We next investigated the effects of varying the 
substitution pattern on the cyclopentanone ring (3.71 through 3.74). We found that a wide 
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range of substitution patterns was tolerated, providing the desired 2-siloxy-1,4-dienes with 
high diastereoselectivity. Additionally, cyclohexanone derived silyl enol ethers could be 
alkenylated using this method (3.75 and 3.76). Acyclic silyl enol ethers also preformed well 
in the intermolecular alkenylation (3.77 through 3.82), however, in most cases the 
corresponding 2-siloxy-1,4-dienes were relatively unstable compared to the cyclic 
substrates. Consequently, the β,γ-unsaturated ketone products were obtained directly via a 
mild hydrolytic workup. In almost all cases the reaction proceeded with a high degree of 
regioselectivity, forming the 1,1-disubstituted alkenes.  
Table 3.2: Substrate Scope of the Intermolecular Alkenylation. 
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3.2.3 Alkenylation of Silyl Enol Ether 3.2 
 Determining conditions to perform the intermolecular alkenylation of substrate 3.2 
(Table 3.3) was of particular interest due to its use in the synthesis of emindole SB (Scheme 
3.1). However, after investigating the effect of altering various reaction parameters we were 
unable to determine a catalytic system that outperformed the stoichiometric reaction. For 
example, running the reaction for various times and temperatures had little effect on the 
yield (entries 1 through 4). Increasing catalyst loading allowed us to use more mild 
conditions, but we observed no significant increase in yield. Both increasing and decreasing 
the amount of alkyne added had a deleterious effect on the formation of 3.83 (entries 7 
through 9). The reason this substrate fails to undergo the catalytic alkenylation is 
presumably a result of the trisubstituted alkene coordinating to the InBr3, inhibiting 
formation of the InBr3-alkyne complex. 
Table 3.3: Attempted Catalytic Alkenylation of Substrate 3.2. 
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3.2.4 Exploring the Selectivity of the Intermolecular Alkenylation  
 An intriguing aspect of this intermolecular alkenylation reaction is that, while we are 
forming silyl enol ethers as the products of the reaction, we do not observe alkenylation of 
the resulting 2-siloxy-1,4-dienes. To further explore this observed reactivity, we subjected 
silyl enol ether 3.84 (Scheme 3.16A) to the alkenylation conditions. Interestingly, we only 
observed formation of silyl enol ether 3.58. To demonstrate the utility of this observed 
selectivity we prepared bis-silyl enol ether 3.85 (Scheme 3.16C) and subjected it to the 
alkenylation conditions followed by a mild hydrolytic workup (Scheme 3.16B). Gratifyingly, 
we observed selective alkenylation of the fully substituted silyl enol ether fragment, 
providing diketone 3.68 in a 49% yield.  
Scheme 3.16 (A) Alkenylation of Silyl Enol Ether 3.84. (B) Selective Alkenylation of bis-Silyl Enol Ether 3.85. (C) 
Synthesis of Silyl Enol Ether 3.85. 
 
3.2.5 Mechanistic Studies of the Intermolecular Alkenylation  
 Our investigation into the mechanism of the In(III)-catalyzed intermolecular 
alkenylation began with a series of experiments using deuterated starting materials. 
However, these experiments were unproductive due to the significant amount of proton-
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deuterium exchange observed in the reaction. We then proceeded to monitor reaction 
intermediates through the course of the alkenylation (Figure 3.1). Consequently, we found 
that at early stages of the reaction there is a higher concentration of ketone 3.59 than is 
observed after the typical reaction times. Furthermore, the concentration of ketone 3.59 
remains relatively constant through the course of the reaction, slowly decreasing as the 
reaction progresses until it reaches levels typically observed in the final product mixtures 
(ca. 5%). This data indicates that ketone 3.59 is reaching a steady-state concentration in the 
reaction and is an intermediate in the alkenylation as opposed to a side product formed via 
hydrolysis of 2-siloxy-1,4-diene 3.58.  
  
To further explore this observation, we set up an experiment in which we added a 
substoichiometric amount of ketone 3.93 to the same alkenylation reaction (Scheme 3.17). 
Over the course of the alkenylation we observed complete silylation of 3.93, forming silyl 
enol ether 3.94. This demonstrates that under the reaction conditions the ketone 
intermediate can be converted to the 2-siloxy-1,4-diene products. Additionally, when ketone 
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Figure 3.1: Monitoring Reaction Progress in the Alkenylation of Silyl Enol Ether 3.57. 
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additive 3.93 was included in the reaction we observed an increase in the rate of the 
alkenylation of 3.57, although the overall yield of 3.58 was less then when 3.93 is omitted 
from the reaction.  
Scheme 3.17: Alkenylation of 3.57 in the Presence of Ketone 3.93.  
 
 Based on these observations, we have proposed the following mechanism for the 
In(III)-catalyzed intermolecular alkenylation (Scheme 3.18). Initial carboindation generates 
vinylindium 3.95 and produces TIPSBr. The vinylindium can then undergo 
protodemetalation via indium(III) bromide–ketone complex 3.96, which concurrently forms 
indium enolate 3.97. Lastly, silylation with TIPSBr produces 2-siloxy-1,4-diene 3.58. While 
the initial proton source for the conversion of vinyl indium 3.95 to ketone 3.59 is not known, 
we suspect the alkyne–indium(III) bromide complex can serve as a Brønsted acid to facilitate 
this protodemetalation. It should be noted that the amount of ketone observed in the early 
stages of the reaction (Figure 3.1) cannot be accounted for by the presence of residual 
TIPSOH or adventitious moisture alone.  
Scheme 3.18: Proposed Mechanism for the In(III)-Catalyzed Intermolecular Alkenylation.  
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3.3 Conclusion 
 In summary, we have developed an indium(III) catalyzed method for the 
intermolecular alkenylation of silyl enol ethers that proceeds through a formal ene 
reaction.19 This transformation is effective at forming sterically hindered quaternary 
centers, and provides access to either 2-siloxy-1,4-diene products or the corresponding β,γ-
unsaturated ketone. 
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3.4 Experimental Section 
3.4.1 General Experimental Details 
All reactions were carried out in flame-dried glassware under positive pressure of dry 
nitrogen unless otherwise noted. Reaction solvents including tetrahydrofuran (THF, Fisher, 
HPLC Grade), dichloromethane (DCM, Fisher, HPLC Grade), and toluene (Fisher, HPLC 
Grade) were dried by percolation through a column packed with neutral alumina and a 
column packed with a supported copper catalyst for scavenging oxygen (Q5) under positive 
pressure of argon. Anhydrous 1,2-dichloroethane (Fisher, ACS Grade) and anhydrous 
triethylamine (Oakwood Chemical) were distilled from calcium hydride (10% w/v) under 
positive pressure of nitrogen. Anhydrous hexamethylphosphoramide (HMPA, Oakwood 
Chemical) was distilled from calcium hydride (10% w/v) under vacuum (ca. 0.1 torr). 
Solvents for extraction, thin layer chromatography (TLC), and flash column chromatography 
were purchased from Fischer (ACS Grade) and VWR (ACS Grade) and used without further 
purification. Chloroform-d and benzene-d6 for 1H and 13C NMR analysis were purchased from 
Cambridge Isotope Laboratories and used without further purification. Commercially 
available reagents were used without further purification unless otherwise noted. Reactions 
were monitored by thin layer chromatography (TLC) using precoated silica gel plates (EMD 
Chemicals, Silica gel 60 F254). Flash column chromatography was performed over silica gel 
(Acros Organics, 60 Å, particle size 0.04-0.063 mm). 1H NMR and 13C NMR spectra were 
recorded on Bruker DRX-500 (BBO probe), Bruker DRX-500 (TCI cryoprobe), Bruker 
AVANCE600 (TBI probe), and Bruker AVANCE600 (BBFO cryoprobe) spectrometers using 
residual solvent peaks as internal standards (CHCl3 @ 7.26 ppm 1H NMR, 77.00 ppm 13C 
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NMR; C6H6 @ 7.16 ppm 1H NMR, 128.00 ppm 13C NMR). High-resolution mass spectra 
(HRMS) were recorded on Waters LCT Premier TOF spectrometer with ESI and CI sources. 
3.4.2 Characterization of Allene Side-Products 
 
Allene 3.99: Alkenylation of enoxysilane 3.98 produced more allene by-products than 
alkenylation of enoxysilane 3.57, and therefore was chosen for the purposes of 
characterization. Alkenylation of enoxysilane 3.98 was performed according to “General 
procedure for the alkenylation of silyl enol ethers” (see below) from silyl enol ether 3.98 
(ratio of tetra- and trisubstituted isomers >10:1) and 1-octyne using InI3 instead of InBr3. 
The reaction was performed in solution on a 0.5 mmol scale with 0.1 equiv of InI3. The 
reaction mixture was heated to 80 °C for 24 h. An inseparable mixture of allene 3.75 and the 
expected silyl enol ether was produced. The crude mixture was treated with 1 mL EtOH and 
0.2 mL of aqueous HCl (6 M) to hydrolyze the silyl enol ether. The resulting solution was 
stirred vigorously for 45 min to ensure complete hydrolysis. The reaction mixture was 
diluted with saturated aqueous NaHCO3, extracted with hexanes and washed with brine. 
Isolation by flash chromatography (elution with hexanes) afforded 96 mg of allene 3.75 
contaminated with an unknown impurity. This mixture was treated with an excess of TBAF 
in THF (1 mL) and stirred at room temperature for 16 h. The reaction mixture was diluted 
with Et2O, washed with saturated aqueous NaHCO3 and brine, dried over anhydrous sodium 
sulfate, and concentrated under reduced pressure. Purification by flash chromatography 
(elution with 10% Et2O in hexanes) afforded 22 mg (20%, 0.10 mmol) of allene 3.99 (ca. 1:1 
mixture of diastereomeric allenes) as a colorless oil. Rf = 0.3 (10% v/v ethyl acetate in 
135 
 
hexanes); 1H NMR (500 MHz, CDCl3): δ 5.27-5.18 (m, 1H), 5.05-5.01 (m, 1H), 3.47-3.40 (m, 
1H), 2.05-1.95 (m, 2H), 1.80-1.69 (m, 3H), 1.55-1.51 (m, 1H), 1.48-1.38 (m, 4H), 1.35-1.26 
(m, 6H), 1.00 (s, 3H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 202.6, 202.3, 101.0, 
93.7, 93.6, 75.7, 75.5, 40.7, 40.6, 37.5, 37.4, 31.5, 29.34, 29.29, 29.23, 29.19, 29.1, 29.0, 24.4, 
22.6, 21.5, 14.2; HRMS (CI) m/z calculated for C15H26O [M]+: 222.1984, found: 222.1989; IR 
(thin film) 3417, 2931, 2865, 1959, 1465 cm-1. 
3.4.3 General Procedure for the Alkenylation of Silyl Enol Ethers 
 
Reactions in solution.  In a glovebox under pressure of nitrogen, a 5 mL Schlenk flask was 
charged with InBr3 (0.05-0.10 equiv). The flask was sealed with a plastic cap, removed from 
the glovebox, and connected to a double bank vacuum manifold. The plastic cap was replaced 
with a rubber septum under continuous flow of nitrogen. Anhydrous 1,2-dichloroethane (1 
M in substrate), the silyl enol ether (1.0 equiv), and alkyne (1.5 equiv) were added. Under 
flow of nitrogen, the septum was replaced with a yellow cap, which was secured with 
Parafilm. The nitrogen inlet for the Schlenk flask was closed and the reaction was heated to 
50-80 °C for 23-72 h. 
Reactions in the absence of solvent.  A 4 mL vial was charged with the silyl enol ether (1.0 
equiv) and alkyne (1.5 equiv). The reagents were degassed with a flow of nitrogen for 10 min 
and transferred to a gloxebox. The reaction vial was charged with InBr3 (0.05-0.10 equiv) 
and sealed with a Teflon-lined plastic screw-cap, which was secured with electrical tape. The 
vial was removed from the glovebox and heated to 50-80 °C for 24-72 h. 
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Isolation of 2-siloxy-1,4-dienes.  The reaction was quenched with anhydrous Et3N (0.5 mL), 
then anhydrous EtOH (1 mL) was added and the reaction was stirred for 20 min at room 
temperature. Purification by flash chromatography on Et3N-treated silica gel yielded the 
desired 2-siloxy-1,4-dienes (Note 1). 
Isolation of β,γ-unsaturated ketones.  The reaction was quenched with anhydrous EtOH (1 
mL) and stirred until TLC analysis indicated complete hydrolysis of siloxydienes (Note 2). 
The reaction was diluted with hexanes, washed with saturated aqueous NaHCO3 and brine, 
dried over anhydrous sodium sulfate, and concentrated under reduced pressure. 
Purification by flash chromatography yielded the desired β,γ-unsaturated ketones (Note 3). 
Note 1: All 2-siloxy-1,4-dienes derived from alkylacetylenes contained small admixture of 
corresponding allenes (ca. 5 mol%; see discussion in the manuscript), inseparable from the 
desired products. 2-Siloxy-1,4-dienes were obtained as mixtures of regioisomers with 
varying ratios (see entries below or Table 2 in the manuscript). The ratios were identified 
based on integration of alkenes in 1H NMR spectra. 
Note 2: In some cases, addition of small amounts of aqueous HCl was necessary. 
Note 3: β,γ-Unsaturated ketones were obtained as mixtures of regioisomers with varying 
ratios (see entries below or Table 2 in the manuscript). The ratios were identified based on 
integration of alkenes in 1H NMR spectra. 
3.4.4 Alkenylation Reactions 
 
Silyl enol ether 3.58: Prepared according to “General procedure for the alkenylation of silyl 
enol ethers” from silyl enol ether 3.5720 (ratio of tetra- and trisubstituted isomers ≥10:1) 
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and 1-octyne. The reaction was performed in solution on a 0.50 mmol scale with 0.1 equiv of 
InBr3. The reaction mixture was heated to 50 °C for 23 h. The alkenylation proceeded in 65% 
yield (0.32 mmol, 0.12 g of silyl enol ether 3.58 obtained, >20:1 r.r.). Rf = Runs with solvent 
front in hexanes; 1H NMR (600 MHz, CDCl3): δ 4.90 (d, J = 1.2 Hz, 1H), 4.77 (d, J = 1.4 Hz, 1H), 
4.53 (t, J = 2.3 Hz, 1H), 2.20-2.17 (m, 2H), 2.03-2.00 (m, 2H), 1.98-1.93 (m, 1H), 1.61 (ddd, J = 
12.9, 8.0, 6.2 Hz, 1H), 1.49-1.43 (m, 2H), 1.33-1.26 (m, 6H), 1.23 (s, 3H), 1.21-1.15 (m, 3H), 
1.09-1.05 (m, 18H), 0.88 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ159.2, 154.4, 107.1, 
99.4, 53.0, 36.4, 32.1, 31.8, 29.7, 28.7, 26.1, 24.0, 22.9, 18.22, 18.20, 14.3, 12.7; HRMS (CI) 
calculated for C23H44OSi [M]+: 364.3161, found: 364.3161. 
 
Silyl enol ether 3.63: Prepared according to “General procedure for the alkenylation of silyl 
enol ethers” from silyl enol ether 3.5719 (ratio of tetra- and trisubstituted isomers ≥10:1) 
and phenethylacetylene. The reaction was performed in solution on a 0.50 mmol scale with 
0.1 equiv of InBr3. The reaction mixture was heated to 50 °C for 22 h. The alkenylation 
proceeded in 68% yield (130.5 mg, 0.34 mmol of silyl enol ether 3.63 obtained, 20:1 r.r.). Rf 
= 0.6 (hexanes); 1H NMR (500 MHz, CDCl3): δ 7.29-7.27 (m, 2H), 7.21-7.16 (m, 3H), 4.99 (d, J 
= 0.96 Hz, 1H), 4.90 (d, J = 1.2 Hz, 1H), 4.54 (t, J = 2.3 Hz, 1H), 2.81-2.77 (m, 2H), 2.37-2.33 
(m, 2H). 2.22-2.14 (m, 2H), 1.96 (ddd, J = 13.2, 7.9, 5.4 Hz 1H), 1.63 (ddd, J = 13.0, 8.4,, 5.8 Hz, 
1H), 1.27 (s, 3H), 1.25-1.16 (m, 3H), 1.10-1.02 (m, 18H); 13C NMR (125 MHz, CDCl3):, δ 158.9, 
153.6, 143.1, 128.5, 128.4, 125.8, 107.8, 99.7, 53.0, 36.2, 35.1, 33.7; HRMS (CI) calculated for 
C25H41OSi [M+H]+: 385.2927, found: 385.2936. 
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Silyl enol ether 3.65: Prepared according to “General procedure for the alkenylation of silyl 
enol ethers” from silyl enol ether 3.5719 (ratio of tetra- and trisubstituted isomers ≥10:1) 
and alkyne 3.100. The reaction was performed in solution on a 0.50 mmol scale with 0.1 
equiv of InBr3. The reaction mixture was heated to 65 °C for 23 h. The alkenylation proceeded 
in 66% yield (0.16 g, 0.33 mmol of silyl enol ether 3.65 obtained, >20:1 r.r.). Rf = 0.35 
(hexanes); 1H NMR (500 MHz, CDCl3): δ 4.91 (d, J = 0.91 Hz, 1H), 4.80 (d, J = 1.3 Hz, 1H), 4.53 
(t, J = 2.3 Hz, 1H), 3.74-3.66 (m, 2H), 2.20-2.15 (m, 2H), 2.12 (dd, J = 9.9, 6.1 Hz, 1H), 2.08-
2.02 (m, 1H), 1.99-1.94 (m, 1H), 1.76-1.71 (m, 2H), 1.64-1.59 (m, 1H), 1.24 (s, 3H), 1.22-1.16 
(m, 3H), 1.11-1.02 (m, 39H); 13C NMR (125 MHz, CDCl3): δ159.1, 153.8, 107.4, 99.5, 63.7, 53.1, 
36.3, 32.3, 27.9, 26.0, 24.0, 18.2, 12.7, 12.2; HRMS (CI) calculated for C29H58O2Si2 [M]+: 
494.3976, found: 494.3981. 
 
Silyl enol ether 3.69. Prepared according to “General procedure for the alkenylation of silyl 
enol ethers” from silyl enol ether 3.101 (ratio of tetra- and trisubstituted isomers 10:1) and 
alkyne 3.100. The reaction was performed in solution on a 0.50 mmol scale with 0.1 equiv 
of InBr3. The reaction mixture was heated to 65 °C for 23 h. The alkenylation proceeded in 
57% yield (145.1 mg, 0.29 mmol of silyl enol ether 3.69 obtained, 16:1 r.r.). Rf = 0.4 
(hexanes); 1H NMR (500 MHz, CDCl3): δ 4.93 (s, 1H), 4.81 (s, 1H), 4.58 (t, J = 2.3 Hz, 1H), 3.73-
3.66 (m, 2H), 2.23-1.98 (m, 5H), 1.90 (ddd, J = 13.0, 8.9, 4.0 Hz, 1H), 1.76-1.65 (m, 3H), 1.63-
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1.56 (m, 1H), 1.24-1.14 (m, 3H), 1.13-0.99 (m, 39H), 0.85 (t, J = 7.4 Hz, 3H); 13C NMR (125 
MHz, CDCl3): δ157.3, 153.0, 107.4, 100.6, 63.7, 56.8, 32.4, 32.2, 28.3, 28.1, 26.4, 18.18, 18.15, 
18.1, 12.7, 12.1, 9.2; HRMS (CI) calculated for C30H60O2Si2 [M]+: 508.4132, found: 508.4117. 
 
Silyl enol ether 3.70. Prepared according to “General procedure for the alkenylation of silyl 
enol ethers” from silyl enol ether 3.102 (ratio of tetra- and trisubstituted isomers >10:1) and 
alkyne 3.100. The reaction was performed in solution on a 0.50 mmol scale with 0.1 equiv 
of InBr3. The reaction mixture was heated to 50 °C for 70 h. The alkenylation proceeded in 
68% yield (198.4 mg, 0.34 mmol of silyl enol ether 3.70 obtained, 11:1 r.r.). Rf = 0.25 (2% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3): δ 7.29-7.25 (m, 2H), 7.19-7.15 (m, 3H), 5.00 
(s, 1H), 4.85 (s, 1H), 4.65 (t, J = 2.3 Hz, 1H), 3.71 (td, J = 6.5, 2.4 Hz, 2H), 2.69-2.62 (m, 1H), 
2.61-2.54 (m, 1H), 2.28-2.16 (m, 3H), 2.15-2.08 (m, 1H), 2.04-1.98 (m, 1H), 1.95-1.89 (m, 2H), 
1.89-1.81 (m, 1H), 1.78-1.70 (m, 2H), 1.27-1.18 (m, 3H), 1.14-1.00 (m, 39H); 13C NMR (125 
MHz, CDCl3): δ 157.3, 152.8, 143.8, 128.5, 128.4, 125.6, 107.8, 101.1, 63.7, 56.6, 38.7, 33.5, 
32.2, 31.5, 28.2, 26.5, 18.4, 18.3, 18.2, 12.8, 12.2; HRMS (CI) calculated for C36H64O2Si2 [M]+: 
584.4445, found: 584.4560. 
 
Silyl enol ether 3.73. Prepared according to “General procedure for the alkenylation of silyl 
enol ethers” from silyl enol ether 3.103 (ratio of tetra- and trisubstituted isomers >10:1) and 
alkyne 3.100. The reaction was performed in solution on a 0.50 mmol scale with 0.1 equiv 
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of InBr3. The reaction mixture was heated to 65 °C for 44 h. The alkenylation proceeded in 
54% yield (161.9 mg, 0.27 mmol of silyl enol ether 3.73 obtained). The minor isomer (ratio 
>10:1) could not be unambiguously assigned as diastereomer or regioisomer. Rf = 0.8 (5% 
EtOAc in hexanes); 1H NMR (500 MHz, CDCl3): δ 7.27-7.24 (m, 2H), 7.17-7.14 (m, 3H), 4.90 
(s, 2H), 4.51 (t, J = 2.2 Hz, 1H), 3.67-3.62 (m, 2H), 2.65-2.60 (m, 1H), 2.51-2.45 (m, 1H), 2.39 
(ddd, J = 14.1, 7.9, 2.9 Hz, 1H), 2.18-2.15 (m, 1H), 2.11-2.05 (m, 1H), 2.03-1.96 (m, 1H), 1.90 
(ddd, J = 14.1, 9.1, 1.8 Hz, 1H), 1.71-1.63 (m, 3H), 1.56-1.50 (m, 1H), 1.19-1.14 (m, 3H), 1.09-
1.04 (m, 42H); 13C NMR (125 MHz, CDCl3): δ 160.0, 153.0, 143.0, 128.34, 128.26, 125.6, 109.0, 
98.4, 63.7, 55.4, 43.5, 34.4, 32.8, 32.5, 32.0, 27.8, 18.11, 18.08, 16.8, 12.6, 12.1; HRMS (CI) 
calculated for C37H66O2Si2 [M+H]+: 598.4601, found: 598.4614. 
 
Ketone 3.75. Prepared according to “General procedure for the alkenylation of silyl enol 
ethers” from silyl enol ether 3.98 (ratio of tetra- and trisubstituted isomers >10:1) and 1-
octyne. The reaction was performed in solution on a 0.25 mmol scale with 0.1 equiv of InBr3. 
The reaction mixture was heated to 50 °C for 64 h. The reaction was quenched with 1 mL of 
EtOH and 0.3 ml of aqueous HCl (2 M) and the resulting solution was stirred for 3 h. The 
alkenylation proceeded in 54% yield (29.9 mg, 0.13 mmol of ketone 3.75 obtained, 11:1 r.r.). 
Rf = 0.58 (10% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3): δ 4.98 (t, J = 1.6 Hz, 1H), 4.88 
(s, 1H), 2.50 (td, J = 13.1, 6.0 Hz, 1H), 2.34-2.24 (m, 2H), 2.00-1.93 (m, 2H), 1.83-1.72 (m, 2H), 
1.66-1.60 (m, 2H), 1.46-1.43 (m, 3H), 1.30-1.27 (m, 6H), 1.10 (s, 3H), 0.88 (t, J = 7.0 Hz, 3H); 
13C NMR (125 MHz, CDCl3): δ 215.0, 150.9, 110.1, 56.0, 40.2, 38.1, 32.0, 31.5, 29.4, 28.3, 28.2, 
25.0; HRMS (ESI) calculated for C15H26ONa [M+Na]+: 245.1881, found: 245.1874. 
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Ketone 3.76. Prepared according to “General procedure for the alkenylation of silyl enol 
ethers” from silyl enol ether 3.10419 and 1-octyne. The reaction was performed in solution 
on a 0.25 mmol scale with 0.1 equiv of InBr3. The reaction mixture was heated to 50 °C for 
64 h. The reaction was quenched with 1 mL of EtOH and 0.3 ml of aqueous HCl (2 M) and the 
resulting solution was stirred for 3 h. The alkenylation proceeded in 48% yield (31.5 mg, 
0.12 mmol of ketone 3.76 obtained, 2:1 d.r., >20:1 r.r.). Rf = 0.6 (10% EtOAc in hexanes); 1H 
NMR (2:1 d.r., 600 MHz, CDCl3): δ 5.04-5.02 (m, 1.5H), 5.00 (s, 0.5H), 4.93 (s, 1H), 2.52-2.49 
(m, 0.5H), 2.41-2.38 (m, 1H), 2.35-2.31 (m, 1.5H), 2.16-2.12 (m, 0.5H), 2.05-1.99 (m, 1.5H), 
1.93-1.81 (m, 2H), 1.70-1.65 (m, 2H), 1.57-1.50 (m, 4.5H), 1.46-1.41 (m, 1.5H), 1.38-1.31 (m, 
12H), 1.27 (s, 1.5H), 1.15 (s, 3H), 0.96-0.92 (m, 13.5H); 13C NMR (2:1 d.r., 150 MHz, CDCl3): δ 
215.1, 214.8, 152.1, 150.6, 110.0, 109.7, 55.2, 55.1, 47.0, 44.4, 43.6, 42.5, 36.8, 34.7, 32.9, 32.6, 
31.87, 31.86, 31.3, 30.8, 29.4, 29.2, 28.9, 28.0, 25.5, 24.8, 24.4, 23.4, 22.68, 22.67, 20.04, 19.99, 
19.7, 19.5, 14.13, 14.11; HRMS (ESI) calculated for C18H32ONa [M+Na]+: 287.2351, found: 
287.2360. 
 
Diketone 3.86. Prepared according to “General procedure for the alkenylation of silyl enol 
ethers” from silyl enol ether 3.85 (ratio of tetra- and corresponding disubstituted isomers 
5:1) and 1-octyne. The reaction was performed in solution on a 0.23 mmol scale with 0.1 
equiv of InBr3. The reaction mixture was heated to 65 °C for 64 h. The reaction was quenched 
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with 1 mL EtOH and 0.2 mL of aqueous HCl (1 M) and the resulting solution was stirred for 
30 min. The alkenylation proceeded in 49% yield (36.5 mg, 0.113 mmol of diketone 3.86 
obtained, 10:1 r.r.). Rf = 0.35 (10% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3): δ 5.04 (t, J 
= 1.42 Hz, 1H), 5.03 (s, 1H), 2.10 (s, 3H), 2.01 (2, 3H), 1.83-1.74 (m, 2H), 1.65-1.61 (m, 2H), 
1.50-1.47 (m, 2H), 1.45-1.40 (m, 2H), 1.33-1.24 (m, 8H), 1.18 (s, 3H), 1.16-1.13 (m, 2H), 1.09 
(s, 6H), 0.88 (t, J = 6.9 Hz, 3H); 13C NMR (150 MHz, CDCl3): δ 214.13, 211.97, 150.79, 110.70, 
57.81, 47.79, 39.98, 34.45, 32.23, 31.82, 29.27, 28.30, 25.45, 25.16, 25.11, 24.84, 24.36, 24.35, 
22.66, 20.07, 14.13; HRMS (CI) calculated for C21H38O2Na [M+Na]+: 345.2769, found: 
345.2770. 
3.4.5 Observation of 3.94 Upon Addition of 3.93 
 
The reaction between silyl enol ether 3.57 and 1-octyne in the presence of 10 mol% of InBr3 
and 7 mol % of ketone 3.93 was set up according to the general procedure and heated to 
65 °C. An aliquot was taken after 1 h and treated with an anhydrous solution of Et3N and 
MeOH in (CH2Cl)2 for 5 min. The crude sample was analyzed by 1H NMR and GC/MSD. 
Conversion of ketone 3.93 to siloxydiene 3.94 was ca. 40%. Note: in this experiment the 
observed amount of ketone 3 in the crude sample corresponds to the sum of the amounts of 
ketone 3.59 and alkenylindium 3.95 (Scheme 3.18) in the reaction. 
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3.4.6 Preparation of Starting Materials 
 
Silyl enol ether 3.98. TIPSOTf (3.23 mL, 12 mmol) was added to a solution of 2-
methylcyclohexanone (1.46 mL, 12 mmol) in DCM (30 mL). Triethylamine (2.17 mL, 15.6 
3.58 
3.94 
3.94 
 
 
3.58 
3.59 
3.59 
3.93 
3.93 
3.94 
3.58 
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mmol) was added over 2 minutes. The reaction was stirred at room temperature for 5.5 h, 
then diluted in hexanes, washed with saturated aqueous NaHCO3 and brine, dried over 
anhydrous sodium sulfate, and concentrated under reduced pressure to yield a 2:1 mixture 
of trisubstituted to disubstituted siloxyalkenes. The crude material was dissolved in DCM 
(12 mL) and added to a Schlenk flask charged with pyridine hydrochloride (0.127 g, 1.1 
mmol) and stirred at room temperature for 1.5 h. The reaction was diluted with hexanes, 
washed with saturated aqueous NaHCO3 and brine, dried over anhydrous sodium sulfate, 
and concentrated under reduced pressure. Purification on Et3N-treated silica (elution with 
hexanes) afforded 2.7 g (84% yield, 13:1 trisubstituted to disubstituted siloxyalkenes) of 
silyl enol ether 3.98 as a colorless oil. Rf = 0.85 (hexanes); 1H NMR (500 MHz, C6D6): δ 2.09-
2.04 (m, 2H), 1.94-1.91 (m, 2H), 1.75 (s, 3H), 1.58-1.53 (m, 2H), 1.49-1.45 (m, 2H), 1.16-1.13 
(m, 21H); 13C NMR (125 MHz, CDCl3): δ 143.4, 111.0, 30.6, 24.1, 23.1, 18.3, 17.9, 16.7, 13.4; 
HRMS (CI) calculated for C16H32OSi [M]+: 268.222, found: 268.2233. 
 
Alkyne 3.100. TIPSCl (4.5 mL, 15 mmol), 4-pentyn-1-ol (1.4 mL, 15 mmol), and imidazole 
(2.0 g, 30 mmol) were dissolved in DCM and stirred at room temperature for 2 h. The 
reaction was diluted in hexanes, washed with saturated aqueous NaHCO3 and brine, dried 
over anhydrous sodium sulfate, and concentrated under reduced pressure. Purification by 
flash chromatography (elution with hexanes) afforded 3.4 g (95% yield) of alkyne 3.100 as 
a colorless oil. 1H and 13C NMR data match that provided in the literature.21 
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Silyl enol ether 3.101. TIPSOTf (0.91 mL, 3.4 mmol) was added to a solution of ketone 
3.10522 (380 mg, 3.4 mmol) in DCM (10 mL). Triethylamine (0.95 mL, 6.8 mmol) was added 
over 2 minutes. The reaction was stirred at room temperature for 3.5 h, then diluted in 
hexanes, washed with saturated aqueous NaHCO3 and brine, dried over anhydrous sodium 
sulfate, and concentrated under reduced pressure to yield silyl enol ether 3.101. Purification 
by flash chromatography (elution with hexanes) afforded 0.68 g (75% yield, 10:1 
trisubstituted to disubstituted siloxyalkene) of silyl enol ether 3.101 as a colorless oil. Rf = 
0.85 (hexanes); 1H NMR (500 MHz, C6D6): δ 2.33-2.29 (m, 2H), 2.27-2.20 (m, 4H), 1.76-1.70 
(m, 2H), 1.13-1.10 (m, 21H), 1.03 (t, J = 7.6 Hz, 3H); 13C NMR (125 MHz, C6D6): δ 146.3, 117.6, 
34.5, 30.8, 20.3, 20.0, 18.2, 13.3. HRMS (CI) calculated for C16H32OSi [M]+: 268.2222, found: 
268.2212. 
 
Silyl enol ether 3.102: Ethyl 2-oxocyclopentanecarboxylate (1.48 mL, 10 mmol), (2-
bromoethyl)benzene (5.48 mL, 40 mmol), K2CO3 (4.15 g, 30 mmol), acetone (30 mL) were 
combined in a round bottom flask and the slurry was refluxed for 21 h. The reaction was 
cooled to room temperature, filtered through Celite, and concentrated to yield an orange oil. 
The crude material was dissolved in AcOH (12 mL) and HCl (6 mL of a 6 M solution) was 
added. The reaction was refluxed for 16 h, cooled to room temperature, diluted with water, 
and extracted with Et2O (three times, 60 mL combined). The combined organic layers were 
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washed with saturated aqueous NaHCO3 and brine, dried over anhydrous sodium sulfate, 
and concentrated under reduced pressure. Purification by flash chromatography (gradient 
elution 1-10% Et2O in hexanes) afforded ketone 3.106 in a 36% yield (0.68 g, 3,6 mmol) as 
a clear oil. 1H and 13C NMR data match that provided in the literature.21 TIPSOTf (0.97 mL, 
3.6 mmol) was added to a solution of ketone 3.106 (0.68 g, 3.6 mmol) in DCM (10 mL). 
Triethylamine (0.65 mL, 4.7 mmol) was added over 2 minutes. The reaction was stirred at 
room temperature for 16 h, then diluted in hexanes, washed with saturated aqueous NaHCO3 
and brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure 
to yield a 1:1 mixture of trisubstituted to disubstituted siloxyalkenes. The crude material was 
dissolved in DCM (3 mL) and added to a Schlenk flask charged with pyridine hydrochloride 
(33.5 mg, 0.29 mmol) and stirred at room temperature for 1 h. The reaction was diluted with 
hexanes, washed with saturated aqueous NaHCO3 and brine, dried over anhydrous sodium 
sulfate, and concentrated under reduced pressure. Purification on Et3N-treated silica 
(elution with hexanes) afforded 0.93 g (75% yield, 14:1 trisubstituted to disubstituted 
siloxyalkene) of silyl enol ether 3.102 as a colorless oil. Rf = 0.6 (hexanes); 1H NMR (500 
MHz, C6D6): δ 7.23-7.17 (m, 4H), 7.09-7.05 (m, 1H), 2.72 (dd, J = 9.4, 6.6 Hz, 2H), 2.56-2.52 
(m, 2H), 2.30-2.27 (m, 2H), 2.22-2.19 (m, 2H), 1.75-1.69 (m, 2H), 1.12-1.06 (m, 21H); 13C 
NMR (125 MHz, C6D6): δ 147.5, 143.1, 128.7, 128.6, 126.0, 115.6, 34.7, 34.4, 31.4, 29.2, 20.4, 
18.2, 13.3; HRMS (CI) calculated for C22H37OSi [M+H]+: 345.2614, found: 345.2599. 
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Silyl enol ether 3.103: A solution of phenethylmagnesium bromide (2.6 mL of a 2.0 M 
solution in THF, 5.2 mmol, prepared from (1-bromoethyl)benzene) was added to a 
suspension of CuBr·SMe2 (82 mg, 0.40 mmol) in THF (4 mL) at –35 ˚C over the course of 5 
min. The resulting solution was stirred for 20 min and cooled to –45 ˚C. 2-Methyl-2-
cyclopenten-1-one (0.39 mL, 4.0 mmol) was added to the reaction mixture over the course 
of 30 min. The resulting solution was stirred for 40 min at –45 ˚C and treated with TIPSCl 
(1.96 mL, 9.2 mmol). The reaction mixture was warmed up to room temperature and treated 
with HMPA (3.2 mL, 18.4 mmol). The resulting suspension was heated to 50 ˚C for 17 h and 
quenched with a 3:1 (v/v) mixture of saturated aqueous NH4Cl and 28% (v/v) aqueous NH3. 
The resulting solution was diluted with hexanes. The layers were separated, and the organic 
layer was washed with water, then brine, dried over anhydrous sodium sulfate, and 
concentrated under reduced pressure. Purification by flash chromatography on Et3N-treated 
silica gel (elution with 1% Et3N in hexanes) afforded 1.25 g (87% yield) of silyl enol ether 
3.103 as a colorless oil. Rf = 0.65 (hexanes); 1H NMR (500 MHz; CDCl3): δ 7.29-7.26 (m, 2H), 
7.20-7.16 (m, 3H), 2.68-2.62 (m, 1H), 2.55-2.46 (m, 1H), 2.47-2.43 (m, 1H), 2.35-2.30 (m, 2H), 
2.07-2.02 (m, 1H), 1.93-1.86 (m, 1H), 1.54 (s, 3H), 1.52-1.47 (m, 1H), 1.45-1.37 (m, 1H), 1.17-
1.11 (m, 3H), 1.09 (d, J = 5.8 Hz, 18H); 13C NMR (125 MHz, CDCl3): δ 147.3, 143.2, 128.5, 128.4, 
125.7, 115.5, 44.5, 36.5, 33.4, 33.0, 26.7, 18.1, 13.0, 10.5; HRMS (CI) calculated for C23H39OSi 
[M+H]+: 359.2770, found: 359.2777. 
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Nitrile 3.89: To a solution of diisopropylamine (2.31 mL, 16.5 mmol) in THF (7 mL) at 0 ˚C 
was added nBuLi (6.68 mL, 2.47 M in hexanes). After 30 min. the solution was cooled to –78 
˚C and isobutyronitrile (1.35 mL, 15 mmol) was added, and the resulting solution was stirred 
for 1 h. The reaction mixture was then transferred via cannula into a vigorously stirring 
solution of 1,4-dibromobutane (5.4 mL, 45 mmol) in THF (35 mL), and allowed to reach room 
temperature overnight. The mixture was then poured into sat. aq. NH4Cl (30 mL) and 
extracted with Et2O, washed with brine, dried over anhydrous sodium sulfate, and 
concentrated under reduced pressure. Purification by flash chromatography (gradient 
elution 2-7% EtOAc in Hexanes) afforded 2.74 g (13.4 mmol, 89%) of 3.89 as a colorless 
liquid. Rf = 0.4 (15% EtOAc in hexanes); 1H NMR (500 MHz, CDCl3): δ 3.43 (t, J = 6.8 Hz, 2H), 
1.91 (tt, J = 7.1, 6.8 Hz, 2H), 1.66-1.62 (m, 2H), 1.56-1.53 (m, 2H), 1.35 (s, 6H); 13C NMR (125 
MHz, CDCl3): δ 125.1, 40.3, 33.2, 32.6, 32.4, 26.8, 24.1; HRMS (ESI) calculated for C8H14BrNa 
[M+Na]+: 226.0207, found: 226.0213. 
 
Ketone 3.90: To a solution of methylmagnesium bromide (9.4 mL, 2.89 M in Et2O, 26.8 mmol) 
and THF (3 mL) in a 25 mL Schlenk flask was added 6-bromo-2,2-dimethylhexanenitrile 
(0.46 mL, 2.68 mmol) as a solution in THF (3 mL).  The reaction mixture was heated to 60 ˚C. 
While heating, Et2O was removed under positive pressure of nitrogen. After 16 h, the 
reaction mixture was diluted with THF (5 mL) and cooled to 0 ˚C. While stirring vigorously, 
excess methylmagnesium bromide was carefully quenched by the slow addition of NH4Cl (8 
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mL). The mixture was extracted with Et2O, and the organic phase was washed with water 
then brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. 
Purification by flash chromatography (gradient elution 0-3% EtOAc in hexanes) afforded 
342 mg (1.55 mmol, 58%) of ketone 3.90 as a colorless oil. Rf = 0.4 (15% EtOAc in hexanes); 
1H NMR (500 MHz, CDCl3): δ 3.39 (t, J = 6.8 Hz, 2H), 2.12 (s, 3H), 1.87-1.80 (m, 2H), 1.53-1.51 
(m, 2H), 1.35-1.31 (m, 2H), 1.12 (2, 6H); 13C NMR (125 MHz, CDCl3): δ 214.0, 47.8, 39.0, 33.6, 
33.3, 25.3, 24.5, 23.5; HRMS (ESI) calculated for C9H17OBrNa [M+Na]+: 243.0360, found: 
243.0367. 
 
Diketone 3.92: Ethyl 2-methyl acetoacetate (2.76 mL, 27.3 mmol), ketone 3.90 (1.44 g, 6.5 
mmol), K2CO3 (5.4 g, 39 mmol), sodium iodide (2.9 g, 19.5 mmol), and 2-butanone (20 mL) 
were combined in a round bottom flask and the slurry was refluxed for 20 h. The reaction 
was cooled to room temperature, filtered through Celite and concentrated under reduced 
pressure. Isolation by flash chromatography yielded an impure mixture of the diketoester 
alkylation product. This crude material was dissolved in MeOH (25 mL) and potassium 
hydroxide (1.02 g, 18.2 mmol) was added. The reaction was refluxed for 4 h, cooled to room 
temperature, concentrated, dissolved in water, and acidified with 2 N HCl. This mixture was 
extracted with diethyl ether and the combined organic layers were washed with saturated 
aqueous NaHCO3 and brine and dried over anhydrous sodium sulfate. Purification by flash 
chromatography (gradient elution 0-5% EtOAc in hexanes) afforded 596 mg (38% yield) of 
diketone 3.92 as a clear oil. Rf = 0.27 (15% EtOAc in hexanes); 1H NMR (600 MHz, CDCl3) δ 
2.48 (tq, J = 7.0, 6.9 Hz, 1H), 2.12 (s, 3H), 2.10 (s, 3H), 1.66-1.61 (m, 1H), 1.50-1.47 (m, 2H), 
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1.36-1.28 (m, 1H), 1.26-1.19 (m, 2H), 1.17-1.13 (m, 2H), 1.09 (s, 6H), 1.07 (d, J = 7.0 Hz, 3H); 
13C NMR (125 MHz, CDCl3): δ 214.1, 212.9, 47.8, 47.1, 39.9, 32.7, 28.1, 27.9, 25.1, 24.9, 24.38, 
24.36, 16.3; HRMS (ESI) calculated for C13H24O2Na [M+Na]+: 235.1674, found: 235.1683. 
 
Silyl enol ether 3.85. TIPSOTf (1.5 mL, 5.6 mmol) was added to a solution of diketone 3.92 
(596 mg, 2.8 mmol) in DCM (8 mL). Triethylamine (1 mL, 7.3 mmol) was added over 2 
minutes. The reaction was stirred at room temperature for 3 h, then diluted in hexanes, 
washed with saturated aqueous NaHCO3 and brine, dried over anhydrous sodium sulfate, 
and concentrated under reduced pressure to yield exclusively product containing two 
monosubstituted siloxyalkenes. The crude material was dissolved in DCM (6 mL) and added 
to a Schlenk flask charged with pyridine hydrochloride (16 mg, 0.14 mmol) and stirred at 
room temperature for 1 h. The reaction was diluted with hexanes, washed with saturated 
aqueous NaHCO3 and brine, dried over anhydrous sodium sulfate, and concentrated under 
reduced pressure. Purification through a plug of neutral alumina (elution with hexanes) to 
afforded 1.13 g (77% yield, 5:1 trisubstituted to monosubstituted silyl enol ether, and a 0.6:1 
mixture of E and Z isomers) of silyl enol ether 3.85 as a light yellow oil. Rf = 0.85 (hexanes); 
1H NMR (500 MHz, C6D6): δ 4.15-4.14 (m, 1.6H), 4.09-4.07 (m, 1.6H), 2.36-2.33 (m, 1.2H), 
2.07-2.02 (m, 2H), 1.86 (s, 3H), 1.84-1.81 (m, 3H), 1.79 (s, 1.8H), 1.62 (s, 1.8H),  1.58-1.52 (m, 
3.2H), 1.48-1.43 (m, 3.8H), 1.39-1.32 (m, 2.6H), 1.17-1.13 (m, 76.8H); 13C NMR (125 MHz, 
C6D6): δ 165.6, 141.4, 140.7,  112.9, 112.3, 86.7, 41.0, 40.8, 40.44, 40.41, 34.1, 32.0, 30.0, 29.3, 
26.89, 26.87, 25.6, 25.4, 18.53, 18.50, 18.4, 18.13, 18.05, 17.0, 16.1, 13.8, 13.7, 13.3; HRMS 
(ESI) calculated for C31H65O2Si2 [M+H]+: 525.4523, found: 525.4510.  
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Appendix A: NMR Spectra for Chapter 2  
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Appendix B: X-Ray Crystallographic Data for 2.115 
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Table 1.  Crystal data and structure refinement for 2.115 
Identification code  svp6 (Stephen Holmbo) 
Empirical formula  C24 H21 Br O6 • C7H8 • H2O 
Formula weight  595.47 
Temperature  133(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P1  
Unit cell dimensions a = 10.3318(9) Å = 78.6657(11)°. 
 b = 10.4224(9) Å = 75.4327(10)°. 
 c = 13.6723(12) Å  = 75.5399(11)°. 
Volume 1365.7(2) Å3 
Z 2 
Density (calculated) 1.448 Mg/m3 
Absorption coefficient 1.553 mm-1 
F(000) 616 
Crystal color colorless 
Crystal size 0.474 x 0.331 x 0.244 mm3 
Theta range for data collection 1.555 to 28.324° 
Index ranges -13 ≤ h ≤ 13, -13 ≤ k ≤ 13, -17 ≤ l ≤ 17 
Reflections collected 16445 
Independent reflections 6453 [R(int) = 0.0388] 
Completeness to theta = 25.500° 99.8 %  
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Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7457 and 0.6087 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6453 / 0 / 476 
Goodness-of-fit on F2 1.045 
Final R indices [I>2sigma(I) = 5815 data] R1 = 0.0319, wR2 = 0.0840 
R indices (all data, 0.75 Å) R1 = 0.0361, wR2 = 0.0864 
Largest diff. peak and hole 0.559 and -0.563 e.Å-3 
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Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for 2.115.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
Br(1) 8371(1) 450(1) 5010(1) 34(1) 
O(1) 5287(1) 3432(1) 8936(1) 22(1) 
O(2) 3442(1) 5519(1) 8868(1) 24(1) 
O(3) 1834(1) 7610(1) 8138(1) 24(1) 
O(4) -104(1) 2475(1) 8648(1) 24(1) 
O(5) 5816(1) 1445(1) 4247(1) 26(1) 
O(6) 7497(1) 608(1) 7273(1) 20(1) 
O(7) -2531(1) 2232(1) 9942(1) 22(1) 
C(1) 4462(2) 2825(1) 8775(1) 17(1) 
C(2) 3079(2) 3430(1) 8734(1) 17(1) 
C(3) 2627(2) 4791(2) 8726(1) 18(1) 
C(4) 1265(2) 5479(2) 8555(1) 18(1) 
C(5) 861(2) 6878(2) 8288(1) 20(1) 
C(6) -478(2) 7451(2) 8190(1) 23(1) 
C(7) -1434(2) 6656(2) 8355(1) 24(1) 
C(8) -1027(2) 5272(2) 8575(1) 22(1) 
C(9) 308(2) 4678(2) 8664(1) 19(1) 
C(10) 699(2) 3169(2) 8966(1) 18(1) 
C(11) 2204(1) 2565(1) 8557(1) 16(1) 
C(12) 2499(1) 2467(1) 7406(1) 16(1) 
C(13) 3977(1) 1917(1) 6897(1) 15(1) 
C(14) 4210(2) 1911(1) 5843(1) 17(1) 
C(15) 5502(2) 1487(1) 5268(1) 18(1) 
C(16) 6601(2) 1060(2) 5763(1) 20(1) 
C(17) 6397(2) 1058(1) 6802(1) 16(1) 
C(18) 5085(1) 1468(1) 7388(1) 15(1) 
C(19) 4931(2) 1400(1) 8539(1) 16(1) 
C(20) 3866(2) 604(2) 9118(1) 19(1) 
C(21) 2566(2) 1163(2) 9130(1) 19(1) 
C(22) 1455(2) 9031(2) 7870(2) 29(1) 
C(23) -2897(2) 7296(2) 8300(2) 34(1) 
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C(24) 4726(2) 1894(2) 3713(1) 26(1) 
C(25) 8181(2) 1655(2) 7260(2) 27(1) 
C(26) 5979(3) 4647(2) 4159(2) 51(1) 
C(27) 4652(3) 5185(2) 4070(2) 51(1) 
C(28) 3671(3) 5534(2) 4912(2) 50(1) 
C(29) 565(2) 4199(2) 4240(1) 31(1) 
C(30) 416(2) 3633(2) 5259(1) 30(1) 
C(31) -152(2) 4430(2) 6018(1) 29(1) 
________________________________________________________________________________ 
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Table 3.   Bond lengths [Å] and angles [°] for 2.115. 
_____________________________________________________  
Br(1)-C(16)  1.8805(15) 
O(1)-C(1)  1.2624(17) 
O(2)-C(3)  1.3348(18) 
O(2)-H(2)  0.89(3) 
O(3)-C(5)  1.3602(19) 
O(3)-C(22)  1.433(2) 
O(4)-C(10)  1.4160(17) 
O(4)-H(4)  0.85(2) 
O(5)-C(15)  1.3578(18) 
O(5)-C(24)  1.4277(18) 
O(6)-C(17)  1.3819(16) 
O(6)-C(25)  1.4359(19) 
O(7)-H(7A)  0.76(3) 
O(7)-H(7B)  0.88(3) 
C(1)-C(2)  1.421(2) 
C(1)-C(19)  1.515(2) 
C(2)-C(3)  1.377(2) 
C(2)-C(11)  1.5143(19) 
C(3)-C(4)  1.465(2) 
C(4)-C(9)  1.409(2) 
C(4)-C(5)  1.413(2) 
C(5)-C(6)  1.393(2) 
C(6)-C(7)  1.391(2) 
C(6)-H(6A)  0.91(2) 
C(7)-C(8)  1.393(2) 
C(7)-C(23)  1.506(2) 
C(8)-C(9)  1.389(2) 
C(8)-H(8A)  0.96(2) 
C(9)-C(10)  1.523(2) 
C(10)-C(11)  1.529(2) 
C(10)-H(10A)  0.974(19) 
C(11)-C(21)  1.521(2) 
C(11)-C(12)  1.5443(19) 
C(12)-C(13)  1.527(2) 
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C(12)-H(12A)  0.976(19) 
C(12)-H(12B)  0.962(18) 
C(13)-C(14)  1.401(2) 
C(13)-C(18)  1.4056(19) 
C(14)-C(15)  1.382(2) 
C(14)-H(14A)  0.916(19) 
C(15)-C(16)  1.400(2) 
C(16)-C(17)  1.384(2) 
C(17)-C(18)  1.400(2) 
C(18)-C(19)  1.5310(19) 
C(19)-C(20)  1.512(2) 
C(19)-H(19A)  0.977(19) 
C(20)-C(21)  1.321(2) 
C(20)-H(20A)  0.96(2) 
C(21)-H(21A)  0.933(19) 
C(22)-H(22A)  0.99(3) 
C(22)-H(22B)  0.94(2) 
C(22)-H(22C)  0.92(2) 
C(23)-H(23A)  0.96(3) 
C(23)-H(23B)  0.87(3) 
C(23)-H(23C)  0.92(4) 
C(24)-H(24A)  0.95(3) 
C(24)-H(24B)  0.98(2) 
C(24)-H(24C)  0.97(2) 
C(25)-H(25A)  0.96(2) 
C(25)-H(25B)  0.97(2) 
C(25)-H(25C)  0.96(2) 
C(26)-C(27)  1.372(4) 
C(26)-C(28)#1  1.372(4) 
C(26)-H(26)  0.91(3) 
C(27)-C(28)  1.371(4) 
C(27)-H(27)  0.96(3) 
C(28)-C(26)#1  1.372(4) 
C(28)-H(28)  1.04(4) 
C(29)-C(31)#2  1.385(3) 
C(29)-C(30)  1.388(3) 
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C(29)-H(29)  0.90(2) 
C(30)-C(31)  1.379(3) 
C(30)-H(30)  0.90(2) 
C(31)-C(29)#2  1.385(3) 
C(31)-H(31)  0.94(2) 
 
C(3)-O(2)-H(2) 104.9(16) 
C(5)-O(3)-C(22) 118.25(13) 
C(10)-O(4)-H(4) 110.7(16) 
C(15)-O(5)-C(24) 117.57(12) 
C(17)-O(6)-C(25) 112.40(11) 
H(7A)-O(7)-H(7B) 104(2) 
O(1)-C(1)-C(2) 123.60(13) 
O(1)-C(1)-C(19) 121.00(13) 
C(2)-C(1)-C(19) 115.28(12) 
C(3)-C(2)-C(1) 119.93(13) 
C(3)-C(2)-C(11) 121.93(13) 
C(1)-C(2)-C(11) 117.60(12) 
O(2)-C(3)-C(2) 119.94(13) 
O(2)-C(3)-C(4) 118.38(13) 
C(2)-C(3)-C(4) 121.67(13) 
C(9)-C(4)-C(5) 118.65(13) 
C(9)-C(4)-C(3) 117.12(13) 
C(5)-C(4)-C(3) 124.23(14) 
O(3)-C(5)-C(6) 122.85(14) 
O(3)-C(5)-C(4) 116.95(13) 
C(6)-C(5)-C(4) 120.20(14) 
C(7)-C(6)-C(5) 120.52(15) 
C(7)-C(6)-H(6A) 122.0(12) 
C(5)-C(6)-H(6A) 117.4(12) 
C(6)-C(7)-C(8) 119.47(14) 
C(6)-C(7)-C(23) 119.93(16) 
C(8)-C(7)-C(23) 120.60(16) 
C(9)-C(8)-C(7) 120.90(15) 
C(9)-C(8)-H(8A) 117.3(12) 
C(7)-C(8)-H(8A) 121.7(12) 
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C(8)-C(9)-C(4) 120.10(14) 
C(8)-C(9)-C(10) 119.58(14) 
C(4)-C(9)-C(10) 120.13(13) 
O(4)-C(10)-C(9) 112.38(12) 
O(4)-C(10)-C(11) 107.75(12) 
C(9)-C(10)-C(11) 113.81(12) 
O(4)-C(10)-H(10A) 109.5(10) 
C(9)-C(10)-H(10A) 105.4(10) 
C(11)-C(10)-H(10A) 107.9(11) 
C(2)-C(11)-C(21) 109.36(11) 
C(2)-C(11)-C(10) 108.88(12) 
C(21)-C(11)-C(10) 108.95(12) 
C(2)-C(11)-C(12) 109.34(11) 
C(21)-C(11)-C(12) 108.43(12) 
C(10)-C(11)-C(12) 111.84(11) 
C(13)-C(12)-C(11) 117.01(11) 
C(13)-C(12)-H(12A) 108.2(11) 
C(11)-C(12)-H(12A) 109.4(11) 
C(13)-C(12)-H(12B) 107.0(11) 
C(11)-C(12)-H(12B) 109.0(11) 
H(12A)-C(12)-H(12B) 105.6(15) 
C(14)-C(13)-C(18) 119.26(13) 
C(14)-C(13)-C(12) 115.01(12) 
C(18)-C(13)-C(12) 125.70(13) 
C(15)-C(14)-C(13) 121.87(13) 
C(15)-C(14)-H(14A) 120.7(12) 
C(13)-C(14)-H(14A) 117.5(12) 
O(5)-C(15)-C(14) 125.70(13) 
O(5)-C(15)-C(16) 115.92(13) 
C(14)-C(15)-C(16) 118.37(13) 
C(17)-C(16)-C(15) 120.79(14) 
C(17)-C(16)-Br(1) 119.56(11) 
C(15)-C(16)-Br(1) 119.64(11) 
O(6)-C(17)-C(16) 119.48(13) 
O(6)-C(17)-C(18) 119.63(13) 
C(16)-C(17)-C(18) 120.85(13) 
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C(17)-C(18)-C(13) 118.82(13) 
C(17)-C(18)-C(19) 117.96(12) 
C(13)-C(18)-C(19) 123.22(13) 
C(20)-C(19)-C(1) 109.33(12) 
C(20)-C(19)-C(18) 110.14(11) 
C(1)-C(19)-C(18) 107.01(11) 
C(20)-C(19)-H(19A) 114.2(10) 
C(1)-C(19)-H(19A) 107.4(10) 
C(18)-C(19)-H(19A) 108.4(11) 
C(21)-C(20)-C(19) 118.17(13) 
C(21)-C(20)-H(20A) 124.1(12) 
C(19)-C(20)-H(20A) 117.6(12) 
C(20)-C(21)-C(11) 119.02(13) 
C(20)-C(21)-H(21A) 122.8(11) 
C(11)-C(21)-H(21A) 118.1(11) 
O(3)-C(22)-H(22A) 102.4(14) 
O(3)-C(22)-H(22B) 110.4(13) 
H(22A)-C(22)-H(22B) 111.9(19) 
O(3)-C(22)-H(22C) 108.5(12) 
H(22A)-C(22)-H(22C) 110.5(19) 
H(22B)-C(22)-H(22C) 112.6(19) 
C(7)-C(23)-H(23A) 111(2) 
C(7)-C(23)-H(23B) 109(2) 
H(23A)-C(23)-H(23B) 112(3) 
C(7)-C(23)-H(23C) 111(2) 
H(23A)-C(23)-H(23C) 106(3) 
H(23B)-C(23)-H(23C) 108(3) 
O(5)-C(24)-H(24A) 103.7(15) 
O(5)-C(24)-H(24B) 110.6(12) 
H(24A)-C(24)-H(24B) 108.4(18) 
O(5)-C(24)-H(24C) 109.6(13) 
H(24A)-C(24)-H(24C) 110.9(19) 
H(24B)-C(24)-H(24C) 113.3(17) 
O(6)-C(25)-H(25A) 106.9(13) 
O(6)-C(25)-H(25B) 111.1(13) 
H(25A)-C(25)-H(25B) 112.0(19) 
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O(6)-C(25)-H(25C) 112.6(12) 
H(25A)-C(25)-H(25C) 108.6(18) 
H(25B)-C(25)-H(25C) 105.5(18) 
C(27)-C(26)-C(28)#1 120.1(2) 
C(27)-C(26)-H(26) 115(2) 
C(28)#1-C(26)-H(26) 125(2) 
C(28)-C(27)-C(26) 120.0(2) 
C(28)-C(27)-H(27) 117.1(17) 
C(26)-C(27)-H(27) 122.9(17) 
C(27)-C(28)-C(26)#1 119.9(2) 
C(27)-C(28)-H(28) 118.4(19) 
C(26)#1-C(28)-H(28) 121.4(19) 
C(31)#2-C(29)-C(30) 120.12(17) 
C(31)#2-C(29)-H(29) 117.9(15) 
C(30)-C(29)-H(29) 121.9(15) 
C(31)-C(30)-C(29) 120.12(17) 
C(31)-C(30)-H(30) 119.1(14) 
C(29)-C(30)-H(30) 120.6(14) 
C(30)-C(31)-C(29)#2 119.77(16) 
C(30)-C(31)-H(31) 119.5(14) 
C(29)#2-C(31)-H(31) 120.7(14) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y+1,-z+1    #2 -x,-y+1,-z+1       
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Table 4.   Anisotropic displacement parameters  (Å2x 103) for 2.115.  The anisotropic 
displacement factor exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
Br(1) 16(1)  58(1) 27(1)  -19(1) -5(1)  8(1) 
O(1) 17(1)  24(1) 29(1)  -10(1) -10(1)  -2(1) 
O(2) 20(1)  21(1) 36(1)  -11(1) -13(1)  -1(1) 
O(3) 25(1)  20(1) 29(1)  -4(1) -11(1)  -1(1) 
O(4) 16(1)  35(1) 24(1)  -9(1) -2(1)  -10(1) 
O(5) 21(1)  39(1) 17(1)  -10(1) -7(1)  2(1) 
O(6) 16(1)  22(1) 24(1)  -4(1) -12(1)  1(1) 
O(7) 19(1)  26(1) 22(1)  -4(1) -6(1)  -6(1) 
C(1) 17(1)  21(1) 14(1)  -2(1) -6(1)  -4(1) 
C(2) 15(1)  22(1) 15(1)  -4(1) -6(1)  -3(1) 
C(3) 16(1)  23(1) 16(1)  -6(1) -5(1)  -2(1) 
C(4) 16(1)  24(1) 14(1)  -6(1) -6(1)  1(1) 
C(5) 22(1)  26(1) 14(1)  -7(1) -6(1)  -1(1) 
C(6) 25(1)  26(1) 18(1)  -6(1) -8(1)  4(1) 
C(7) 18(1)  36(1) 15(1)  -6(1) -6(1)  4(1) 
C(8) 16(1)  35(1) 17(1)  -6(1) -5(1)  -2(1) 
C(9) 16(1)  27(1) 13(1)  -6(1) -4(1)  -1(1) 
C(10) 14(1)  26(1) 15(1)  -4(1) -3(1)  -5(1) 
C(11) 14(1)  20(1) 14(1)  -2(1) -5(1)  -4(1) 
C(12) 13(1)  18(1) 16(1)  -2(1) -5(1)  -3(1) 
C(13) 15(1)  14(1) 16(1)  -2(1) -6(1)  -3(1) 
C(14) 16(1)  18(1) 17(1)  -3(1) -7(1)  -2(1) 
C(15) 18(1)  21(1) 16(1)  -5(1) -6(1)  -1(1) 
C(16) 13(1)  23(1) 22(1)  -8(1) -3(1)  1(1) 
C(17) 16(1)  15(1) 20(1)  -3(1) -9(1)  0(1) 
C(18) 17(1)  14(1) 15(1)  -2(1) -7(1)  -3(1) 
C(19) 15(1)  18(1) 16(1)  -1(1) -8(1)  -2(1) 
C(20) 24(1)  19(1) 15(1)  2(1) -9(1)  -5(1) 
C(21) 22(1)  23(1) 14(1)  0(1) -5(1)  -9(1) 
C(22) 35(1)  21(1) 31(1)  -5(1) -13(1)  0(1) 
C(23) 20(1)  45(1) 35(1)  -5(1) -12(1)  4(1) 
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C(24) 26(1)  33(1) 19(1)  -7(1) -10(1)  -1(1) 
C(25) 18(1)  33(1) 34(1)  -9(1) -10(1)  -5(1) 
C(26) 69(2)  28(1) 48(1)  -2(1) 11(1)  -22(1) 
C(27) 93(2)  29(1) 45(1)  12(1) -36(1)  -29(1) 
C(28) 44(1)  26(1) 84(2)  11(1) -25(1)  -14(1) 
C(29) 29(1)  42(1) 22(1)  -12(1) -3(1)  -5(1) 
C(30) 27(1)  31(1) 30(1)  -2(1) -7(1)  -5(1) 
C(31) 27(1)  43(1) 18(1)  -1(1) -7(1)  -10(1) 
______________________________________________________________________________ 
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Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) for 2.115. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
H(2) 4210(30) 4940(30) 8940(20) 52(7) 
H(4) -830(30) 2420(20) 9095(18) 38(6) 
H(6A) -690(20) 8350(20) 8002(15) 23(5) 
H(7A) -2640(30) 2600(20) 10390(20) 40(7) 
H(7B) -3230(30) 2640(20) 9651(18) 38(6) 
H(8A) -1660(20) 4690(20) 8695(16) 30(5) 
H(10A) 535(19) 3029(17) 9709(15) 20(4) 
H(12A) 1920(20) 1923(18) 7289(14) 22(4) 
H(12B) 2226(19) 3344(18) 7041(14) 18(4) 
H(14A) 3466(19) 2189(17) 5545(14) 18(4) 
H(19A) 5833(19) 1047(17) 8704(14) 18(4) 
H(20A) 4180(20) -300(20) 9411(16) 27(5) 
H(21A) 1860(20) 719(18) 9449(14) 21(4) 
H(22A) 2320(30) 9320(20) 7802(19) 46(6) 
H(22B) 1150(20) 9240(20) 7255(17) 32(5) 
H(22C) 800(20) 9370(20) 8404(16) 27(5) 
H(23A) -2940(30) 8090(30) 7800(30) 83(10) 
H(23B) -3270(30) 6710(30) 8170(20) 70(9) 
H(23C) -3390(40) 7570(30) 8910(30) 91(11) 
H(24A) 5170(20) 1800(20) 3025(19) 43(6) 
H(24B) 4070(20) 1306(19) 3946(15) 26(5) 
H(24C) 4310(20) 2830(20) 3780(16) 33(5) 
H(25A) 8930(20) 1260(20) 7600(17) 37(6) 
H(25B) 8490(20) 2070(20) 6567(19) 39(6) 
H(25C) 7590(20) 2370(20) 7611(17) 33(5) 
H(26) 6570(30) 4410(30) 3570(30) 82(10) 
H(27) 4360(30) 5330(30) 3430(20) 60(8) 
H(28) 2650(40) 5840(30) 4840(30) 83(10) 
H(29) 910(20) 3700(20) 3731(19) 40(6) 
H(30) 740(20) 2750(20) 5433(17) 35(6) 
H(31) -260(20) 4040(20) 6704(18) 39(6) 
________________________________________________________________________________ 
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Table 6.  Torsion angles [°] for 2.115. 
________________________________________________________________  
O(1)-C(1)-C(2)-C(3) 9.4(2) 
C(19)-C(1)-C(2)-C(3) -166.60(13) 
O(1)-C(1)-C(2)-C(11) -178.73(13) 
C(19)-C(1)-C(2)-C(11) 5.23(18) 
C(1)-C(2)-C(3)-O(2) -7.4(2) 
C(11)-C(2)-C(3)-O(2) -178.86(13) 
C(1)-C(2)-C(3)-C(4) 172.17(13) 
C(11)-C(2)-C(3)-C(4) 0.7(2) 
O(2)-C(3)-C(4)-C(9) -164.33(13) 
C(2)-C(3)-C(4)-C(9) 16.1(2) 
O(2)-C(3)-C(4)-C(5) 15.8(2) 
C(2)-C(3)-C(4)-C(5) -163.73(14) 
C(22)-O(3)-C(5)-C(6) 0.2(2) 
C(22)-O(3)-C(5)-C(4) -179.76(14) 
C(9)-C(4)-C(5)-O(3) -176.65(13) 
C(3)-C(4)-C(5)-O(3) 3.2(2) 
C(9)-C(4)-C(5)-C(6) 3.3(2) 
C(3)-C(4)-C(5)-C(6) -176.83(14) 
O(3)-C(5)-C(6)-C(7) -179.86(14) 
C(4)-C(5)-C(6)-C(7) 0.1(2) 
C(5)-C(6)-C(7)-C(8) -2.9(2) 
C(5)-C(6)-C(7)-C(23) 176.85(15) 
C(6)-C(7)-C(8)-C(9) 2.1(2) 
C(23)-C(7)-C(8)-C(9) -177.63(15) 
C(7)-C(8)-C(9)-C(4) 1.4(2) 
C(7)-C(8)-C(9)-C(10) 176.43(13) 
C(5)-C(4)-C(9)-C(8) -4.1(2) 
C(3)-C(4)-C(9)-C(8) 176.04(13) 
C(5)-C(4)-C(9)-C(10) -179.09(13) 
C(3)-C(4)-C(9)-C(10) 1.1(2) 
C(8)-C(9)-C(10)-O(4) 29.17(19) 
C(4)-C(9)-C(10)-O(4) -155.83(13) 
C(8)-C(9)-C(10)-C(11) 152.00(13) 
C(4)-C(9)-C(10)-C(11) -33.00(18) 
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C(3)-C(2)-C(11)-C(21) -150.40(14) 
C(1)-C(2)-C(11)-C(21) 37.93(17) 
C(3)-C(2)-C(11)-C(10) -31.46(18) 
C(1)-C(2)-C(11)-C(10) 156.88(12) 
C(3)-C(2)-C(11)-C(12) 91.00(16) 
C(1)-C(2)-C(11)-C(12) -80.66(15) 
O(4)-C(10)-C(11)-C(2) 170.78(11) 
C(9)-C(10)-C(11)-C(2) 45.45(15) 
O(4)-C(10)-C(11)-C(21) -70.03(14) 
C(9)-C(10)-C(11)-C(21) 164.64(11) 
O(4)-C(10)-C(11)-C(12) 49.83(15) 
C(9)-C(10)-C(11)-C(12) -75.50(15) 
C(2)-C(11)-C(12)-C(13) 57.58(15) 
C(21)-C(11)-C(12)-C(13) -61.59(15) 
C(10)-C(11)-C(12)-C(13) 178.25(11) 
C(11)-C(12)-C(13)-C(14) -176.87(12) 
C(11)-C(12)-C(13)-C(18) 1.3(2) 
C(18)-C(13)-C(14)-C(15) -0.6(2) 
C(12)-C(13)-C(14)-C(15) 177.70(13) 
C(24)-O(5)-C(15)-C(14) 0.9(2) 
C(24)-O(5)-C(15)-C(16) -179.00(14) 
C(13)-C(14)-C(15)-O(5) 179.85(13) 
C(13)-C(14)-C(15)-C(16) -0.3(2) 
O(5)-C(15)-C(16)-C(17) -179.93(13) 
C(14)-C(15)-C(16)-C(17) 0.2(2) 
O(5)-C(15)-C(16)-Br(1) -1.06(19) 
C(14)-C(15)-C(16)-Br(1) 179.05(11) 
C(25)-O(6)-C(17)-C(16) 88.34(16) 
C(25)-O(6)-C(17)-C(18) -93.65(16) 
C(15)-C(16)-C(17)-O(6) 178.82(13) 
Br(1)-C(16)-C(17)-O(6) -0.05(18) 
C(15)-C(16)-C(17)-C(18) 0.8(2) 
Br(1)-C(16)-C(17)-C(18) -178.04(10) 
O(6)-C(17)-C(18)-C(13) -179.71(12) 
C(16)-C(17)-C(18)-C(13) -1.7(2) 
O(6)-C(17)-C(18)-C(19) 0.17(19) 
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C(16)-C(17)-C(18)-C(19) 178.16(13) 
C(14)-C(13)-C(18)-C(17) 1.61(19) 
C(12)-C(13)-C(18)-C(17) -176.53(12) 
C(14)-C(13)-C(18)-C(19) -178.26(12) 
C(12)-C(13)-C(18)-C(19) 3.6(2) 
O(1)-C(1)-C(19)-C(20) 137.77(14) 
C(2)-C(1)-C(19)-C(20) -46.08(16) 
O(1)-C(1)-C(19)-C(18) -102.97(15) 
C(2)-C(1)-C(19)-C(18) 73.18(15) 
C(17)-C(18)-C(19)-C(20) -126.28(13) 
C(13)-C(18)-C(19)-C(20) 53.59(17) 
C(17)-C(18)-C(19)-C(1) 114.98(13) 
C(13)-C(18)-C(19)-C(1) -65.15(16) 
C(1)-C(19)-C(20)-C(21) 44.07(18) 
C(18)-C(19)-C(20)-C(21) -73.24(17) 
C(19)-C(20)-C(21)-C(11) 0.6(2) 
C(2)-C(11)-C(21)-C(20) -42.03(18) 
C(10)-C(11)-C(21)-C(20) -160.93(13) 
C(12)-C(11)-C(21)-C(20) 77.13(16) 
C(28)#1-C(26)-C(27)-C(28) -0.5(3) 
C(26)-C(27)-C(28)-C(26)#1 0.5(3) 
C(31)#2-C(29)-C(30)-C(31) 0.5(3) 
C(29)-C(30)-C(31)-C(29)#2 -0.5(3) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y+1,-z+1    #2 -x,-y+1,-z+1       
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Table 7.  Hydrogen bonds for 2.115  [Å and °]. 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 O(2)-H(2)...O(1) 0.89(3) 1.68(3) 2.5119(16) 155(2) 
 O(4)-H(4)...O(7) 0.85(2) 1.88(3) 2.7194(16) 172(2) 
 O(7)-H(7A)...O(2)#3 0.76(3) 2.26(3) 2.9413(17) 151(2) 
 O(7)-H(7A)...O(3)#3 0.76(3) 2.32(3) 2.9364(17) 140(2) 
 O(7)-H(7B)...O(1)#4 0.88(3) 1.95(3) 2.8307(16) 176(2) 
 C(19)-H(19A)...O(6) 0.977(19) 2.294(18) 2.8049(18) 111.6(13) 
 C(25)-H(25A)...O(4)#5 0.96(2) 2.59(2) 3.2482(19) 125.5(16) 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y+1,-z+1    #2 -x,-y+1,-z+1    #3 -x,-y+1,-z+2       
#4 x-1,y,z    #5 x+1,y,z       
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Appendix C: NMR Spectra for Chapter 3 
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